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Whilst the life expectancy in the world is increasing, there is an epic increase in the 
proportion of people with Alzheimer's disease (AD). Statistics show that over 35 million 
people all over the world and 0.8 million in the United Kingdom living with AD. his 
number is anticipated to double by 2030. AD is characterized by an immense loss of 
neurons leading to a loss of cognitive functions. Despite much effort and advances in 
scientific research and technology, we still don't know the exact mechanism of AD and 
as a result, there is still no cure for this detrimental disease. According to the Amyloid 
hypothesis, AD is caused by the aggregation of neurotoxic Aβ which is cleaved from 
the C-terminal of a very large protein, the amyloid precursor protein (APP).  
A molecular-level understanding is critical to understanding the development and 
progression of AD. Whilst molecular-level experimental techniques such as NMR 
spectroscopy, X-ray crystallography, or atomic force microscopy have advanced the 
field considerably, the early stages of Aβ aggregation largely remain inaccessible by 
experiment. An effective alternative approach is the use of molecular dynamics 
simulation, which has been employed here. 
The thesis aims to advance our molecular-level understanding of Aβ aggregation and 
how it is modulated by selected endogenous and exogenous chemical co-factors. There 
are 4 aspects to the study: (i) a systematic comparison of the popular protein force fields 
to see whether they could reproduce various hierarchical structures of Aβ; (ii) self-
assembly of Aβ using both an all-atom and coarse-grained (CG) approach; (iii) 
interaction of the endogenous glycosaminoglycan heparan sulfate with Aβ; and (iv) 
interaction of curcumin (a predominant component of the spice turmeric) with Aβ – 
curcumin is an inhibitor of Aβ aggregation and also has potential for being a diagnostic 
for detecting amyloid. 
The systematic comparison of protein force fields to see whether they could reproduce 
various hierarchical structures of Aβ revealed that the choice depends on the size and 
complexity of the Aβ structure and the nature of the problem being studied. For 
example, the GROMOS family of force fields is known and was demonstrated here to 
stabilize β-sheets. So, for studying α-helix to β-sheet conversion during Aβ 
oligomerization, GROMOS would be the preferred choice. Similarly, for larger more 
complex systems, our study shows that OPLS-aa is a better choice as it achieves a good 
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balance between α-helix and β-sheet secondary structures and gives significantly less 
deviation (RMSD) for the larger Aβ structures.  
Heparan sulfate is endogenous and is known to co-exist within Aβ deposits and can 
enhance fibril formation, suggesting a pathological connection. Here we have shown 
that it has a strong interaction with Aβ and indeed forms a composite structure with Aβ. 
Its flexibility is considered to be essential and we have also rationalized its molecular 
weight and concentration effects. Curcumin is a natural fluorescent dye and has a 
potential for serving as a non-invasive, highly specific diagnostic agent, along with its 
possible therapeutic role of inhibiting Aβ aggregation. The simulations explain the 
nature of the high specificity of curcumin for Aβ including the variation in contrast 
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1 Introduction 
1.1 Protein structure and function 
Proteins are undoubtedly the most diverse macro-molecules that perform a variety of 
functions including their role as neurotransmitters, enzymes, catalysts, signal 
transductors, and in cellular transport and storage. Proteins are composed of a linear 
chain of amino acids linked together by peptide bonds. The peptide bonds join the amino 
group of one amino acid to the carboxyl group of a neighboring amino acid, giving rise 
to the primary structure of the proteins. The chemistry of amino acids is very important 
because their side chains are involved in holding a specific conformation or structure of 
the protein. The folding of the primary structure of protein together with intra-peptide 
side chain bonding drives the evolution of protein’s unique three-dimensional structure. 
Hydrogen bonding between the amide and carbonyl groups of the main chain of 
peptides is the basis of the secondary structure of proteins. The important secondary 
structures are the alpha helices, beta strands, turns, and sheets (Pauling, Corey, and 
Branson, 1951). There are 3.6 residues per turn in an alpha helix, which means that 
there is one residue every 100 degrees of rotation (360/3.6). This regular ordering of 
residues allows all amino acids in the chain to form hydrogen bonds with each other 
giving rise to alpha helices. The hydrogen bonds are formed between the carbonyl 
(C=O) group of the upper coil and amide group (N-H) of the lower turn. These 
hydrogen-bonding interactions also give rise to parallel and anti-parallel β-sheets 
(which are often represented by flattened arrows). Two anti-parallel β -strands give rise 
to a secondary structure motif known as a β-hairpin. The loop between the two β-strands 
is called a β-turn. Turns and loops are important secondary structure components 
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connecting β-strands to each other and α-helices, or helices to each other, thus playing 
a very important role in the folding process (Berg, Tymoczko and Stryer, 2002). The 
tertiary structure is formed by local folding of single linear amino acids chain into 
polypeptides and multiple polypeptide chains together form the quaternary structure of 
proteins.  Proteins must be present in a folded native conformation to perform their 
biological functions. However, abnormal changes in amino acid sequence (point 
mutations) result in the misfolding of the primary structure leading to the loss of 3D 
structure associated with many misfolding diseases such as Alzheimer’s disease 
(Dobson, 2004). 
1.2 Physiological role of protein self-assembly  
A primary question concerning protein self-assembly is what is its physiological role in 
normal cells? The self-assembly of proteins is ubiquitous in biological systems and is 
crucial to the formation of highly ordered protein architectures that support cellular 
matrix and connective tissues (Sanders et al., 2016). Some proteins undergo assembly 
by design e.g. virus capsid assembly (Selivanovitch and Douglas, 2019) while others 
do so when something goes wrong i-e. a conformational change in the protein, an amino 
acid mutation, or changes in the cellular environment such as solvent, temperature or 
pH (Carrick et al., 2007). The precursor to Aβ production is the protein APP (amyloid 
precursor protein) which itself plays a very important role in many biological activities 
such as regulating multiple aspects of neuronal development (Ramaker et al., 2016). 
Other than Aβ being linked with plaque formation, there is ample evidence that Aβ has 
numerous beneficial roles in human physiology. Aβ peptides may contribute to 
antimicrobial activity (Gosztyla, Brothers and Robinson, 2018), recovery from brain 
injuries (McKenzie et al., 1996), maintaining neuron development (Morley and Farr, 
2014), suppressing certain cancer forms (Ma et al., 2014), and sealing leaks in blood-
brain-barrier (Bishop and Robinson, 2002).  
1.3 Alzheimer’s Disease 
Discovery and Definition of Alzheimer’s Disease 
Alzheimer’s disease was first described in 1911 by the German psychiatrist and 
neuropathologist, Alois Alzheimer, who is considered as the father of neuropathology. 
He discovered the main characteristics of dementia i-e inexorable memory loss, aphasia, 
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delusions, and cognitive impairment, and linked them to physical changes in brain tissue 
using Bielschowsky’s silver staining technique (Graeber, 1998; Zilka and Novak, 
2006). Alzheimer’s disease is the most common cause of dementia which is a 
neurodegenerative disease characterized by memory loss, cognitive impairment, and 
difficulties with language and problem solving. Worldwide, an estimated 54 million 
people are living with dementia. With respect to the UK, there are currently around 
850,000 people with dementia which is expected to rise to 1.6 million and the total cost 
of social care of dementia patients is projected to reach £94.1 million by 2040 
(‘Alzheimer’s disease facts and figures’, 2019). 
During the course of this disease, extracellular plaques and intracellular tangles are 
formed in the brain, which leads to the loss of connection between neurons. This 
eventually causes cell apoptosis and loss of brain tissue (Pant, Mukhopadhyay, and 
Lakshmayya, 2014). As the brain shrinks in volume because of neuronal cells death, 
symptoms become more severe (see Figure 1.1). During the early stages of damage, the 
hippocampus is affected which is involved in day-to-day memory storage. The earliest 
symptoms include difficulty in recalling recent events and learning new information. 
Often the long term memory remains unaffected (Kung, 2012). In later stages, the 
condition becomes worse and the patient suffers from complete cognitive impairment. 
 
Figure 1.1. Cross-sections of the brain as seen from the front. Left represents a normal 
brain and the one on the right represents a brain with Alzheimer's disease. (Brain with 
Alzheimer’s Disease | BrightFocus Foundation, 2017) 
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Key Features of Alzheimer’s disease 
In AD, the normally soluble proteins accumulate in the extracellular space of various 
tissues as insoluble deposits of 10nm fibrils that are rich in β-sheet structure and have 
characteristic dye-binding properties (Glenner, 1980). The common structural motif of 
almost all amyloid fibrils is the β sheets in which the peptide strands are arranged 
perpendicular to the long axis of the fiber, irrespective of the protein sequence 
(Bucciantini et al., 2002). 
Molecular basis of Amyloidosis 
The molecular basis of amyloidosis is protein misfolding. When a polypeptide chain 
fails to remain in its native state or loses its 3-D structure, the potential number of 
misfolded or partially folded structures increases. In this aberrant state the hydrophobic 
residues are more exposed to the solvent, resulting in the formation of oligomers that 
behave as primary nucleus or seed for further aggregation. The peptide chains come 
closer and form a critical nucleus or a seed (nucleation phase) and then elongate to give 
rise to a mature fibril (elongation phase) (Stefani and Dobson, 2003). The process of 
protein assembly was once considered to follow a linear path that initially resulted in 
intermediate species that were very similar to the final native structures (Jahn and 
Radford, 2005). The current perspective is that the partially folded species are 
heterogeneous and there is no single way for them to go to the native states. On their 
journey towards the native state, peptides undergo many conformational changes and if 
suitable contacts are formed, the heterogeneity is reduced (Gilmanshin, Dyer and 
Callender, 1997). This is the case for smaller peptides having amino acid residues less 
than 100.  For larger systems (amino acids greater than 100) with complex and bigger 
side chains compact annular species are formed as a result of the interaction of side 
chains with the solvents. This leads to partially folded intermediate states. Such states 
can either lead to native states or misfolded and aggregated states (Hartl, Bracher, and 
Hayer-Hartl, 2011). 
Pathophysiology of Alzheimer’s disease 
The three important hallmarks of AD are amyloid plaques, neurofibrillary tangles, and 
neuronal cell deaths. The underlying biochemical and physical pathways for AD are 
complex involving various chemical messengers and pathophysiological processes. 
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Various theories have been put forward to explain the cause of the disease. The major 
ones are: 
• Amyloid hypothesis 
• Cholinergic hypothesis  
• Glutamatergic hypothesis  
• Oxidative stress hypothesis  
• Cholesterol  
• Chronic inflammation 
The amyloid hypothesis 
The exact molecular mechanism of AD is still not known, yet one theory, the “amyloid 
hypothesis” overshadows all other theories as to the factors that cause and lead to 
neuropathological damage. This thesis focuses on the amyloid hypothesis to investigate 
the process of aggregation of Aβ and how it is or can be modulated by other molecules 
both endogenous (the glycan heparan sulfate) and exogenous (curcumin) as well their 
interaction with the resulting Aβ assemblies. The amyloid hypothesis views 
extracellular Aβ deposits in the hippocampus and overlying the cortical region of the 
brain as the fundamental cause of the disease. The major protein in neuritic plaques is 
Aβ, a 40-42 amino acid peptide, which is derived from β-amyloid precursor protein 
(APP) after sequential cleavage by β-site APP cleaving enzyme 1 (BACE1).  As a result, 
C99 fragment of APP is released giving rise to a variety of Aβ peptides of varying 
residue lengths during subsequent cleavage by β-secretase (see Figure 1.2). Normally, 
the Aβ peptides that are present in the brain in soluble form are released into the 
extracellular matrix and then rapidly (Abramowski et al., 2008) cleared by the 
cerebrospinal fluid (CSF) directly into the blood (Tarasoff-Conway et al., 2015). The 
two most common Aβ isoforms present in the CSF of normal brains are Aβ40 and Aβ42. 
The Aβ peptides form varying molecular weight oligomers that are released slowly from 
the brain. These oligomers aggregate to form fibrous aggregates of toxic proteins that 
are believed to cause Alzheimer's (Kung, 2012). 
Tau-Hypothesis 
Healthy neurons are supported by microtubules, which are involved in the transport of 
nutrients and neurotransmitters from the body of neurons to axons. Tau protein 
stabilizes microtubules and it generally contains many phosphate groups. In AD, a large 
number of phosphate groups get attached to the tau proteins causing 
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“hyperphosphorylation”. As a result, Tau disconnects from microtubules and gets 
entangled with other tau threads from tangles. Tangles are abnormal or twisted proteins 
found inside the nerve cells. So the microtubules get destroyed and the internal network 
of transport collapses causing cell death (Chou, 2014).  
 
Figure 1.2. Mechanism of amyloid aggregation as explained by the amyloid hypothesis. 
Beta and gamma secretases snip off a segment of APP to yield the amyloid protein that 
assembles with other fragments giving rise to oligomers and then ultimately mature 
fibrils. These fibrils accumulate in the brain in the form of plaques. “Image courtesy of 
the National Institute on Aging/National Institutes of Health”(Alzheimer’s Scientific 
Images and Video) 
Chapter 1: Introduction 
Beenish Khurshid - December 2020       7 
Cholinergic Hypothesis 
Acetylcholine is an important neurotransmitter in the brain, which is involved in 
memory and moods. In later stages of the AD number of cholinergic neurons is 
decreased. It is thought that by preventing degradation of cholinergic neurons and 
associated loss of acetylcholine neurotransmission or by increasing its level in the brain 
may reduce cognitive impairment seen in AD patients (Rogawski and Wenk, 2003).  
Oxidative Stress Hypothesis 
 Amyloid plaques are believed to cause lipid peroxidation in AD brains, which give rise 
to reactive oxygen and nitrogen species. These species react with other molecules and 
achieve a stable state releasing high-energy free electrons (free radical). These free 
radicals cause cell damage and react with all macromolecules including lipids, proteins, 
and carbohydrates. The brain is susceptible to oxidative stress because of its high 
oxygen consumption (Zhao and Zhao, 2013). The net effect of oxidative stress on 
neurons is to make them more vulnerable to damage.  
Glutamatergic Hypothesis  
Postsynaptic glutamate receptors N-methyl-D-aspartate (NMDA) are associated with 
neuronal plasticity i-e learning and memory. Dysregulation at this receptor due to the 
interaction with amyloids, is thought to initiate a vicious cycle of neuronal damage. It 
also increases the production of APP leading to increased rates of plaque development 
and hyperphosphorylation of tau protein (thus NFT formation), oxidative stress 
followed by neuronal toxicity (Butterfield and Pocernich, 2003). 
Cholesterol 
Elevated cholesterol levels appear to increase Aβ production, whereas reduced 
cholesterol synthesis reduces Aβ levels, thus the risk of AD progression (Sjögren and 
Blennow, 2005). 
Chronic Inflammation 
As a natural response to the amyloid plaques, tangles, and damage to the brain, 
inflammation is stimulated. Microglia are the nerve cells, which are involved in the 
defense system of the brain. Thus, they release cytotoxic molecules such as cytokines 
and reactive oxygen species to counter the cell damage. But they do more harm than 
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
8   Beenish Khurshid - December 2020 
protection. This cytotoxicity stimulate other inflammatory processes which may lead to 
apoptosis or cell death (Pimplikar, 2014). 
1.4 The mechanism of Aβ aggregation 
Nucleation and template-assisted self-assembly of amyloid peptides 
The formation of amyloid aggregates is most likely a nucleation dependent 
polymerization mechanism. The rate-limiting nucleation step is the lag phase followed 
by rapid polymerization and fibril formation. A secondary nucleation process may also 
occur whereby fibril surfaces stimulate new oligomer formation, resulting in the 
coexistence of both fibrils and oligomers in the same solution (Cohen et al., 2013). One 
can argue why this nucleation dependent polymerization takes place despite the 
extraordinary resistance of native proteins to aggregate. Evidence in the favour of 
aforementioned mechanism has been presented by many experimental and 
computational studies showing that a peptide may convert from initial conformation 
into disordered intermediate oligomeric states (seeds) and then their reorganization into 
ordered fibrils following a nucleation dependent mechanism (Auer et al., 2008). To 
identify the forces that drive the proteins to fold or misfold is very crucial. The balance 
between hydrophobic forces and hydrogen bonding is different in the normal folding of 
peptides as compared to their amyloid aggregates.  Free-energy calculations show that 
the minimum for the folding process is dominated by hydrophobic interaction while that 
for misfolding is dominated by hydrogen bonding interactions  (Fitzpatrick et al., 2011). 
During aggregation the transition from α-helix to β-sheet depends upon hydrogen 
bonding that is not sequence-specific. This transition occurs for all proteins irrespective 
of their amino acid sequence making it a crucial step of Aβ assembly (Ding et al., 2003). 
The partially folded or misfolded proteins are intrinsically prone to aggregation, and if 
they get the opportunity of favorable intermolecular contacts, their association leads to 
the formation of stable amyloids and ultimately causes amyloid diseases (Estácio et al., 
2014). Aβ may not necessarily give rise to amyloid fibrils following a direct route, 
rather it may give rise to various oligomeric products. Many simulation studies of 
amyloid aggregation show that Aβ dimers show a transition from parallel to antiparallel 
alignment during the simulation (Klimov and Thirumalai, 2003; Santini et al., 2004). 
Zheng et al.’s simulations confirm this transition and proposed that parallel dimers are 
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metastable, and nucleation may proceed with antiparallel conformation. So it may be 
inferred that the antiparallel conformations are formed first, then new peptides are added 
to these oligomers in a parallel fashion (Zhang et al., 2007). The oligomeric state, which 
is considered to play the main role in amyloid aggregation, is a disordered micelle-like 
state. Recent studies on animal models with diseased symptoms show that the amount 
of oligomer extracted correlates better with the severity of amyloid disease as compared 
to the fibrils (Sengupta, Nilson and Kayed, 2016).  
FTIR studies show that the oligomers at low salt and low temperature 25℃ conditions 
show no secondary structure characteristics. However, an increase in temperature to 
37℃ showed the appearance of β-sheets which indicates the conversion of oligomers to 
protofibrils (Ahmed et al., 2010).  MD also supports this conformational conversion at 
a critical temperature below which the peptides remain in α-helical structures and above 
which they misfold into β-sheet rich structures with greater chances to aggregate (Ding, 
LaRocque and Dokholyan, 2005). 
1.5 Structures of Aβ Aggregates 
Various organizational levels of Aβ exist during its aggregation starting from the small, 
soluble monomeric form to oligomers and large insoluble protofibrils/fibrils that are 
visible under a light microscope (Figure 1.3). The formation of Aβ fibrils is not always 
a straightforward process that proceeds from monomers to fibrils. In homogeneous 
aqueous solutions there appear to be different pathways that depend upon conditions 
such as temperature, pH, ionic strength, and agitation. Literature often refers to “on-
pathway” or “off-pathway” structures. “On-pathway” structures are those that will 
eventually form fibrils while “off-pathway” are those that do not form fibrils (Verma, 
Vats and Taneja, 2015).  
It is hard to get reliable structural information on Aβ because of its conformational 
flexibility and its tendency to aggregate in aqueous solution. The primary amino acid 
sequence of Aβ42 is shown in Figure 1.3g. The 3D NMR structure of Aβ42 in aqueous 
SDS micellar solution reveals that it is predominantly α-helical, comprising of two 
helical regions at residues 8 to 25 (helix I) and 28 to 38 (helix II) linked by a turn at 
residues 26-28 (Orlando Crescenzi, Tomaselli, Guerrini, Salvadori, Anna M D’Ursi, et 
al., 2002). A general view based on many structural studies on Aβ fragments and model 
peptides is that the Aβ monomer does not possess a definite secondary structure in 
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aqueous solution, rather it exists in a complex conformational ensemble of collapsed 
coil structures (Zhang et al., 2000). Molecular dynamics simulations of Aβ40 and Aβ42 
suggest that the C-terminal of Aβ42 is more structured as compared to Aβ40 (which is 
short by two amino acids at this terminal). This hydrophobic C-terminal of the Aβ42 is 
crucial in initiating the α-helical to β-sheet conversion that is responsible for its greater 
propensity to aggregate into larger amyloid fibrils (Liu et al., 2010). The soluble Aβ 
monomers aggregate to give rise to a heterogeneous size distribution ranging from low-
molecular weight oligomers (100–200 kDa) to protofibrils and fibrils.  Oligomers are 
short-lived and highly unstable, which is why little is known about their structure and 
conformation. These oligomers that are rich in β-sheets assemble to form protofibrils 
(approximately 5 nm in diameter). Protofibrils then linked linearly to form 
protofilaments, and ultimately fibrils (approximately 10 nm in diameter and may extend 
up to 1μm in length) (Johansson, 2005). 
All the known Aβ species in amyloid cascade are neurotoxic to different extents. An 
increasing number of recent studies suggest oligomers to be more toxic species than 
mature fibrils as they cause rapid neuronal death in vitro and lead to increased 
membrane conductance and rapid calcium influx that triggers apoptotic pathways. 
Besides, they are highly unstable, smaller in size, and have exposed hydrophobic 
surfaces that allow greater interaction with membranes and other cellular targets. The 
difference in the level of toxicity of oligomers and fibrils may reside in the variability 
in their structure and conformation (Verma, Vats and Taneja, 2015).  
Anti-AD therapies  
Since 1998, only five drugs have made it through rigorous clinical trials and been 
approved by the FDA as AD drugs (What’s New in the Alzheimer’s Treatment Pipeline? 
| BrightFocus Foundation-2020). These drugs however; can only reduce the disease 
symptoms but are unable to halt or reverse the process causing AD. Out of these five, 
three drugs donepezil, galantamine, and rivastigmine are cholinesterase inhibitors that 
control the breakdown of a chemical messenger responsible for activity and learning 
(Birks, 2006; Haake et al., 2020). The fourth drug memantine regulates the activity of 
another neurotransmitter called glutamate that is considered to be important for 
memory, attention, reason, language, and learning processes (McShane et al., 2019). 
The fifth drug is a combination of (donepezil) with memantine (Nikl et al., 2019). 
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Figure 1.3. The pathway of amyloid assembly starting from Aβ monomer to low-weight 
oligomers, protofibril, and large fibrils. (a) Solution structure of Aβ42 in the apolar 
microenvironment (PDB: 1iyt); (b) The structure of KLVFFA fragments of Aβ42 
presenting the hydrophobic patch of Aβ42 responsible for higher-order assemblies (PDB: 
3ow9) ; (c) Lower molecular weight oligomer ; (d) Structure of protofibril composed of 
parallel, in-register β-sheets; (e) Aβ42 amyloid fibril displaying triple parallel-β-sheet 
segments; (f) Key showing color codes for secondary structure content in (g); (g) The 
primary amino acid sequence Aβ isoform (Aβ42). 
As of 2019, there were 156 trials of anti-AD therapies out of which 73% are disease-
modifying drugs that are aimed at modifying the course of the disease rather than 
managing the symptoms (Cummings et al., 2019). About 14% of the drugs are being 
tested for their ability to improve cognitive impairment. About 11% are aimed at 
improving behavioral issues related to cognitive decline such as agitation and sleep 
disturbances.  
Disease-modifying small molecules such as Insulin-related molecules, Omega-3 fatty 
acid (Docosa-hexaenoic acid DHA) (Lim et al., 2005), and curcumin derivatives are 
designed to interfere with multiple disease pathways. Epidemiological studies show that 
Curcumin is a good candidate for research in regards to AD because of its multiple 
neuroprotective properties including Aβ inhibition, clearance of existing Aβ plaques, 
reducing oxidative stress, and anti-inflammatory properties (Walker and Lue, 2007).  In 
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
12   Beenish Khurshid - December 2020 
vitro and in vivo studies points towards the beneficial role of resveratrol in reducing Aβ 
toxicity by decreasing Aβ production, enhancing the clearance of Aβ peptides, and 
reduction Aβ aggregation (Rivière et al., 2007; Huang et al., 2011; Granzotto and Zatta, 
2014; Zhao et al., 2015; Santos et al., 2016). Biochemical assays show that resveratrol 
seems to exert its neuroprotective role through inhibiting Aβ aggregation, scavenging 
ROS and exhibiting anti-inflammatory activities (Liu and Bitan, 2012). Similarly other 
herbal compounds like Chinese, Asian, or Korean ginseng which have steroid-like 
active compounds i.e. ginsenosides are thought to be effective for cognition and 
neuroprotective properties (Chen, Eckman and Eckman, 2006). Melatonin is a powerful 
hormone that regulates sleep, provides mitochondrial support, reduces Aβ toxicity, and 
hyperphosphorylation (Pandi-Perumal et al., 2008). 
1.6 Therapeutic issues 
Although amyloid pathology is now decades old, (potential) drug after drug aimed at 
slowing down Alzheimer’s disease have failed in clinical trials. There may be a few 
reasons for this: 
Targeting either synthesis of Aβ peptides, the oligomers, or only the final insoluble 
amyloid aggregate may fail to significantly reduce soluble load. Thus, treatments may 
fail unless the trial target simultaneously all the culprits in the equation, which is the 
"triple therapy" thinking (Mucke and Selkoe, 2012). 
In a few therapeutic approaches, the material in equilibrium with the insoluble Aβ in 
plaques is removed, hoping that it would trigger the release of soluble oligomers from 
the plaques a response analogous to shifting a chemical reaction to the left. If plaque 
removal results in the release and deposition of soluble Aβ and if some soluble species 
are neurotoxic then this would explain why plaque-removing trials have failed 
(Rosenblum, 2014). The structure and dynamic characterization of toxic oligomers have 
been going on at a very slow pace because of their transient nature and intrinsic 
disorders. The nature of amyloid species is highly dynamic so to preserve them to 
maintain native state characteristics for the in-vitro study is a real challenge. Although 
computational methods have an advantage of atomistic detail, yet they lack time and 
length scales available in experiments. 
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1.7 Role of molecular dynamics simulations in biomolecular 
research 
With the advent of high-performance computing, in-silico modeling has become an 
important tool to bridge the gap between experiment and theory. It’s been called 
“computational microscopy” by Schulten (HistoricaPollack, L. Klaus Schulten Reflects 
on his 2015 National Lecture Series) who strongly believes that computational 
techniques have reached to the point where they can present a realistic molecular-level 
picture of cellular components that is not attainable through current NMR spectroscopy, 
x-ray crystallography or atomic force microscopy which are challenged by soft matter. 
The first MD protein simulation was of BPTI (bovine pancreatic trypsin inhibitor) in 
the vacuum in 1977, which were followed by many simulations based on smaller 
systems and shorter timescales (McCammon, Gelin and Karplus, 1977). To overcome 
the sampling problems, system size and timescale issues, many enhanced sampling 
techniques have been developed and successfully employed that include steered 
molecular dynamics (SMD) (Do, Lee and Le, 2018), umbrella sampling (US) (Kästner, 
2011) and metadynamics (Laio and Gervasio, 2008). Besides, efficient molecular 
simulation packages such as Gromacs (Abraham et al., 2015), Desmond (Bowers et al., 
2006), NAMD (Phillips et al., 2005) and Amber (Case et al., 2005) have led to better 
and faster outputs. A wide range of biological processes occur over a timescale of 
several orders of milliseconds that were way beyond the duration of the longest MD 
simulations. To overcome this problem, massively parallel machines called Anton is 
developed that is capable of executing millisecond-scale classical MD simulations of 
such biomolecular systems (Shaw et al., 2008). 
In this era of modern research, molecular modeling is not only making a great impact 
on the field of biomolecular systems but is driving many scientific endeavors.  This 
spans a wide variety of applications ranging from understanding the structure and 
dynamics of small fragments of biomolecules like heptapeptide fragment GNNQQNY 
(Szała-Mendyk and Molski, 2020) to the modeling of large macromolecular systems 
such as the entire viral capsids of viruses (Fujimoto et al., 2020; Jana and May, 2020; 
Marzinek, Huber and Bond, 2020), disease treatment such as prediction of disease 
associated single nucleotide polymorphisms (SNPs) (Pandey et al., 2020), to 
biotechnological applications, e-g designing of nanocomposites and nanostructured 
polymer materials for energy storage (Bačová and Rissanou, 2018; Tafrishi et al., 
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2020). A wide variety of applications include studies of structure-activity relationships 
of biomolecules (Rahman et al., 2020), drug-design (Selivanovitch and Douglas, 2019; 
Kumar, Singh and Patel, 2020; Rahman et al., 2020; Suárez and Díaz, 2020), binding 
free energy calculations for ligands/drugs to their targets (Wang, Zhang and Zheng, 
2020), modeling of membrane pores (Di Scala et al., 2016; Kholina et al., 2020), ion-
channels and transport across the membrane (Maroli and Kolandaivel, 2020) and 
deciphering complex kinetics of protein misfolding (Zhou and Bates, 2013; Liu et al., 
2020). This latter area of protein misfolding and self-assembly is of particular interest 
as it is related with a large number of diseases including Creutzfeldt–Jakob disease, 
Parkinson's disease, multiple system atrophy and Alzheimer’s, disease (Walker and 
LeVine, 2000; Chiti and Dobson, 2009; Westermark et al., 2018).  
The study of amyloid assembly is challenging as these assemblies are inherently 
heterogenous and complex. Molecular dynamics has played an important role in 
complementing the experimental techniques like XRD, NMR and cryo-EM wherever 
possible. All of these techniques though quite powerful in the development of structural 
biology still have their limitations; including the use of non-physiological conditions 
and lack of sufficient resolution to monitor the structural conformations and dynamics. 
By combining molecular dynamics with these static techniques, it has now become 
possible to understand the structures and dynamics biological molecules at an atomic 
scale. Owing to major developments in the efficiency and ease of use of MD simulations 
we are now able to understand to some extent the mechanism of amyloid self-assembly, 
nature of amyloid aggregates including small oligomers and large fibrillar assemblies, 
their kinetic pathways and the mechanisms of how amyloid aggregation can be 
inhibited. For example; a recent study shows that flavonoids directly bind to Aβ both in 
monomeric and pentameric forms and attenuate their hydrogen bonding, salt bridges 
and interpeptide bonds and convert on-pathway fibrils to off-pathway fibrils without 
interfering with the secondary structure motifs (Gargari and Barzegar, 2020). A discrete 
molecular dynamics (DMD) study uncovers the molecular mechanism of how casein 
coated-gold nanoparticles (βCas + AuNP) inhibit Aβ aggregation. The simulations 
show that βCas + AuNPs bind to Aβ fibrils and stop the aggregation process by either 
sequestering the Aβ monomers or coating the surface of the Aβ fibrils and stop the 
secondary nucleation process (Javed et al., 2019) .  
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1.8 Aims and objectives of the thesis 
The present thesis investigates the aggregation of Aβ peptides employing molecular 
dynamics (MD) simulations. The principal goal of this study is to understand the 
aggregation behaviour of Aβ peptides including full-length Aβ(1-42) and shorter 
fragments Aβ(17-22) as model systems, and how this can be modulated by endogenous 
and exogenous substances, using two specific examples curcumin and heparin. 
Aggregation inhibition is an important strategy to develop therapeutic drugs for 
Alzheimer’s. Endogenous co-factors that promote aggregation may serve as additional 
intervention points.  
There are four specific research objectives each of which forms a separate result 
chapter:  
(a). A systematic comparison of force fields used for molecular dynamics simulations 
of hierarchical structures of Aβ peptides. (Chapter 3).  
(b). To understand the aggregation of Aβ monomers into various morphologies as a 
function of concentration using coarse-grain molecular dynamics (Chapter 4) 
(c). To investigate the molecular basis of curcumin’s specificity for Aβ fibrils that 
makes it a promising candidate for non-invasive amyloid tracer. (Chapter 5)  
(d). To investigate the role of heparin in enhancing the process of amyloid aggregation 
and the influence of heparin’s flexibility, molar ratio, and degree of polymerization on 
the formation of Aβ fibrils. (Chapter 6). 
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2 Methodology 
2.1 Molecular simulations theory 
Statistical mechanics 
Molecular dynamics (MD) is a powerful tool in modern computational science that 
calculates the time-dependent behavior of a molecular system. For bio-molecular 
systems such as proteins and nucleic acids, MD simulations provide detailed 
information on the fluctuations and conformational changes that are not readily 
available otherwise.   
Molecular dynamics simulations generate information at the microscopic level, 
including atomic positions and velocities. The conversion of this microscopic 
information to macroscopic observables such as thermodynamic and structural 
properties requires statistical mechanics. Statistical mechanics bridges the gap between 
microscopic motion of individual atoms and macroscopic observables such as pressure, 
energy, heat capacities and temperature, chemical potential, viscosity, spectra, reaction 
rates, etc. It provides rigorous mathematical expressions that relate macroscopic 
observable to atoms and molecules of the N body system. In classic mechanics, a single 
particle in one dimension is described by two coordinates, a position coordinate q and 
the momentum coordinate p. So the microstate of the N-body system in 3-D, is 
described by 6N coordinates.  As the system evolves in time the coordinates of the 
particles change and the system follows a trajectory in this 6N dimensional phase space 
giving rise to fluctuations in macroscopic properties. Most often, precise microscopic 
details are unimportant and a concept of “ensemble” is employed which is a  collection 
of all possible systems with different microscopic states but identical macroscopic states 
(BRYAN, 1902). 
There exist three different equilibrium ensembles with different characteristics defined 
for any isolated system.  
Microcanonical ensemble (NVE): The microcanonical (NV E) ensemble is the simplest 
of all the thermodynamic ensembles. This thermodynamic state corresponds to an 
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isolated system that contains a fixed number of atoms (N), a fixed volume (V), and 
precise energy (E). The first postulate of statistical mechanics principle of equal a priori 
probabilities states that all microstates with an equal energy are equally probable 
(BRYAN, 1902).  
Canonical Ensemble (NVT): This describes a system where the thermodynamic state is 
described by a fixed composition (N), a fixed volume (V), and a fixed temperature (T). 
The system is in thermal equilibrium with a heat bath of fixed temperature.  
Isobaric-Isothermal Ensemble (NPT): In this ensemble thermodynamics sate has a fixed 
number of atoms (N), a fixed pressure (P), and a fixed temperature (T). 
Molecular simulations 
Molecular simulation is a powerful tool that simulates the microscopic properties of 
molecules in terms of structure and interaction between them that is not accessible 
through experiments. There are two main molecular simulation techniques are 
molecular dynamics (MD) and Monte Carlo (MC). In this thesis we have used MD, so 
we will concentrate on MD. One of the main advantages of MD is that it gives direct 
access to the dynamics of a system, as well as a route to measure thermodynamic and 
structural properties with the help of statistical mechanics.  
In the classic MD, all atoms are represented as hard spheres linked by harmonic springs 
that represent bonds. Hard spheres present the position of the atomic nuclei. The charges 
are centered on these nuclei for all atoms that bear charge. Molecular dynamics 
simulation time-step through the trajectory of the interacting atoms. During the first step 
intermolecular force acting on each atom due to its neighboring atoms is calculated. The 
new positions and velocities are then predicted using Newton’s equations of motion and 
the atoms are moved to their new positions. At the new positions, the intermolecular 
forces are re-calculated, and then another step-in time is made. This iteration continues 
for millions of steps in a typical simulation. The intermolecular forces may be calculated 
classically using molecular mechanics (force field) approximation. The integration of 
Newton’s Laws gives rise to trajectories, linking atomic motions through time. 
Application of force to each atom causes an acceleration, dependent upon the atomic 
mass. This relationship was expressed in Newton’s second law is given by: 
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 𝐹! 	= 	𝑚!𝑎! 																																				  
where Fi is the force exerted on particle i, mi is the mass of particle i and ai is the 
acceleration of particle i.  
Other fundamental relationships to relate force, acceleration, mass and position of the 














                           (3) 
The current positions (r), velocities (v) and accelerations (a) can be used to calculate 
the change in the position of the particle in the system.  The calculation of interaction 
forces, in particular, the nonbonded interactions i.e. Lennard Jones and charge-charge 
interaction, is the most expensive part in MD simulation. The number of these pair 
interactions is given by N(N-1)/2 where N is the number of atoms, hence increase by N2 
as the size of the system increases. To compute these forces usually a cut-off is applied 
at some specific interatomic separation, beyond which the forces are assumed to be 
zero. 
Integration Algorithms 
The approximate numerical method used to advance the system by one-time step is 
known as an integration algorithm. A good integrator should be computationally cheap, 
accurate, and allow a longer time step. The popular integrators are the Verlet algorithm, 
the Verlet leapfrog algorithm, and the velocity Verlet algorithm. 
Verlet algorithm 
The equations of the Verlet algorithm are as follows. 
 𝑟"#$	 = 2𝑟" −	𝑟"&$	 +	
𝑓"
𝑚	∆𝑡




	[𝒓𝒏-𝟏 −	𝒓𝒏.𝟏] + 𝑶+∆𝒕𝟒.																					(5) 
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Suppose the system is in the middle of the simulation at time step n. rn is the starting 
position for this time step, rn-1 is the corresponding position at a previous time step. 
Using Equation 5, the position of the atoms at time step n+1 can be calculated. When 
this is done, we are ready to begin the next time step. The algorithm is straight forward, 
needs only modest storage, and is time-reversible. 
The integrator is simple but has a few drawbacks. The positions are given for the n+1th 
time step and velocities for the nth time step. So, the velocities are one step behind the 
positions. In total we have to store atom positions for three consecutive time steps, 
which makes it demanding in terms of memory.  
Leap-frog algorithm 
This is an improved and computationally cheaper version of the Verlet algorithm, as it 
needs to store only one set of positions and velocities. The equations defining this 








 𝒓𝒏-𝟏	 = 𝒓𝒏 +	𝒗𝒏-𝟏𝟐	
	∆𝒕 + 𝑶+∆𝒕𝟒.																		(8) 
 
 
Once the forces fn of the current time step are calculated, the algorithm calculates 
velocities that are half a time step ahead of the current time step n. These velocities are 
then used in calculating the positions of the atoms at one time step ahead using the 
equation. So it seems as if the velocities leap over positions, which is the origin of the 
algorithm's name (Van Gunsteren and Berendsen, 1988). 
The Velocity Verlet algorithm  
This integrator provides both the atomic positions and velocities at the same time step, 
and for this reason may be regarded as the most complete form of the Verlet algorithm 
(Spreiter and Walter, 1999). The basic equations are as follows: 
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 𝒗𝒏-𝟏 = 𝒗𝒏 +		
∆𝒕
𝟐𝒎




Force fields can be classified into two families; all-atom and coarse grain force fields. 
All-atom force fields represent molecules in terms of each of the individual atoms while 
coarse grain force fields replaces atomistic detail with lower resolution, for example, 
the MARTINI force field represents molecules as beads mapping four heavy atoms to 
one interaction site (Marrink et al., 2007). Though coarse grain force fields reduce the 
level of accuracy and information about the properties of the system, yet these are a 
robust approach to simulating very large systems for longer simulation time.  Atomistic 
force fields can further be divided into two groups: all-atom and united atom. All-atom 
force fields represent each atom of the system explicitly for example Amber (García 
and Sanbonmatsu, 2002), OPLS-aa (Jorgensen and Tirado-Rives, 1988) and Charmm 
(Huang and Mackerell, 2013). In contrast united-atom force fields include non-polar 
hydrogens into their connected carbon atoms treating the CHn group as a single particle 
with increased mass. Polar and aromatic hydrogen are still represented explicitly. The 
advantage of a united-atom force field is that it allows the use of longer time-step 2fs 
which makes the calculations faster as compared to 1fs in case of all-atom force fields.  
are derived  
For each force field method, the total energy consists of various energy contributions: 
 𝚬𝒕𝒐𝒕 =	𝚬𝒔𝒕𝒓 +	𝚬𝒃𝒆𝒏𝒅 + 𝚬𝒕𝒐𝒓 + 𝚬𝒗𝒅𝒘 + 𝚬𝒆𝒍𝒆𝒄 +⋯													(11) 
 
where Etot is the total energy which is a combination of bonded and non-bonded energy 
terms. Estr is the energy change as a bond stretches from the ideal unstrained length and 




	𝒌𝒃(𝒃 − 𝒃𝟎)																																(12) 
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where kb is the bond-stretching force constant, b and b0 are the actual and equilibrium 
bond lengths. 




	𝒌𝒒(	𝜽 −	𝜽𝟎)										                          (13) 
 
 
where θ0 and θ are the equilibrium and actual angle bending terms and kq is the angle-
bending force constant.  




	𝒌𝚽	[𝟏 + 𝒄𝒐𝒔(	𝒏𝚽	 − 	𝛄	)]																					(14) 
 
 
where k𝚽 is the barrier to rotation, n is the multiplicity,  𝜱 is torsional angle, and γ is 
the phase factor. The multiplicity corresponds to the number of energy minima as the 
bond rotates through 360 °. The phase factor γ is an important factor as it decides where 
the dihedral potential passes through its minimum value. 
The van der Waals forces are calculated based on the Lennard-Jones potential, which 
computes the energy of interaction between two atoms as a function of the distance 
between them (Jones, Jones, and E., 1924). 












where r is the distance between two interacting atoms, 𝜀 is the energy well depth and σ 
is the diameter of the atoms at zero potential. 
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Figure 2.1. (A). Lennard Jones potential; (B).  Potential energy functions as a sum of its 
components. 









where ε represents the dielectric constant and q1 and q2 show the charges of the 
interacting atoms while rij is the interatomic distance. The various parameters such as 
epsilon and sigma in the LJ equation, partial charges q1 and q2, force constants, and 
ideal bond lengths and angles are all-atom specific and are termed as force field 
parameters. 
System setting in MD simulations 
Setting up an MD simulation is not a trivial task as one needs to consider many factors 
before setting up. This includes the starting configuration of the system under study, the 
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choice of force field and integration algorithms, time and length scales, boundary 
conditions, solvation, and then analysis methods.  
For most of the proteins, the initial structures are generally obtained from protein data 
bank that stores a huge number of x-ray crystallography and NMR structures. If the 
parameters are missing for some proteins, theoretical methods such as homology 
modeling is used. The systems are energy minimized to remove any net fore on them. 
Once the initial choice on the structure of the model, force field, and MD code is made, 
the timescale and time step are chosen. The length of the time scale depends upon the 
system under study and the availability of the computational resources. The choice of 
time step is very important and as a general rule it should be one-tenth of the time that 
the shortest motion takes place. In proteins simulations this is usually the C-H bond 
vibrations which occurs at 10fs timescale, so generally the time step is 1fs. With the use 
of constraints  over C-H bonds with methods like SHAKE, the time step can be doubled 
i-e 2fs (Swope et al., 1982). MD studies are traditionally performed using NVE 
ensemble s but for bio-simulations, it is more practical to use NPT because it resembles 
experimental conditions more closely. 
Ewald summation 
The laborious part of MD is to calculate long-range interactions such as the charge-
charge interaction (Equation 16). It cannot be truncated using a cut-off as employed for 
the Lennard-Jones interaction. There are a variety of ways to address this problem. An 
efficient technique is to use Ewald summation that relies on the system having 
periodicity but is appropriate for molecular simulation whenever periodic boundaries 
are employed, which is the usual case. Ewald summation divides a potentially infinite 
sum in real space into two finite sums; one in real space and the other in reciprocal 
space. Generally, the model consists of a system of simple point charges interacting via 
the Coulombic interaction. Ewald method makes two amendments in this simple model. 
First, each ion is effectively neutralized at a longer range by the superimposition of a 
spherical Gaussian that carries an opposite charge (see Figure 2.2). The point charges 
and Gaussian charges form the real space part of the Ewald sum, which is now short-
range. The second amendment is to superimpose a second set of Gaussian charges, but 
this time it has the same charges as the original point ions (so it cancels the effect of the 
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first set of Gaussians). The potential due to these Gaussians is calculated using Poisson's 
equation and is solved as a Fourier series in reciprocal Space.  
This method is computationally demanding because the reciprocal sum increases with 
𝑁(, where N is the number of particles. That is the reason it is generally applied to 
smaller systems. For larger systems, Ewald summation is normally implemented in the 
simulation codes using the particle mesh Ewald (PME) technique. In this method, the 
charges are mapped onto the grids rather than performing direct summation of wave 
vectors, making the method very efficient (Ewald, 1921). 
 
Figure 2.2. Ewald summation: The sum is divided in the real space and reciprocal space 
by adding a Gaussian 
Periodic boundary conditions 
Even with large computational resources we are still unable to simulate systems that are 
large enough to serve as bulk systems. Therefore, a small section of the system is taken 
to serve as a model/ representative of the bulk system. The boundaries of the system 
must be taken into consideration otherwise it would produce large surface effects. One 
of the solutions to avoid surface effects is to employ periodic boundary conditions (see 
Figure 2.3). This involves generating a box of any geometrical shape (generally cubic) 
and placing a small block of in a cell, and then surrounding the cell with a replica of its 
mirror images of the system. In doing so, now the atoms in the cell are interacting with 
an array of replicas and the cell is no more an isolated section in vacuum rather it is 
surrounded again by the bulk phase. So now if a molecule leaves the simulation box 
from one end, an identical molecule will enter the box from the other side. This 
technique works in conjunction with an idea of minimum image convention for short-
range forces, according to which the molecule will interact only with the closest 
periodic image of its neighbors. These short-range forces are often truncated to reduce 
Chapter 2: Methodology 
Beenish Khurshid - December 2020       25 
computational consumption. This cut-off distance must be less than or equal to half the 
box vectors (Berendsen, van der Spoel and van Drunen, 1995).  Now, the interaction 
energies can be calculated across cell boundaries overcoming the boundary effects. 
Once the choice about MD and other parameters is made, the system is ready to set up, 
and start the simulations. The most important steps of MD simulations are as follows: 
 
Figure 2.3. An example of periodic boundary condition; the primary cell (grey) is 
surrounded by its images (white) 
Energy minimization 
Before starting any dynamics simulation, the system undergoes rigorous energy 
minimization to remove any net energy or high-energy overlaps between atoms. The 
process continues until a stable point or a minimum on the potential energy surface is 
reached. At a minimum, the net force on each atom vanishes. Molecular systems, in 
general, have a very large number of minima and in practice the system converges to a 
local minimum rather than the global minima. 
Energy minimization involves changing the geometry of the system in a stepwise 
manner, so that the system can achieve a minima. In Figure 2.4 below, point 1 is the 
present geometry of the system, so we calculate the energy or slope of the function at 
this point. If this comes out to be positive, it shows that the gradient or step size is too 
large. So the minimization adjusts the coordinates and slope is calculated again. If the 
value comes out to be negative; it shows the coordinate is too small. When the slope 
becomes zero, a minimum has reached. There are a variety of minimization methods 
and I outline the three commonly employed algorithms below. 
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Figure 2.4. The process of energy minimization takes place in a stepwise manner until a 
minimum is reached. 
Newton Raphson method 
This is the most expensive energy minimization technique based on the Taylor series 
expansion of the potential energy surface.  






Here the correction term depends on the 1st derivative (slope or gradient) of the potential 
energy surface and also on the 2nd derivative (curvature). So one needs to calculate both 
of these at every step, which makes it computationally expensive, which is the biggest 
disadvantage of this method.  
Steepest descent 
This makes use of the first derivative of the energy function to locate the minima instead 
of relying on the 2nd derivative, which makes it faster as compared to the Newton 
Raphson method. It assumes 2nd derivative to be a constant hence it is based on 
approximation; that is why this method is less reliable as compared to the above 
mentioned. The energy is calculated for the initial position and the system is moved 
with a very small increment. The cycle is repeated many times and eventually the 
system reaches downhill on the energy surface. The procedure stops when it reaches 
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predefined threshold energy. The advantage of this method is that it is very robust and 
converges even when far away from the minimum. 




The conjugate gradient algorithm accumulates information from one cycle to the next 
to avoid the reverse of the progress made in the previous cycle. For each step the 
gradient is calculated and stored. The computational requirement and storage are a lot 
more than steepest descent, but it is better for larger systems and gives efficient 
convergence. The advantage of this method is that it keeps the previously calculated 
gradients stored in the memory thus avoiding backtracking. It generally finds a 
minimum in fewer steps than steepest descent. Sometimes, it may face challenges when 
the initial conformation is far from a minimum. For such systems, one should first use 
the steepest descent algorithm and follow up with the conjugate gradient for 
convergence. 
Equilibration 
After minimization the system is at 0K temperature. To run MD, the system needs to 
reach the temperature of interest. The velocities are assigned to the atoms by a random 
velocity generator using the constraint of the Maxwell-Boltzmann distribution. The 
temperature of the system is related to the average kinetic energy of the system. The 
most common means of temperature scaling is velocity scaling.  





 where K.E is the average kinetic energy of the system under study, kB is the 
Boltzman constant. The temperature of the system is calculated using this expression If 
it is less than the desired value, it is simply multiplied by the square root of (To/T), where 
To is the required temperature. This step is repeated until we reach the desired 
temperature (Walton and Vanvliet, 2006).  
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
28   Beenish Khurshid - December 2020 
The temperature of the system is controlled during a constant temperature MD as it may 
rise as a result of frictional forces, integration errors, or drift during equilibration. 
Gromacs uses weak coupling schemes such as Berendsen (Berendsen et al., 1984), 
Andersen thermostat (Andersen, 1980), the extended ensemble Nosé-Hoover 
scheme(Hoover, 1985; NosÉ, 2002), or a velocity-rescaling scheme (Bussi, Donadio 
and Parrinello, 2007) to simulate constant temperature MD. 
In the Berendsen scheme, the system is weakly coupled to an external heat bath at some 
given temperature T0. The thermostat will overcome any fluctuations in the kinetic 
energy that will result in incorrect canonical ensemble especially for smaller systems, 
but for very large systems the approximation yields roughly correct results for most 
calculated properties. The deviation of the system temperature from T0 is slowly 






This equation shows that temperature deviation decays exponentially with a time 
constant τ. This method of temperature coupling has a gain of relaxing the system to the 
desired temperature efficiently but because it gives rise to incorrect sampling, it is often 
used in combination with the Nose-Hoover thermostat which correctly generates 
trajectories consistent with canonical ensembles.  
 For constant pressure simulations, the system is coupled to a barostat. The two most 
common and efficient barostat are Berendsen (Berendsen et al., 1984) and Parinello 
Rahman barostat (M Parrinello and Rahman, 1981). The Berendsen algorithm scales 
coordinates of the system and box dimensions every step. These methods Berendsen 
can be combined with any of the temperature coupling methods above. 
The Berendsen algorithm has the effect of a first-order kinetic relaxation of the pressure 






For the systems where fluctuations in pressure or volume are important; for example 
where thermodynamic properties are being calculated, this barostat does not simulate 
the true NPT ensemble. GROMACS also supports constant-pressure simulations using 
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the Parrinello-Rahman approach which is similar to the Nosé-Hoover temperature 
coupling, and in theory gives the true NPT ensemble. 
Production run 
Once the system properties become equilibrated at the desired temperature and pressure, 
one then carries out a production run in which the trajectory of the molecules is stored 
for future analysis. Millions of time steps are required to derive an accurate description 
of the phenomenon under observation. 
2.2 MARTINI model 
Atomistic MD simulation provides structural and dynamic information at a sub-
nanometer length scale and femtosecond timescale. These time and length scales are 
computationally very expensive and cannot be extended beyond microseconds. Several 
approaches have sampling and size limitations. One such approach is coarse-graining 
which reduces the computational cost by decreasing the number of degrees of freedom 
for the molecules thereby reducing the complexity of the system. While using a CG 
model, it is essential not to over-simplify the description of the system as it will lose the 
important features that are required to drive a certain phenomenon. We used the popular 
coarse grain model “MARTINI” for studying the aggregation of Aβ at various 
concentrations described in chapter 4. It was originally designed by Marrink and co-
workers for membranes composed of lipids but later extended to proteins and other 
small biomolecules (Periole and Marrink, 2013). MARTINI model is based on 1:4 
mapping which means that on an average four heavy atom and associated hydrogen 
atoms are mapped on to one interaction site which is represented as a single bead. There 
are four main types of interacting beads i-e polar (P), nonpolar (N), apolar (C), and 
charged (Q). These are further divided into subcategories based on hydrogen-bonding 
capabilities (donor, acceptor, both or none) and polarity ranging from 1 (low) to 5 
(high). The interaction between coarse grain beads describing bond lengths, angles, and 
dihedrals are represented by the parameters that are typical of a classic force field. The 
non-bonded interactions are defined by the Lennard-Jones 12–6 potential. This force 
field was originally designed to be used with GROMACS, but because of easy use and 
implementation, the general form of the potential energy function is now efficiently 
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used in other MD codes such as DESMOND (Bowers et al., 2006), GROMOS (Baron 
et al., 2007) and NAMD (Shi, Izvekov and Voth, 2006). 
2.3 Analysis methods 
After the production run, the trajectories were analyzed using various analysis 
parameters for quality assurance using convergence parameters; root mean square 
deviation (RMSD) and root mean square fluctuations( RMSF) and structural analysis 
for example hydrogen bonds, salt bridges, inter-and intrasheet contacts and distances, 
clustering analysis based on RMSD and secondary structure analysis. 
RMSD 
RMSD is a strong indicator of structure stability and also of any large conformational 
change. We used Gromacs utility gmx rms, which calculates the deviation of atoms in 
a structure as compared to a reference structure (either crystal or energy minimized) 
using the equation below: 
𝑹𝑴𝑺𝑫	(𝒕𝟏, 𝒕𝟐) = [𝟏/𝑴∑ 𝒎𝒊||𝒓𝒊(𝒕𝟏) − 𝒓𝒊(𝒕𝟐)||𝟐]
𝟏
𝟐⋯𝑵𝒊G𝟏 	(23) 
where the term on the right-hand side of equation 23 describes the position of the atom 
i of mass mi at certain time t1. The second term represents the position of atom i of mass 
mI at time t2.  
We used RMSD by implementing g_rms in Gromacs to calculate the standard deviation 
of pre-formed structures from the reference crystal structure.  
RMSF 
To get insights into the stability of the structure, the role of residue flexibility is very 
important. RMSF which is the square root of the variance of the fluctuation around an 
average position for Cα of each participating residue is calculated as: 
𝑹𝑴𝑺𝑭 =	O𝟏/𝑻∑ 𝑻𝒕G𝟏 (𝒓𝒊𝒕−	< 𝒓𝒊 >)𝟐 	⋯(24) 
 
where T is the total number of snapshots from the trajectory, 𝑟!𝑡 is the position of Cα  
atom of residue i at time t and < 𝑟! > is the average position of Cα atom of residue i. 
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Secondary structure analysis 
The secondary structure analysis program (DSSP) is a powerful tool that shows the 
conformational changes occurring during a simulation. This program relies on the 
identification of hydrogen bond patterns and broadly classifies the secondary structure 
motifs into three classes helix (α-helix, 3-10-helix and π-helix), β-strand (isolated β-
bridge, extended β-sheet) and loop (turn, bend). We used DSSP implemented in 
Gromacs and the web-interface of STRIDE (Dmitrij Frishman and Argos, 1995) that is 
also a secondary structure analysis program but also includes dihedral angle potentials 
along-with hydrogen bonds criteria. 
Inter-strand and inter-sheet distances 
Especially for our force field study (Chapter 3), to compare the structural stability of 
various amyloid fibrils, we calculated inter and intrastrand and intersheet distances. The 
interstrand distance is calculated by averaging the distance between Cα atom of a 
residue in one strand and Cα atom of its corresponding residue in the adjacent strand in 
the same β-sheet which is approximately equal to ≈ 0.48nm, whereas inter-sheet 
distance is calculated by averaging the distance between Cα atom of a residue in one β-
sheet and its corresponding Cα atom of the other residue in the adjacent sheet (≈ 
1.07nm) (Nguyen and Hall, 2004).  
 Hydrogen bond analysis 
gmx hbond was employed to calculate intrapeptide hydrogen bonds. g_hbond assigns a 
hydrogen bond between two atoms if the distance between a donor atom and an acceptor 
atom is ≤0.35nm and the angle donor-hydrogen-acceptor ≥120°(Krishna Deepak and 
Sankararamakrishnan, 2016). 
Clustering analysis based on rmsd 
 To explore the conformation heterogeneity of Aβ monomer we used the gromos 
method implemented in the gmx cluster analysis program. This method counts the 
number of neighbors, takes the structure with the largest number of neighbors, assign it 
to one cluster, and eliminates it from the pool using a default cut-off (0.1nm). RMSD is 
used as a criteria to define the distance between structures (Daura et al., 1999). 
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Twist angle 
The β-sheets generally twist in amyloid fibrils to optimize hydrogen bonds, electrostatic 
interactions, and side-chain interactions. Twist angles were calculated from the average 
dihedral angles connecting the first Cα atom to the last Cα atom in the same β-strand 
between adjacent β-sheets along the fibril axis following Jie Zheng,s work. (Zheng et 
al., 2007). 
MM(PBSA) method 
The molecular mechanic Poisson-Boltzmann or the generalized born solvent accessible 
surface area (MM-PBSA) method is a powerful analytical technique to provide a 
quantitative measurement of the binding of molecules e.g. a ligand to a receptor 
(Kumari, Kumar and Lynn, 2014), (Baker et al., 2001). We used this method as 
implemented in Gromacs 5.1 to calculate the binding free energy of amyloid and 
Curcumin. It is a single trajectory approach, which assumes no change in the 
conformation of the complex. The snapshots were saved from the last 30ns trajectory 
of MD performed, which has a stable backbone RMSD value. The binding energy is 
calculated using the following equation 
𝚫𝑮𝒃𝒊𝒏𝒅 =	< 𝑮𝑪 > −< 𝑮𝑨 > −< 𝑮𝑩 > ⋯	(25) 
where C, A and B denote the complex, molecule A and molecule B respectively.  
𝚫𝑮𝒃𝒊𝒏𝒅 =	< 𝚫𝑬𝑴𝑴 > +	< 𝚫𝑮𝒔𝒐𝒍𝒗 >	−< 𝑻𝚫𝑺 > ⋯	(26) 
The free energy of each system is calculated as:  
< 𝑮𝑿 >=	< 𝚫𝑬𝑴𝑴 > +	< 𝚫𝑮𝒔𝒐𝒍𝒗 >	−𝑻 < 𝑺 > ⋯(27) 
where EMM is the standard molecular mechanics' energy terms from bonded, 
electrostatic, and van der Waals interactions. 
𝑬𝑴𝑴 = 𝑬𝒊𝒏𝒕 +	𝑬𝒆𝒍𝒆 +	𝑬𝒗𝒅𝒘⋯	(28) 
while Δ𝐺>?@A  represents the solvation energy comprising polar solvation energy and 
non-polar solvation energy. 
𝚫𝑮𝒔𝒐𝒍𝒗 = 	𝚫𝑮𝑮𝑩 + 	𝚫𝑮𝑺𝑨 	⋯		(29) 
Polar solvation energy Δ𝐺BCis calculated by using the generalized Born (GB) model in 
a continuum model of the solvent and non-polar solvation energy term +	Δ𝐺DE linearly 
depends upon the solvent accessible surface area.  
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2.4 Hamiltonian replica exchanges 
Classical MD suffers from insufficient sampling of conformational space. The free 
energy landscape for protein folding is rugged with hills, traps, and energy barriers. If 
these energy barriers are larger than the available thermal energy, they remain trapped 
in some local minima. To overcome this problem and increase the sampling of 
conformational sampling, several methods have been developed throughout the years. 
These include simulated annealing (Brünger, Adams and Rice, 1997), metadynamics 
(Leone et al., 2010), and parallel tempering or replica exchange MD (REMD) (Qi et al., 
2018). 
REMD has been widely used to enhance conformational sampling. In most REMD 
method, temperature is used as a variable. The conformations that are trapped in a low 
energy minimum escape from it at a higher temperature. For an effective exchange, 
replicas need a sufficient overlap of potential energy at all the temperatures. This 
requires a very large number of replicas and in-turn increased computational time and 
resources.  
A solution to temperature-based replica exchange is Hamiltonian exchange (H-REMD) 
which runs at a constant temperature and uses force field or Hamiltonian as a replica 
coordinate. H-REMD protocol uses the method of simultaneous switching off 
electrostatic and Lennard-Jones (LJ) parameters  (Affentranger, Tavernelli and Di Iorio, 
2006). As protein dynamics are dominated by the interparticle non-bonded interactions; 
modifying these parameters should in principle increase the sampling of conformational 
space. 
The H-REMD simulations were performed with the stochastic velocity Verlet 
integrator. Stochastic dynamics itself control the temperature, so using the Nose-Hoover 
thermostat is no longer required. The Parrinello−Rahman barostat was used for pressure 
coupling in the NPT ensemble with a time step of 20 fs. The nonbonded peptide-peptide 
interactions scaled in each replica using the soft-core scaling method when van der 
Waals parameters were zero. The parameter λ allows smooth scaling of the nonbonded 
interactions. When λ = 0 it represents that all the interactions are switched on and λ = 1 
where all the interactions including van der Waals and columbic are switched off and 
the atoms are behaving like ghosts (non-interacting). To avoid sampling of a completely 
unrealistic system with large overlapping of atoms, a maximum λ =0.8 was used with 
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Δλ = 0.02. Replica exchanges were attempted every 1000 steps. The results of HREMD 
were analyzed by using bar and energy algorithms implemented in Gromacs.  
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3.1 Abstract 
Molecular dynamics simulations are increasingly becoming widespread as an important 
part of biomolecular research. However, the choice of chosen parameters such as the 
force fields significantly affects the outcome. Making this choice is important but 
challenging at the same time as different force fields are calibrated and tested using 
different parameters, which may affect the outcome of the simulation. In this paper, we 
investigate the conformational behavior of four Aβ peptide models varying in size and 
complexity using three popular force fields namely AmberGS, Gromos53a6, and 
OPLS-aa using brute force MD simulations. Our study rationalizes that for Aβ 
monomer AmberGS is biased towards helical structures. Gromos53a6 favors the 
formation of a pair of anti-parallel β-sheets while OPLS-aa produces a mixture of 
secondary structure contents. We report that for large more complex structures such as 
dodeca-fibrils and ring fibrils; OPLS-aa is slightly a preferable choice because it 
resulted in a reasonable agreement with experiments. To our knowledge, this is the first 
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study to compare the effects of force fields on different Aβ assemblies for longer 
timescale. Such a systematic comparison will offer useful guidance to others conducting 
molecular simulations on Aβ aggregation and fibrillar polymorphism. 
3.2 Introduction 
Statistics show that over 35 million people worldwide and 0.8 million in the UK are 
living with Alzheimer’s disease (AD). This number is expected to double by 2030 
(‘Alzheimer’s disease facts and figures’, 2019). Unfortunately, there is no cure for AD 
yet and a full mechanistic understanding still eludes us. According to the popular 
amyloid hypothesis, it is the aggregation and deposition of neurotoxic amyloid β-
peptide (Aβ) which gives rise to the symptoms of AD (Hayden and Teplow, 2013). The 
neurotoxicity in AD is often associated with the formation of β-sheet rich structures 
(Hardy and Selkoe, 2002) of Aβ which means that the conversion of Aβ from native α-
helix form to β-sheet could be a critical stage for intervention. Thus, it's critical to 
accurately predict the conformational state and structure of Aβ and its various 
oligomeric forms. Being soft matter, the various forms and hierarchical structure of Aβ 
exhibit considerable polymorphism and metastability, making it difficult for 
experimental methods such as x-ray crystallography, atomic force microscopy, or NMR 
spectroscopy, to characterize the structures.  and provide comprehensive data on the 
relationship of the structure to the energetics, the effects of specific amino acid 
alteration, and a continuous movie of the events in real-time. Molecular simulation 
studies, wherein we utilize intermolecular interactions to simulate molecular dynamics, 
can overcome some of these limitations. However, the effectiveness of the simulation 
methodology critically depends upon the accuracy of the intermolecular interactions, 
which for biomolecules are modeled using the molecular mechanics approximation 
comprising a potential energy function and a set of atom-specific parameters – the so 
called force field (Petrov and Zagrovic, 2014). 
A wide body of literature investigates the effects of force fields on amyloid peptides, 
(Nguyen, Li and Derreumaux, 2011)’(Cino, Choy and Karttunen, 2012)’(Watts et al., 
2018)’(Fluitt and De Pablo, 2015)’(Zhang et al., 2000) but because each study uses a 
different set of parameters, simulation conditions and force fields, comparisons and 
interpretations of these results is quite difficult. Despite of large array of data, the area 
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describing the effects of force fields on intrinsically disordered peptides is still largely 
unexplored.  
Despite growing interest in using molecular simulation to gain insights into the amyloid 
assembly, there is a limited and sometimes contradictory data as to which force field is 
best for the purpose. The four most widely used in biomolecular simulations are 
AMBER (García and Sanbonmatsu, 2002), (Cornell et al., 1995), GROMOS (Scott et 
al., 1999), OPLS (Jorgensen and Tirado-Rives, 1988) and CHARMM (Brooks et al., 
1983) families. These force fields generally differ in their parameterization, although 
they are regularly being reparametrized to obtain better performance. The OPLS-aa 
force field includes functional forms for all 20 amino acids and has the same functional 
form as AMBER. The parameters for OPLS were optimized to fit experimental 
properties of liquids such as densities and heat of vaporization. GROMOS united atoms 
force field was optimized with respect to the condensed phase properties of alkanes. In 
GROMOS87 the carbon and attached hydrogen atoms are represented as one group 
and van der Waals interactions were calculated from the crystal structures 
of hydrocarbons and amino acids using 0.8nm cutoff radii (Meacham and Green, 1996) 
while in GROMOS96 van der Waals interactions are reparametrized using longer 
nonbonded cutoff radii (1.4 nm) (Schuler, Daura and Van Gunsteren, 2001). AMBER 
ff94 is the most widely used force field for protein simulations in the condensed phase 
which is inspired by the functional form of OPLS and includes fixed partial charges 
calculated by fitting electrostatic potential using Hartree-Fock 6– 31G* level and no 
explicit treatment for hydrogen bonding. The dihedral parameters φ/ψ are optimized to 
fit relative quantum-mechanical energies of alternate conformations of glycine and 
alanine dipeptides (Cornell et al., 1995). The optimized versions of Amber ff94, 
particularly ff99 and ff96 were observed to over stabilize α-helical(Okur et al., 2003) 
and β-strand (Ono et al., 2004; Kamiya, Higo and Nakamura, 2009) secondary structure 
content respectively. This motivated the experts to re-optimize AMBER ff94/96/99 to 
adjust the backbone parameters in order to fix the bias towards a particular secondary 
structure. One of such optimization led to the development of AMBERGS by Garcia 
and Sanbonmatsu where the dihedral parameters φ/ψ are simply zeroed and as a result 
a greater improvement in the agreement of secondary structure content to the 
experimental values is observed (García and Sanbonmatsu, 2002). 
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The basic steps needed to develop new force fields include selection of the function i-e 
force field parameters i-e bonded and non-bonded interactions and adjusting these 
interaction potentials to reproduce selected target data such as x-ray diffraction data, 
force constants from vibrational spectroscopy, heats of sublimation or vaporization and 
densities. This is not a trivial task and is performed by specialists. End user normally 
selects a force field and parameters found in the literature. However, if the required 
parameters are missing, the process is started by borrowing parameters from a similar 
group and then assigning partial charges using QM calculations. This is followed by 
adjusting non-bonded interactions to ensure the characteristic molecular geometry. 
Generally, all force fields for biomolecular simulations have parameters for 20 amino 
acids but parameters must be available to perform simulations of systems containing 
other functionalities such as co-factors, prosthetic groups, inhibitors and non-naturally 
occurring amino acids. Certain force fields contain parameters for a range of groups that 
are readily transferable to other molecules (Halgren, 1996),(Lii and Allinger, 1991). 
Though the transferability of parameters can make simulations possible for any kind of 
system but they should be tested for accuracy and optimized in the same way as the 
original parameters set.  
 Previous studies on comparisons of force fields in the literature focussing on secondary 
structure and conformations of biomolecules, but the results are not unambiguous. For 
example, according to one study CHARMM, AMBER and OPLS force fields produced 
remarkably similar structural and dynamic properties such as SASA, Rg, RMSD and 
secondary structures for three proteins (bovine apo-calbindin D9K, human interleukin-
4 R88Q mutant, and domain IIA of Bacillus subtilis glucose permease-) in a 2-ns long 
simulation(Price and Brooks, 2002). On the other hand, another study found significant 
differences in the ensembles of peptide conformations using CHARMM and AMBER 
(Yeh and Hummer, 2002).  
A notable trend observed in simulations of Aβ is the different structural motifs, 
particularly the secondary structure, being favored depending on the force field. For 
instance, the CHARMM all-atom force field stabilized Aβ as a mixture of helices and 
β-strands with collapsed coils and loops (Siwy, Lockhart and Klimov, 2017).  Lemkul 
and Bevan showed in one of their studies (Gerben et al., 2014) that Aβ40 consists of 
helices (residues 15-23 and 28-38) and random coils in membrane mimicking 
environments using Gromos96 53A6 and SPC water model while AMBER produces a 
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helical structure. Other, later studies have shown similar results (Watts et al., 2018). 
Barz and Urbanc carried out a series of simulations using a combination of OPLS with 
SPC and TIP3P water models showing that the secondary structures of both Aβ40 and 
Aβ42 monomers and dimers consist of β-strands and turns (Barz and Urbanc, 2012).  The 
issue is further complicated by the limited timescale of such simulations, making it hard 
to attribute whether the differences in structure and molecular organization come from 
the different force fields or a lack of sampling. 
Whilst the above simulation studies provided valuable insights into how a force field 
can affect the secondary and tertiary structures of Aβ peptides, their focus was largely 
on how the force fields influenced the structure of a single Aβ peptide or smaller peptide 
fragments.  As simulation interest extends to the various intermediate stages of amyloid 
formation such as Aβ oligomers, protofibrils and fibrils, there is a need to develop a 
better understanding of how well current force fields can reproduce these hierarchical 
structures 
A particular challenge in MD is to study molecular self-assembly, especially of 
biomolecules. The majority of events happening in the cell include self-assembly 
reactions, for example, protein synthesis/degradation, gene transcription, cell 
movement, communication, shape control, and formation of amyloids (Thomas and 
Schwartz, 2017). Despite its centrality, no major efforts are seen to develop such 
modeling tools.  Though there are some recent advances in systems biology tools 
(Faeder, Blinov and Hlavacek, 2009), (Gruenert et al., 2010) and modeling (Karr et al., 
2012) to incorporate parameters for complex self-assembly, major limitations remain 
such as sampling problem arising from extremely large conformational space and the 
accuracy of the force fields. Mass action differential equation (DE) models, coarse-
grained (Baschek, R Klein and Schwarz, 2012) models or even methods based on 
Gillespie's stochastic simulation algorithm (SSA), face challenges because of very large 
systems containing large numbers of intermediate species, high computational cost, 
longer timescales and extensive simplification requirement (Frazier, Chushak and Foy, 
2009). Many studies,  using small peptides with well-defined structures such as 
ubiquitin, the villin headpiece, and the FiP35 WW domain (26–29) have been carried 
out to study their assemblies but they are unable to predict correct secondary and tertiary 
structures, folding mechanisms, and NMR chemical shifts and couplings (Fluitt and De 
Pablo, 2015). Amyloid aggregation is a prime example of self-assembly process causing 
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Alzheimer’s disease but the peptides responsible there lack a unique native 
conformation and are inherently disordered (IDPs) (Ke et al., 2017). From a 
computational viewpoint learning about the structure of amyloid assemblies, the nature 
of forces governing these interactions and amyloid aggregation pathway is very 
interesting but is especially challenging. Therefore, it is difficult to select a force field 
that is anticipated to behave well for modeling IDPs. 
 The polymorphism resulting from the structural inhomogeneity and instability of Aβ is 
the basis for differences in morphology, physicochemical properties, and level of 
cellular toxicity. Therefore, we need to have a good understanding of the structures and 
conformation of various amyloid-forms i-e monomers, oligomers/protofibrils and 
mature fibrils involved in the aggregation process.  Here we have carried out a 
systematic study to investigate the quality of three popular force fields, AmberGS, 
Gromos53a6, and OPLS-aa, for their ability to reproduce hierarchical structures of 
amyloid Aβ. To our knowledge, this is the first study to explore the effect of force fields 
on the structure of large amyloid morphologies. Particular features of the study are the 
extended simulations times (400ns each) enabling sampling of long-timescale 
fluctuations and our mindfulness of the fact that peptide self-assembly is a nucleation 
dependent mechanism.  
Classical nucleation theory predicts a critical nucleus size below which any emerging 
structure is liable to disintegrate and go back into to solution. Above the critical size the 
nucleus is stable and can proceed to develop into an appropriate solid structure. The 
critical nucleus size results from a free energy barrier to the formation of a stable 
nucleus. The barrier results from an intricate interplay between the bulk free energy and 
interfacial free energy of the emerging structure (Anwar and Zahn, 2011) (see Figure 
3.1). When the size of the emerging structure is small (pre-critical), the overall free 
energy for nucleation is dominated by the interfacial free energy which in general is 
positive (unfavorable). The other term, the bulk free energy, is negative (favorable) for 
a supersaturated solution and is proportional to the number of molecules in the emerging 
nuclei and hence to its volume. At some stage as the particle size increases, the favorable 
bulk free energy begins to dominate as the r3-dependent volume term overwhelms the 
r2-dependent interfacial free energy term, where r is the radius of the emerging nuclei. 
Above the critical nucleus size the overall free energy begins to decline and then 
becomes negative, thus stabilizing the nucleus which then can proceed to the growth 
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phase. The critical nucleus size depends on supersaturation, being smaller for higher 
supersaturations. The significance of nucleation for molecular simulation of Aβ 
aggregates is that if the structure is below the critical nucleus size, it may disintegrate. 
Furthermore, we should expect the peptides at the surface to disorder in a bid to 
minimize the interfacial free energy. Consequently, one should be mindful that 
observing structural disintegration or distortions in a simulation need not be a failure of 
the force field, though it could be. 
 
Figure 3.1. Free energy associated with homogenous nucleation of a sphere of radius r. 
3.3 Methodology 
We investigated the stability of 3 distinct peptide structures along with the Aβ monomer 
(1IYT(O Crescenzi et al., 2002)) in MD simulations using the force fields AmberGS, 
Gromos53a6, and OPLS-aa. In total twelve independent simulations were performed 
each of a 400ns trajectory with a cumulative simulation time of 4.8μs. The selected 
structures include (i) 2BEG (Luhrs et al., 2005) a protofibril of the U-shaped peptide 
(5-mer). This U-shaped protofibril is composed of two β-sheets, β1 and β2 that are 
tightly packed with each other. The loop region is stabilized by a salt bridge that is 
formed by the interaction of ASP23-LYS28. Studies show that only these three 
intersheet interactions can maintain the well-defined U-shaped structure of this 
protofibril. (ii) 2MXU (Xiao et al., 2015a) a fibril of S-shaped peptides (12-mer) The 
ss-NMR and cryo-EM experiments show that it consists of an S-shaped triple parallel-
β-sheet segments. The structure shows three β-sheets at residues VAL12-VAL18(β1), 
VAL24-ILE33 (β2) and VAL36-ILE40(β3). (iii) M3Q_3 (1-40) a ring fibril (18-mer), 
fiber diffraction studies show that Aβ ring fibrils consist of cross-β structure having two 
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β-sheets running parallel and β-strands perpendicular to the fibril axis. NMR studies 
show that the two β-sheets (β1 and β2)  are composed of residues LYS16-ALA21 and 
31ILE-VAL36, respectively, and are joined by a turn region.  These β-sheets are held 
together by three specific side-chain contacts formed between residues PHE19-GLY38 
and ALA21-VAL36 and a salt bridge between residues ASP23 and LYS28 (Paravastu 
et al., 2008).The last structure was generated in Modeller V 9.13 (Webb and Sali, 2016) 
using 2LMQ.pdb as a starting structure (Paravastu et al., 2008), whilst the other three 
are solution NMR structures and were taken from protein data bank  (see Figure 3.4). 
The PDB identifiers, amino acid sequences, and initial structures are given in Table 9.1. 
The peptides were solvated using TIP3P, SPC, and SPCE water models for AmberGS, 
Gromos53a6, and OPLS-aa respectively in a cubic box with a distance of at least 1nm 
between the peptide and edges of the box. The simulation details are given in SI-Table 
2. The system was electro-neutralized by adding suitable counter ions so that the total 
charge is zero.  The steepest descent algorithm was used for energy minimization. The 
system was equilibrated stepwise in an NVT ensemble simulation followed by an NPT 
simulation each for 500ps. 
All the simulations were carried out at 300K using the MD code Gromacs version 
5.1.0(Abraham et al., 2015). The van der Waals interaction cut off was 0.8nm for 
AmberGS and 1.4nm for Gromso53a6 and OPLS-aa. Electrostatic interactions were 
handled using the particle mesh Ewald (PME) method with a grid spacing of 0.16 
(Bussi, Donadio and Parrinello, 2007). The temperature and pressure were regulated 
using the Nose-Hoover thermostat and the Parrinello Rahman barostat respectively (M. 
Parrinello and Rahman, 1981). Bonds were constrained using the LINCS algorithm 
(Hess et al., 1997).  
Data analysis  
The peptide structures were characterized by a variety of analytical methods including 
root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of 
gyration (Rg), hydrogen bonds, Cα- Cα inter and intra-sheet distances, and salt bridges 
of peptides. The RMSD-based clustering analysis was performed to explore 
representative peptide conformations for the monomer Aβ from the simulated 
trajectories. For every conformation sampled during the simulation, residues belonging 
to α-helices, β-sheets, or turns were identified using the DSSP program (D Frishman 
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and Argos, 1995). The secondary structure contents (β, helix, and coil) were analyzed 
using the STRIDE algorithm available online (Dmitrij Frishman and Argos, 1995). The 
twist angles for comparison of U-shaped and S-shaped peptides were calculated by 
averaging over the dihedrals between two vectors connecting the first Cα atom to the 
last Cα atom in the same β-strand portion between two neighboring β-strands within a 
β-sheet following Jie Zheng,s work (Zheng et al., 2007). 
3.4 Results 
Aβ42 monomer  
Wild type Aβ42 peptide (-3 charge) represents the first species modeled in this study. 
This is the biologically relevant charged state that is present at physiological pH and 
under the conditions of our systems (Baumketner, 2006). The study of various 
conformational states of Aβ42 during the aggregation process is a challenging task 
because monomer Aβ is intrinsically disordered in aqueous environments(Weber and 
Uversky, 2017). NMR solution studies show that Aβ(1–40), or Aβ(1–42) possess no α-
helical or β-sheet structure(Shao et al., 1999) rather they exist predominately as 
collapsed coils(Zhang et al., 2000). While in the apolar medium, both Aβ(1–40) and 
Aβ(1–42) are present in α-helical conformations (Tomaselli et al., 2006). 
Overall, our simulation for the Aβ42 monomer show similar conformation as other 
helical structures of full-length Aβ, i-e Aβ40(Vivekanandan et al., 2011), however a 
detailed analysis of various force fields reveals significant differences. AmberGS favors 
helical structure while Gromos53a6 stabilizes a pair of β-sheets. OPLS-aa generates a 
variety of secondary structure motives.  The averaged secondary-structure probability 
per residue in terms of regular secondary structure characteristics i-e α-helices, β-sheets, 
turns, and coils is presented in Figure 9.1. Our results show that AmberGS force field 
yields and stabilizes a well-defined elbow-shaped structure that contains two α-helices 
separated by a turn region at residue VAL24-ASN27.  
Whereas in Gromos53a6, in first 10ns, one of the α-helix of Aβ42 monomer converts 
into a pair of antiparallel β-strands and aligns itself right in front of the other α-helix. 
During the next 100ns, another pair of anti-parallel β-strands appears and the β-sheet 
content increases to 14%. After 400ns simulation, the Aβ42 monomer stabilizes a pair 
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of β-sheets at residues LEU34-VAL36 and VAL39-ILE41 and an α-helix at VAL12 -
VAL24. 
In OPLS-aa force field peptide conformation appears mostly to be dominated by turns 
and coils probably due to the intrinsically disordered nature of Aβ42. During the first 
50ns, one of the helices is lost and converted to coil while the other helix persists at 
residues TYR10-VAL24. At the end of 400ns long simulation the structure consists of 
22% α-helix and no β-sheet (see Figure 3.2). The details of secondary structure content 
are shown in table 3 in SI. 
 
Figure 3.2. Representative snapshots of secondary structures of Aβ42 from a 400ns long 
trajectory under the influence of (upper panel): AmberGS, (middle panel): Gromos53a6 
and (lower panel): OPLS-aa. 
As the starting structure of the Aβ42 monomer used in this study consists of primarily 
α-helices, we found from the clustering analysis (clusters indicate some population‐
average conformational similarity) that for AmberGS, all of the major clusters consist 
of two helices separated by a turn region (see Figure 9.1). Structural changes such as 
end-to-end distances vary in all the conformations, though their magnitude is not so 
prominent. There is one major cluster accounting for 48% of the conformations, 
whereas the other account for 20, 20, 5, and 2%. In the Gromos53a6 system, the Aβ42 
structures became more diverse. Besides the major cluster (51%), the other clusters 
account for 13, 8, 7, and 3.5%, respectively. Changes in the secondary structure of the 
residues occur along the sequence for smaller clusters, though the most populated 
clusters stabilize their secondary structures. OPLS-aa structures show varying 
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conformational forms. The most populated cluster (27%) contains the largest α-helical 
content while it is observed to be gradually lost in other clusters. Cluster 3 doesn’t 
contain any α-helix at all.  We measured the secondary structure distribution of Aβ42 
monomer in the three force fields by Stride and shown in Figure 9.3. 
RMSD for the backbone of the Aβ42 for each of the force fields is plotted as a function 
of time in Figure 3.3. In all instances, the RMSD increases with time and then reach a 
plateau, confirming convergence of the simulations. The RMSD for AmberGS is the 
lowest being 0.96±0.1nm and highest for Gromos53a6 at 1.34±0.1nm.  These values 
are relatively large indicating a significant change in the structure and conformation but 
expected as the structure samples a substantial conformational space.  
RMSF reveals a high degree of variability in the residues forming the turn and the C-
terminal region. During the simulation, the Cα atomic fluctuations for AmberGS 
indicated that the residues 10-30 are rigidly stable during simulation with a Cα RMSF 
of approximately 0.25 nm. The obtained results augment the results of secondary 
structure analysis that shows that AmberGS stabilizes the helical structure. The RMSF 
for residues 31–42 ranges from 0.26 to 1.0nm. This sharp increase in the RMSF value 
of the terminal region indicates a conformational change i-e an increase in the bend 
content at C-terminal is observed. Gromos53a6 and OPLS-aa show wider variation in 
RMSF indicating that the regions of greatest flexibility are terminal residues and the 
polar residues. (see Figure 3.3B).  
Looking at the time evolution of secondary structures snapshots for Gromos53a6 in 
Figure 3.2 it is evident that, the most critical step of aggregation i-e conversion of α-
helix to β-sheet takes place in the initial 100ns of the simulation. During the next 300ns 
the structure looks stable. For OPLS-aa there are small fluctuations in RMSD that 
represent the formation of coil and bends.  AmberGS has the lowest RMSD as it 
stabilizes the initial α-helices but the fluctuation represents the change in the structure 
as it becomes more compact. 
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Figure 3.3. Representative data set from 400ns long simulation of Aβ42: (A) Backbone 
RMSD of Aβ42	for	the	three	force	fields, (B) RMSF, (C) Radius of gyration of Aβ42	for	
the	three	force	fields.	
 
The variation in radius of gyration (Rg) for each of the force fields is shown in Figure 
3.3C. The data indicate that the Aβ peptides generally converge to a more compact 
structure.  The measured radii of gyration lies between 0.9±0.08 nm for Gromso53a6, 
1.0±0.09 for OPLS-aa, and 1.2±0.1 nm for AmberGS which is in accordance with the 
literature(Nag et al., 2011). 
Part-2 Fibrils 
This part of the study employs MD to provide detailed structural characterization of 
three fibrils of varying sizes and complexity i-e U-shaped protofibril, S-shaped fibril 
and ring fibril, under the influence of the three force fields as mentioned earlier.   
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2BEG (U-shaped protofibril): 
Over the course of 400ns, we observed very small deviations from the initial structure. 
Some twisting was seen that is evident by an initial increase in RMSD. The converged 
RMSD values for all three force fields range from 0.46- 0.57 nm. 
 
Figure 3.4. Structures of three fibrils of varying sizes and complexity i-e (A). U-shaped 
protofibril,  (B). S-shaped fibril and (C) ring fibril,  (D),(E) and (F) present the top views 
of  U-shaped protofibril. S-shaped fibril and ring fibril. 
 
Figure 3.5. Asp23 – Lys28 (COO - NH3+) forming the salt bridge responsible for 
maintaining the U-shape of the U-shaped protofibril. 
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There appeared to no significant long-range fluctuations in the converged values. 
Having said that, the protofibril using the Gromos53a6 force field showed some 
fluctuations over the period 50-150ns which is due to the disruption of salt bridge 
ASP23-LYS28 (see Figure 3.5) in the top end (chain A) of the protofibril (will be 
discussed later in detail). The converged average RMSD was the highest for AmberGS  
0.57± 0.03nm, giving rise to a compact structure (Rg= 1.33nm) (see Figure 3.6) 
followed by 0.49± 0.04 for Gromos53a6, and then OPLS-aa with a value of 0.46 ± 
0.03nm. The number of interchain hydrogen bonds also remain stable across all 
simulations, with an average of 87.0±4 for AmberGS and Gromos53a6 and 72.0±4 for 
OPLS-aa persisting throughout all of the 400 ns trajectories (see Figure 3.6D). The 
RMSD, Rg, and hydrogen bond analysis as a function of simulation time for the U-
shaped protofibril for each of the force fields are shown in Figure 3.6.	
 
Figure 3.6. (A). Backbone RMSD for U-shaped protofibril from 400ns long simulations 
for AmberGS, Gromos53a6 and  OPLS-aa forcefields. (B) Hydrophobic interactions 
between side chains of PHE19-GLY38 and ALA21-VAL36 of U-shaped protofibril, (C) 
Rg (nm) and (D) Average number of interpeptide hydrogen bonds for U-shaped 
protofibril in AmberGS, Gromos53a6 and OPLS-aa force fields 
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Focusing on the behavior of individual chains, for all force fields, on average each 
protofibril chain stabilized at an RMSD value of approximately 0.25±0.02 nm, 
indicating minimal structural change except for the top chain A of the protofibril that 
showed large fluctuations. NMR studies show that the central chain of the pentamer has 
an RMSD of 0.118nm (Lührs et al., 2005b). The simulations reproduced this RMSD 
remarkably well, the values being 0.12±0.03 nm, 0.25±0.02 nm, and 0.12±0.06 nm for 
AmberGS, Gromos53a6 and OPLS-aa respectively. Representative structures, 
trajectory RMSD and RMSF for selected representative peptide chains, and the 
variation of the Asp23 – Lys28 (COO - NH3+) distances within a chain as a function 
of time are shown for each of the force fields in Figure 3.7 (AmberGS), Figure 3.8 
(Gromos53a6) and Figure 3.9 (OPLS-aa). 
 
Figure 3.7. Representative data set from 400ns long simulation of AmberGS: (A) 
structure of the U-shaped protofibril after 400 ns, generated with VMD; Top, centre and 
lower chain’s ends are denoted by red balls, (B) RMSD values of representative peptide 
chain, (C) RMSF values of representative peptide chains and (D) Asp23 – Lys28 (COO - 
NH3+) distances for all protofibrillar chains. 
The RMSF data shows that the most flexible regions of each chain of the U-shaped 
fibril are the C-terminal residues and those in close proximity of the bend region 
(residues 25-30) which in line with previous reports (Barale et al., 2019). An exception 
here is the top chain in AmberGS, which shows dramatic flexibility in the whole chain 
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with the most prominent being the N- and C-terminal residues (see Figure 3.7C). This 
is due to the deformation caused at the loop region due to the over twisting of the top 
chain (dihedral angle -12°). 
To find out what makes some of the regions of protofibril more stable than the others, 
the role of hydrophobic interactions between side chains of PHE19-GLY38 and 
ALA21-VAL36 was investigated. We calculated the interchain distances between 
PHE19 from β1 of the top chain and GLY38 of β2 of the next chain and so on Figure 
3.6B. 
 
Figure 3.8. Representative data set from 400ns long simulation of Gromos53a6: (A) 
structure of the U-shaped protofibril after 400 ns, generated with VMD; Top, centre and 
lower chain’s ends are denoted by red balls, (B) RMSD values of representative peptide 
chain, (C) RMSF values of representative peptide chains and (D) Asp23 – Lys28 (COO - 
NH3+) distances for all protofibrillar chains. 
The U-shape of the protofibril is stabilized by these interactions, the average separation 
distance being 0.75 ± 0.1nm, 0.99 ± 0.01 nm, and 1.15± 0.05 nm for AmberGS, 
Gromos53a6 and OPLS-aa respectively (distances listed in Table 4 in SI). The 
interactions remain stable for all the chains except for the bottom chains for the 
AmberGS force field where the interaction between ALA21-VAL36 show large 
fluctuations (see Figure 9.4). Similarly for Gromos53A6, generally the hydrophobic 
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interactions remain stable except for the top and lower chains that show large 
fluctuations as evident from the RMSD and RMSF values (see Figure 3.8C). For OPLS, 
all the chains show an increase in the interchain distances at the beginning of the 
simulation but for the rest of the simulation the distances converge to an equilibrium 
value and show little fluctuations (see Figure 9.5). The average distances between 
(F19Cα, G38Cα) and (A21Cα, V36Cα) is close to 1.0nm which is in good agreement 
with the inter-sheet inter-residue distances determined from experiments namely NMR 
(0.8nm) and x-ray fiber diffraction (1.0nm) (Lührs et al., 2005b). 
 
Figure 3.9. Representative data set from 400ns long simulation of OPLS-aa: (A) 
structure of the U-shaped protofibril after 400 ns, generated with VMD; Top, centre and 
lower chain’s ends are denoted by red balls, (B) RMSD values of representative peptide 
chain, (C) RMSF values of representative peptide chains and (D) Asp23 – Lys28 (COO - 
NH3+) distances for all protofibrillar chains. 
The loop region connecting β1 and β2 of the protofibril is stabilized by the interchain 
salt bridge formed by ASP23-LYS28 with an average distance of 0.39 ± 0.05 nm(Barale 
et al., 2019) (see Table 9.3 ). This salt bridge is formed by a Cγ atom of residue ASP23 
and Nζ atom of residue LYS28 (Figure 9.6). Consistent with ssNMR data on amyloid 
fibrils, the structures in all of the force fields maintain interchain Asp23/Lys28 salt-
bridge contacts in the loop region except for Gromso53a6 where the distance between 
interchain salt bridge forming residues show large fluctuations. 
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Table 3.1. Average interpeptide Asp23 – Lys28 NH3+ COO– distances (nm ± Std. Dev.) 
Forcefields Chain AB Chain BC Chain CD Chain DE 
AmberGS 0.38± 0.05 0.37±0.02 0.38±0.02 0.31±0.01 
Gromos53a6 0.41±0.1 0.37±0.07 0.40±0.08 0.58±0.2 
OPLS-aa 0.37±0.07 0.35±0.02 0.36±0.01 0.35±0.03 
The β-sheet is the most prominent secondary structure feature of amyloid fibrils. As 
discussed above the protofibril is composed of two β-sheets, β1 and β2 containing 
residues 18-26 and 31-41 respectively. The interchain distances between PHE19 and 
GLY38 and ALA21 and VAL36 are a measure of the compactness of two β-sheets. The 
strong hydrophobic interactions between these residues provide a stable β-sheet 
structure to the protofibril. Among the three force fields, Gromos53a6 finds 68% of the 
residues in β-sheet conformation while OPLS-aa samples the lowest percentage (41%) 
of β-sheet structure but the highest percentage of coil (42%). For AmberGS the 
percentages of β-sheet structure are around 55%. The percentage of the bend population 
for all the force fields is in the range of 6−12%. Overall, we can rationalize that 
Gromos53a6 strongly favors the β-sheet structure while OPLS-aa provides a good 
balance between β-sheet and coil. 
 
Figure 3.10 The dihedral angle between C-alpha atoms of VAL18 and VAL24 of two 
adjacent β-sheets. 
The presence of twist along the fibrillar axis is common to amyloid fibrils.  However, 
there appeared to be no twisting of β-strands in the initial structure obtained from PDB, 
which may be attributed to the restraints on the inter-strands backbone hydrogen bonds 
used during structure determination. The twist angle of the U-shaped protofibril was 
calculated by averaging the dihedral angle between C-alpha atoms of VAL18 and 
VAL24 (see Figure 3.10). We observe that the force field does affect the topology of 
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the protofibril. The twist angle for the initial energy minimized structure is very small 
but non-zero (-0.6°) between adjacent β-strands, after 400ns, the structure under all the 
force fields adopts a left-handed twist with an average value of -10.73°,  -3.24° and -
9.69° for AmberGS, Gromos53a6 and OPLS-aa respectively. Taken together with an 
intersheet distance of ≃ 4.9nm the twist values extrapolated along the fibril axis result 
in a pitch of 21nm, 6.35nm, and 19nm for AmberGS, Gromos53a6 and OPLS-aa 
respectively. This shows that the conformational plasticity of the protofibril in 
AmberGS is higher but is characterized by a compact conformation as shown by a 
smaller value of the radius of gyration. 
2MXU (S-shaped fibril): 
Overall, the triple-β motif of the S-shaped protofibrils stays preserved throughout the 
simulation (see Figure 3.11). Compared to the structures obtained by Gromos53a6 and 
OPLS-aa, the AmberGS force field simulation yields a more stable structure with a 
lower RMSD  0.37±0.05 nm as compared to 0.61±0.02 nm for Gromos53a6 and 
0.53±0.05 nm for OPLS-aa. This stability is a result of the larger number of hydrogen 
bonds for AmberGS (≥320) The RMSD for similar structures obtained by(Lee, Yoon 
and Shin, 2019) at 500 ns were ∼0.34 nm for CHARMM27 and ∼0.5 nm for 
Amber99sb-ildn, respectively. Note that at around 280ns, there is a sharp increase in 
the RMSD of the fibril for AmberGS due to the extraordinary flexibility of the C-
terminal region of the lowest chain, while the structure in Gromos53a6 though having 
a higher RMSD approaches a plateau and remains stable throughout the simulation 
period Figure 3.12. This difference may be attributed to many factors including the 
larger flexibility of the end chains that induce loss of hydrogen bonds and as a result 
there is the loss in secondary structure as well. 
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
54   Beenish Khurshid - December 2020 
 
Figure 3.11. Representative snapshots of S-shaped Aβ fibril at 400ns. (A) Initial 
structure (B) AmberGS, (C) Gromos53a6, and (D) OPLS-aa force fields.  
 
The main conformation of the structures obtained in all the force fields consists of β-
sheets, i.e., 57% (AmberGS), 80% (Gro-mos53a6), and 42% (OPLS-aa). The content 
of these β-sheets reduces in AmberGS and OPLS-aa resulting in an increase in the other 
conformations, e.g., to bend structures by 11% and 16% respectively. While the fraction 
of bend conformation in Gromos53a6 is 4% compared to the native structure (Table 
9.3). 
Most of the peptides of the fibril especially in the central region forming the core are 
structurally stable with a deviation of less than 0.3 nm. In contrast, the ends of the fibril 
show plasticity. RMSD values show that both the ends, top, and bottom are relatively 
unstable as compared to the center. For AmberGS and OPLS-aa, the lower chains show 
large rsmd indicating big structural changes at the ends. The RMSF of amino acid side 
chains is calculated to measure local changes in the residues of the peptides forming the 
fibril. In both the outermost chains, upper and lower, most flexible regions of the fibril 
are at the N terminal and C-terminal residues.  
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Figure 3.12. Representative data set of S-shaped fibril.from 400ns long simulation of 
AmberGS, Gromos53a6 and OPLS-aa force fields. (A) RMSD values of representative S-
shaped fibril showing the structure in AmberGS has the lowest RMSD  (B) Number of 
residues adopting β-sheet structure; increasing for Gromos53a6 as a function of time, 
(C) Radius of gyration showing OPLS-aa has a higher value of gyration showing more 
extended conformation (D) Total number of hydrogen bonds in the three force fields. 
 
The residues from β1 and β2 sheets are relatively stable because of the interpeptide 
hydrophobic contacts. In both the outermost chains, residues 21−28 show disordered 
conformation while residues 38−42 of the lower end are highly unstable and show 
disordered conformations. This region contains the C-terminal of the fibrils that are 
involved in the formation of the salt bridge (LYS28-ALA42) and is responsible for the 
structural integrity of the triple parallel-β-sheet structure. Due to these fluctuations and 
other effects such as twisting, this particular interaction is no more adequate making 
these regions unstable. For top, centre and lower chains of the fibril, the RMSDs and 
RMSF values are shown in Figure 3.13, Figure 3.14, and Figure 3.15 for AmberGS, 
Gromos53a6, and OPLS-aa respectively. 
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Figure 3.13. Representative data set from 400ns long simulation of AmberGS: (A) 
RMSD values of representative peptide chains; Top, centre and lower chains (B) RMSF 
values of representative peptide chains (C) Representative structures of Top, centre and 
lower chains of S-shaped fibril generated by VMD, (D) Average interpeptide distances. 
The peptides in the centre show minor deviation from the NMR structure irrespective 
of the instability of the ends, especially the lower end. As the data shows the central 
region of the fibril is mostly stable for all the force fields, we chose two chains from the 
core of the fibril to calculate the inter sheet residual distance to get an idea about how 
this interaction is affected by the effect of various force fields. The three β-sheet regions 
(β1, β2, β3) of the fibrils form two hydrophobic cores. β1 and β2 forms the first 
hydrophobic core while β2 and β3 form the second hydrophobic core. These 
hydrophobic cores are stabilized by the interactions of residues HIS14, LYS17, PHE19 
& 20, ASN27, ALA30, and LEU34 of two adjacent chains which in turn stabilizes the 
S-shaped conformation of the fibril (data presented in Table 9.7). These interactions 
generally remain stable for the central chains in all simulations of AmberGS and 
Gromos53A6. While the structure in OPLS-aa, show some variations in the inter-sheet 
residual distances. This is also confirmed by large rms deviation for the central chain 
and overall structure in OPLS-aa.  Plots of inter-chain distances are given in  Figure 
3.13D, Figure 3.14D, and Figure 3.15D for AmberGS, Gromos53a6, and OPLS-aa 
respectively. 
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Figure 3.14. Representative data set from 400ns long simulation of Gromos53a6: (A) 
RMSD values of representative peptide chains; Top, centre and lower chains (B) RMSF 
values of representative peptide chains (C) Representative structures of Top, centre and 
lower chains of S-shaped fibril generated by VMD, (D) Average interpeptide distances. 
A gradual left-handed twisting of β-strands in the β1 region of the fibril is observed (see 
Figure 3.16). To calculate the twist of the fibril during the simulations we calculated the 
average dihedral angles between two vectors connecting the first Cα atom of residue 
VAL12 to the last Cα atom of residue VAL18 in the same β-strand. At the end of the 
respective trajectories,  these two strands from the core region of the fibril show a 
gradual twist for Gromos53a6 (total twist angle of ca. -78° ) but both the ends show 
large twist, unlike AmerGS where the consecutive β1-strands show large fluctuations 
in the dihedral angles and develop a total twist angle of -98°. The structure in OPLS-aa 
is quite disordered and shows large rms deviation as discussed earlier. A similar trend 
is observed in the twist angle for OPLS-aa where the fibril adopts a disordered structure 
with an average twist angle of -104°. Assuming that the distance between two 
consecutive peptides i and i+1 in the fibril is about 0.5 nm, we obtained a pitch of 38nm, 
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48nm, and 51nm for AmberGS, Gromos53a6 and OPLS-aa respectively which is 
comparable to experimental findings  (Schmidt et al., 2009; Zhang et al., 2009). 
 
Figure 3.15. Representative data set from 400ns long simulation of OPLS-aa: (A) RMSD 
values of representative peptide chains; Top, centre and lower chains (B) RMSF values 
of representative peptide chains (C) Representative structures of Top, centre and lower 
chains of S-shaped fibril generated by VMD, (D) Average interpeptide distances. 
M3Q_3-Ring fibril: 
To investigate the relative conformational stability of ring fibril, we calculated 
backbone RMSD with respect to the initial energy minimized structure as a function of 
time. The results are plotted in Figure 3.17. For all the force fields initially RMSD 
increases and then fluctuates around an equilibrium value except for AmberGS (RMSD 
=1.94± 0.21nm) that keeps on increasing.  We found that RMSD for Ring fibril is lower 
in OPLS-aa (RMSD =1.31± 0.07nm) as compared to AmberGS and Gromos53a6 
(1.41±0.12nm). 
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Figure 3.16. (A) Residues defining twist angle dihedral angle between C-alpha atoms of 
VAL12 and VAL18, Representative snapshots of the S-shaped fibrils, (A) AmberGS, (B) 
Gromos53a6 and (C) OPLS-aa. Red stick representations are to point out residue 
VAL18 of β1-sheet where twisting starts. 
Overall large RMSD shows that the structure in all the force fields is undergoing large 
structural changes and systematic distortion especially for AmberGS, i-e conversion of 
initially present disordered regions at N-terminal to α-helices. The three segments of 
this 3-fold symmetry fibril are originally at 60° to each other but undergo a change 
especially for AmberGS which gives rise to a distorted symmetry. Out of all the force 
fields, the structure in OPLS-aa can maintain the original symmetry to some extent, and 
here the angles between the three segments are close to 60° (see Figure 9.7). This is 
consistent with the STEM data and solid-state NMR spectra (Paravastu et al., 2008). In 
all the simulations, the Rg initially decreases but then oscillates around the same value 
during 400ns. The radius of gyration fluctuates about 3.1 nm for AmberGS that has the 
largest RMSD values too (see Figure 3.17B) 
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Figure 3.17. Representative data set of ring fibril.from 400ns long simulation of 
AmberGS, Gromos53a6 and OPLS-aa force fields. (A) RMSD values of representative 
ring fibril showing the structure in AmberGS have the highest RMSD,  (B) Radius of 
gyration of ring fibril; largest for ring fibril as a function of time. 
To understand the difference in the structure and conformation in detail, we performed 
analysis on individual chains forming the fibril segments. In the initial conformation 
both the β-sheets were closely spaced (2.0nm)(Paravastu et al., 2008) but later, the ends 
start to open up except for OPLS-aa,  increasing the distance between two adjacent β 
sheets (end-to-end distance ≥ 3.0nm for AmberGS). The increase in the end-to-end 
distance at the lower half of the fibril and high RMSD of the lower chains together point 
towards a very significant phenomenon of amyloid fibrils i-e twisting. 
For AmberGS, RMSD increases and shows large fluctuations for the lower end (average 
RMSD=0.7±0.1nm) while the centre region and top-end (average RMSD 0.6±0.1nm) 
show slight fluctuations (see Figure 3.18). To further characterize this structural 
fluctuation, we calculated hydrogen bonds between the top two chains, central two 
chains, and the last two chains (donor-acceptor distance cut-off value assigned is 0.35 
nm). Time series of hydrogen bonds is given in Figure 3.18D and it indicates as 
expected that the increase in the RMSD for the lower chain resulting in the opening of 
this end which is due to a smaller number of hydrogen bonds between the last two 
chains. While the central region showing stable RMSD value has a maximum number 
of hydrogen bonds between the two chains. RMSD for the top (1.0±0.1nm) and bottom 
end (0.9± 0.1nm) in Gromos53a6 is even larger than the other two force fields. The 
structure in OPLS-aa shows the least deviation from the initial energy minimized 
structure for all the three regions of the fibril (see Figure 3.20). 
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Figure 3.18. (A). Ring fibril in AmberGS, a snapshot after 400ns (B) Secondary 
structure evolution of ring fibril indicating an increase in α-helical structure (C) RMSD 
values for top, center, and bottom chains (D) Intra-sheet hydrogen bonds between 
representative chains of ring fibril. 
The secondary structure for each force field, is plotted in Figure 3.18B, Figure 3.19B, 
and Figure 3.20B for all the three force fields. For clarity, we have plotted only those 
secondary motives that undergo a significant change. AmberGS produces a remarkable 
difference in the secondary structure as compared to the other force fields in a way that 
there is a high percentage of helical content (17%) as compared to the structures in other 
force fields. Both Gromos53a6 and OPLS-aa show negligible helical content. This high 
propensity of helical structures is correlated to an increase in the RMSD values for ring 
fibril under the influence of AmberGS. Th increase in the number of residues adopting 
helical conformation is clearly visible in Figure 3.18B. For Gromos53a6, the major 
secondary structure is β-sheet (46%) of the residues adopt it (28% for AmberGS) and it 
is stabilized throughout 400ns. OPLS-aa gives a mixture of coils bend) and β-sheet 
regions ( 40%,21% and 29% respectively). 
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Figure 3.19. (A). Ring fibril in Gromos53a6, a snapshot after 400ns(B) Secondary 
structure evolution of ring fibril indicating stable β-sheet and coil structure (C) RMSD 
values for top, center and bottom chains (D) Intra-sheet hydrogen bonds between 
representative chains of ring fibril. 
To investigate this large RMSD fluctuation at different regions of the ring fibril, we 
calculated side chain intrasheet contacts i-e the Cα-Cα distance between, PHE19 and 
GLY38, ALA21 and VAL36 and ASP23-LEU34. If the Cα-Cα distance Ala21 and 
Val36 exceeds 2.0nm, we considered it as an open form of the fibril(Okumura and Itoh, 
2016) and follow the same criteria for other residue pairs. Looking at the values of  Cα-
Cα distances for the chains D, E, and F in table 7 in SI. It is clear that the Cα-Cα distance 
between all the above-mentioned residue pairs noticeably increases at the lower end in 
all the force fields indicating that the β-sheets are well separated at the lower section of 
the fibril giving rise to an open end. While these pairs are close at the top end making 
the β-sheets at the top closer and forming a relatively closed end. We also calculated 
the angle Cα-Cα-Cα which indicates the stability of the loop, i-e the kink region 
connecting the two β-sheets. This angle is around 68°(Okumura and Itoh, 2016) 
according to the NMR conformation but neither of the force field was able to reproduce 
this angle. This difference of the behavior at two ends of fibril is primarily due to the 
difference in the arrangement of the atoms of residues at two β-sheets (even and odd 
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ends). In the lower end, β2 forms weaker hydrogen bonds while β1 forms stronger 
hydrogen bonds that keep it closer to the other β-strands.  This variation in the 
conformation at both ends can explain the unidirectional extension of the amyloid 
fibrils. 
 
Figure 3.20. (A). Ring fibril in OPLS-aa, a snapshot after 400ns (B) Secondary structure 
evolution of ring fibril indicating stable β-sheet, bend, and coil structure (C) RMSD 
values for top, center and bottom chains (D) Intra-sheet hydrogen bonds between 
representative chains of ring fibril. Secondary structure evolution (C) RMSD values for 
top, center, and bottom chains (D) Intra-sheet hydrogen bonds. 
3.5 Discussion 
Molecular dynamics simulations are now a fundamental part of chemical research and 
increasingly essential to understanding biomolecular systems. The accuracy and hence 
confidence in these simulations depends on the force field parameters. Whilst the force 
field parameters for biomolecular assemblies such as lipid membranes are well 
developed, the quality and effectiveness of protein force fields for peptide and protein 
assemblies have largely remained investigated. This is understandable given that we do 
not have ample structural data that could form the basis for parameter optimization. 
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Here we have carried out a systematic comparison of three widely used protein force 
fields in MD simulations to reproduce an increasingly complex set of Aβ assemblies. 
These simulations test the subtle and critical interplay between intra-molecular and 
inter-molecular interactions including hydrophobic and electrostatic interactions in 
stabilizing the fibrillar structures. A particularly challenging test of the parameters is 
the twisting observed in the larger structures.  In making our inferences we also need to 
be mindful that nanocrystal structure instability or disordering of surface sub-structures 
does not necessarily imply a failure of the force field, as nucleation theory 
considerations need to be taken into account. 
The comparison between the force fields is achieved through the use of parameters such 
as RMSD, RMSF, hydrogen bonding, secondary structures, inter, and intrasheet 
contacts.  Generally, the force fields yield results that are in good agreement with 
experiments at a coarse level. Yet, significant differences in the behaviors of peptide 
systems at a finer level of detail are observed as a result of size and complexity. The 
convergence of MD simulations is evaluated by tracking RMSD as a function of time. 
These results assure the quality of the sampling and indicate if the length of the 
trajectories is good enough.  
As shown in the results, the effects of force fields on the structures of Aβ peptides are 
complicated, depending on the size and complexity of systems under investigation. 
Nevertheless, based on these results and the supporting data from previous experiments 
and simulations, we rationalize that for studying amyloid formation, AmberGS has 
strong biases toward α-helical structures. Gromos53a6 that is generally employed for 
studying amyloid formation, favors β-sheet and may lead to incorrect kinetics when 
converting from α-helix to β-sheet which is a crucial step of amyloid aggregation. OPLS 
might provide a good balance in structure as well as in kinetics and, therefore, is suitable 
for simulations of biomolecules.  These force field effects are discussed here based on 
two main aspects: structure and dynamics of Aβ.  
The effects of force fields on the parameters associated with the structural integrity such 
as Rg revealed little differences between the force fields, suggesting that the range of 
conformations sampled by each force field is, roughly, the same. Examination of Cα -
backbone stability gives some idea about the reproducibility of the experimental 
structure. For the monomer Aβ, the peptide is undergoing a large conformational change 
which results in a larger RMSD value. Especially for Gromos53a6 where the initial α-
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helical structure is converting to a pair of antiparallel β-strands. For the large fibrillar 
structures, each of the force fields tested give comparable results in most of the cases. 
Generally, for all the model peptides, OPLS-aa produce stable structures with less 
deviations from the experimental structures. 
Now talking about the fibrillar Aβ, we have observed in our simulations that no matter 
which force field is employed, there are structural and fluctuational differences between 
the ends and core of the fibrils. In many instances, even the top and bottom chains of 
the fibrils show significantly different behaviour that is linked with the unidirectional 
elongation of the fibrils (Han and Schulten, 2014). The ends of the fibril form an 
interface between the fibril and solution and may generally adopt a different molecular 
structure and character from the peptides in the bulk region. The two ends of the fibrils 
(even and odd based on the direction of hydrogen and oxygen atoms) expose different 
sides to the solvent. For example in U-shaped protofibril comprising two β-sheets (β1 
and β2), the β1 exposed at the even end makes stronger hydrogen bonds and favors β-
sheet formation while the β2 exposed at the odd end forms weak hydrogen bonds.  That 
is the reason that one end can easily interact with the incoming monomer forming 
hydrogen bonds and leads to unidirectional fibril growth. Generally, it’s the lower end 
of the Aβ, that fluctuates more adopting mostly open and sometimes a close form. While 
the upper end adopts a close form. The conformational flexibility of the lower chain 
(that is actually the odd end of the fibril) is due to the position of the β2 sheet (Okumura 
and Itoh, 2016). Our findings well agree with the results of recent high-speed AFM 
experiments (Watanabe-Nakayama et al., 2016). From the previous studies using 
AMBER parm99SB force field48, it was found that there is less fluctuation at the top 
end (even) than at the lower (odd) end. As a result, the even end forms much stronger 
β-sheet that is favourable for any incoming peptide at this end (Kahler, Sticht and Horn, 
2013). Another study predicted that the extension speed is 40 times larger for this end 
as a result of stable hydrophobic interactions (Han and Schulten, 2014). But there are a 
few studies that report much smaller difference in the behaviour of the two fibrillar ends 
as in reference  (Schwierz et al., 2016). We see in our simulations that for ring fibrillar 
structures in AmberGS, the lower end shows large fluctuations (average 
RMSD=0.7±0.1nm) as a result of smaller number of hydrogen bonds between the last 
two chains of the fibril while the centre region and top end show slight fluctuations. Cα-
Cα distance between PHE19 and GLY38, ALA21 and VAL36 and ASP23-LEU34 
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noticeably increases (longer than 2nm) at the lower end in all the force fields indicating 
that the β-sheets are well separated at the lower section of the fibril giving rise to an 
open end. Similarly, for the S and U-shaped fibrils, in AmberGS and OPLS-aa, the 
lower chains show large rsmd indicating big structural changes at the ends while the 
centre shows minor deviation from the NMR structure irrespective of the instability of 
the ends.   
Fibril twisting is fundamental to the stability of the amyloid fibrils. Generally, we 
observed the presence of a gradual left-handed twist of β-strands of the fibril that is 
more prominent in AmberGS and OPLS-aa (Schmidt et al., 2009, 2015; Gremer et al., 
2017). The values of the twist angles for the S-shaped fibril in AmberGS (-98°), 
Gromos53a6 (ca. -78°) and OPLS-aa (-104°) show that deviations from the starting 
structure results from the twisting of the β-sheets as described in literature (Kahler, 
Sticht and Horn, 2013). Additionally, reduced intermolecular LYS28-ALA42 salt 
bridge interactions for the lower chains in these structures in all three force fields are 
indicative of such structural changes (Table 9.8 in SI). For the U-shaped protofibril the 
structure under all the force fields adopts a left-handed twist with an average value of -
10.73°, -3.24° and -9.69° for AmberGS, Gromos53a6 and OPLS-aa respectively. Here, 
the magnitude of the twisting is not that high as in longer fibrils and the interchain salt 
bridges are well preserved except for Gromso53a6. This observation suggests that 
twisting of the fibrils is size dependent and the twist angles increase rapidly with length 
of the fibril as seen in Aβ Protofilament pair twisting in Amber force field (Kahler, 
Sticht and Horn, 2013). These observations also indicate that twisting of the fibrils is 
favoured by AmberGS and OPLS-aa force fields.  
In the context of the secondary structure of the monomer, the structural data suggest 
that Aβ is highly α-helical in the apolar environment, is largely coil form in aqueous 
solution (Zhang et al., 2000), and forms β-sheets in fibrillar form (Chen et al., 2017). 
Whatever the conformational state may be at the beginning of the assembly process, the 
equilibriu, conformation of Aβ monomer is predominately β-sheet. CD spectroscopy 
presents Aβ,s solution structure in water consisting of 1.1% α-helix, 60.4% β-strand, 
31.4% random coil, and 7.1% β-turn. Here, we found that none of the force fields could 
exactly produce these values and the coil structure is the most dominant conformation 
in both Gromos53a6 (35%) and OPLS-aa (33%) while α-helix varies with the force 
field. The equilibrium structures are essentially compact for all the three force fields 
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with a radius of gyration ranging from 0.9-1.2nm (AmberGS force field that predicted 
the most elongated structure out of three; Rg=1.2nm). This is consistent with the 
experimental hydrodynamic radius of 0.9 nm determined by single-molecule 
fluorescence spectroscopy(Nag et al., 2011). This result points out that Gromos53a6 
and OPLS-AA produce more compact structures that are in accordance with the 
previous study that indicates that in water Aβ is collapsed into a compact structure that 
is a mixture of  loops, strands, and turns (Zhang et al., 2000). These compact structures 
are believed to serve as a nucleus for further aggregation in-vivo. In addition, the α-
helical content is largest for AmberGS (73%) while β-sheet (14%) is maximum for 
Gromos53a6. This is comparable to experimental CD spectra of WT Aβ42 that contains 
12% β-sheet and 3% α-helix. Though the β-sheet content of Aβ in the simulations is 
well below the experimentally observed value but our simulation shows the formation 
of antiparallel β-sheet, which is one of the fundamental events underlying amyloid 
diseases. Furthermore it is also consistent with the  experimental NMR chemical-shift-
index (CSI) analysis in that β-sheet is present at the C-terminal region at residues 
LEU34-VAL36 and VAL39-ILE41(Chong, Yim and Ham, 2013). The presence of a 
high coil, bend and turn population in the residues ILE31-LEU34 and VAL36-VAL39 
in simulated Aβ42 is also in accord with the experimental NOE intensities, which 
suggest disordered structures in the hydrophilic regions. Such agreements with the 
experimentally observed NMR J-coupling constants, CD spectra, NMR CSI and NOE 
intensity analyses validate our simulation procedures for the monomer Aβ42, which 
were also employed for simulating other amyloid models (Hou et al., 2004).  
For the larger more complex Aβ fibirls, a number of studies have shown that the 
prominent secondary structure is β-sheet. So, the question is, how well a certain force 
field is preserving the  the β-sheet conformation of the peptides. Our simulations show 
that significant and predictable deviations are observed in terms of the percentage of the 
residues adopting β-sheets.  For the U-shaped protofibril, in Gromos53a6,  68% of the 
residues adopt  β-sheet conformation (47% for experimental solution NMR structure). 
Only OPLS-aa produced β-sheet content closer to the experimental value (41%). For 
the larger fibrils S-shaped fibril, again Gromos53a6 overestimates β-sheet content by a 
whooping 30% while OPLS-aa stabilizes the originally present β-sheets quite well. For 
the complex 3-fold symmetry structure, the disordered region present in the structure at 
the N-terminal is converted into α-helix in AmberGS with the subsequent loss of coil 
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content while Gromos53a6 and OPLS-aa do not produce any significant α-helix. This 
is in accordance with a number of studies showing that Amber favours helical structures 
over extended β-strand conformations, Gromos53a6 may overestimate β-sheet 
conformations, while OPLS produces a balance between α and extended-β 
conformations (Gerben et al., 2014). These results are coherent throughout the 
simulations and also rationalize the other experimental and computational observations. 
The biases in  the force fields towards a specific secondary structure motif comes from 
inadequate backbone dihedral term parametrization. Dihedral terms in the original force 
fields especially Amber are continuously being reparametrized to improve the 
agreement with high level QM data but only partially succeeded. Therefore, a more 
systematic revision is clearly needed. 
3.6 Conclusion: 
To obtain a combined picture of the effects of force fields, we conclude that force fields 
for a particular system may give different answers that may not be appropriate for a 
given problem. Depending on the force field and the choice of parameters during the 
simulation, it may work very well or very poorly. In terms of biomolecular simulations 
in general and amyloids in specific, it is important to recognize the actual problem, 
expected behaviour and the properties being tested and then making a judgment in 
selecting a suitable force field. The next and the most important question is of-course 
the kind of accuracy a user is looking for? Is it qualitative, quantitative or a general 
behaviour or a trend? So in totality, one can argue that since Aβ is known to be largely 
composed of β-strand and random coil elements, it appears that the Gromos53a6 and 
OPLS-aa may be a better choice for modeling Aβ which is also supported by other 
studies on shorter Aβ fragments (Smith et al., 2015). Since α-helix-β-sheet conversion 
forms the basis of Aβ oligomerization and is a crucial step of Aβ aggregation, to study 
such a process, Gromos53a6 seems a better choice as the conversion of α-helix-β-sheet 
is achieved in Gromos53a6 in the available timescale. While for larger system such as 
Aβ fibrils, for which secondary structure is already known to be stable β-sheets or 
consist of folded states, OPLS may be slightly preferred. The observed differences in 
the behaviours of force fields highlight the importance of continuous force field 
refinement. These findings may have implications for simulations of other IDPs 
Intrinsically disordered proteins) of varying sizes and complexities. 
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4.1 Abstract 
In this study, a hierarchical computational approach (all-atom to coarse grain to 
enhanced sampling) is introduced to study self-organizing structures of peptides as a 
function of concentration. Several sets of U-shaped single peptide of Aβ42 containing a 
pair of β-strands are considered as an example to illustrate the phenomenon of self-
assembly which is believed to be involved in various amyloid diseases such as 
Alzheimer’s disease. We observed that there is a sweet spot of concentration for fibril 
growth where a unidirectional fibrillar structure is formed. Above and below that 
diffused and spherical aggregates are formed receptively. Analysis of the gyration 
radius of peptides, solvent accessible surface areas, and cluster formation as a function 
of time provides insights into the assembly mechanism of Aβ42. The aggregation 
propensity and aspect ratio at that particular concentration indicates that the fibril 
growth is unidirectional, and elongation of the structure is preferred over lateral growth. 
This is indicative that at a longer time scale there may be a rearrangement in the fibrillar 
aggregates to produce ordered fibrils. 
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4.2 Introduction 
Amyloid aggregation/self-assembly is at the core of more than 25 diseases which 
include Alzheimer's, Parkinson's, type II diabetes, amyotrophic lateral sclerosis, 
and prion diseases (Chiti and Dobson, 2009). Amyloid aggregation is a spontaneous 
process in which small Aβ peptides produced by the fragmentation of amyloid precursor 
protein (APP), self-assemble to form highly organized fibrillar aggregates. Aβ is largely 
unstructured and highly flexible. It is present in the form of a collapsed coil in the 
aqueous solution. The lack of a structure is perhaps one of the reasons for the poorly 
understood function of Aβ peptides. A better understanding of the structure and 
mechanism of its aggregation and the effect of various physiological conditions can 
develop a clear perspective of amyloid aggregation and its biological implications.   
A large number of in vitro studies performed on amyloid aggregation clearly show that 
the kinetics of amyloid fibril formation is controlled by peptide concentration and the 
critical step of the formation of cross β-structures. The process involves the transition 
from a homogenous solution to the formation of an aggregate that co-exists with 
monomers in the solution phase.  It follows a sigmoidal growth curve which comprises 
three stages: a lag phase, growth phase, and a plateau phase (Arosio, Knowles and 
Linse, 2015). The monomers form a β-sheet rich disordered oligomer during the lag 
phase which is thermodynamically unfavorable and thus considered a rate-limiting step. 
When the emerging nuclei reaches a critical size, more monomers join in and the 
elongation process starts that leads to the formation of ordered fibrils (Luiken and 
Bolhuis, 2015). According to the classical nucleation theory, small clusters (formed 
from monomers), are characterized by large, unfavorable interfacial energy between 
solute and water. The nucleation is governed by a balance between interfacial free 
energy and bulk-free energy. Initially when the size of the nucleus is smaller than the 
critical size, the nuclei is unstable because of the large interfacial energy. As the size of 
the cluster increases, the interaction energy between monomers in the bulk of the cluster 
increases decreasing the total free energy. As a result, the cluster/nuclei become stable 
and the probability of monomer addition increases further, leading to the growth phase. 
This process growth by nucleation is the key step in amyloidosis (see Figure 4.1) (Chiti 
and Dobson 2006). However, the nucleation in biomolecular systems may not 
necessarily follow classical nucleation due to the size and flexibility of proteins and the 
macromolecular crowding inside cells. Macromolecules including proteins, nucleic 
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acids, polysaccharides, and co-factors together take up around 40% of the cell volume. 
In-vitro experiments are conducted on solutions containing lower concentrations (less 
than about 1 mg/ml) of these crowders as compared to the real biochemical environment 
in the living systems (50–400 mg/ml) (Minton, 2001). This crowding is thought to be 
characterized by repulsive interactions between macromolecular species that lead to 
proteins adopting more compact conformations (as compared to the more expanded 
unfolded state) thus speeding up aggregation. In terms of intermolecular interactions, it 
means that crowding pushes the equilibrium towards the aggregated states that are more 
compacts. As shown by simulations performed by (Latshaw, Cheon and Hall, 2014); 
that crowding can increase the aggregation rate by speeding up the formation of the 
fibril nucleus (the transition state) but the fibril elongation is reduced as a result of 
increased viscosity and excluded volume.  
However, recent technological advancements especially with in-cell NMR (Li and 
Pielak, 2009) and fluorescence resonance energy transfer (FRET) probes (Groen et al., 
2015) it has become clear that the description based entirely on steric repulsion is not 
sufficient.  Each protein is subject to multiple interactions through specific and 
nonspecific interactions such as hydrogen bonding, hydrophobic and electrostatic 
integrations, and Vander Waals. The combined effect of all these forces determines the 
stability of the structure formed and the process of aggregation (Sarkar, Li and Pielak, 
2013). For example, repulsive electrostatic interactions between negatively charged 
surface patches of peptides can result in the formation of more expanded structures 
rather than compact states resulting in the destabilization of the structure and increase 
in the amount of unfolded protein in the cell. The strong dependence of protein’s 
structure, conformation, and aggregation on the nature of the crowding agents hampers 
the effort to reproduce the environment that mimics the living cell. These studies are 
mandatory to completely understand amyloid aggregation but are highly challenging.   
The physical chemistry perspective of the effects of crowding are pretty clear. Crowding 
implies high concentrations of the various molecules in the extracellular milieu. This in 
general raises the chemical potential (the affinity of a molecule for an environment) of 
any given molecular species. The chemical potential reflects the supersaturation and is 
the driving force for excluding the molecules out of the solution leading to nucleation 
and growth of the solid phase, in this case the Aβ structures. 
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Figure 4.1. A schematic diagram of nucleation-dependent self-assembly of Aβ 
Circular dichroism (CD), Fourier-transform infrared (FTIR) and nuclear magnetic 
resonance (NMR) spectroscopy are currently being used as powerful techniques to 
characterize structural transitions during amyloid aggregation. It has now become 
possible to explore the phenomenon with increase molecular understanding by the use 
of fluorescence methods, isotope-edited infrared Spectroscopy and quasi-elastic light 
scattering spectroscopy (Streets et al., 2013). These methods are successful in providing 
useful information about the mechanisms of fibril formation, identification, and 
classification of peptide self-assemblies such as oligomers, proto-fibrils, amyloid fibrils 
and crucial parameters which are difficult to measure otherwise due to heterogeneity of 
the products in the system (Chiti and Dobson, 2006). The NMR diffusion experiments 
employing the pulse-field gradient show that Aβ40 and Aβ42 are present as random coils 
in aqueous solution, while in a lipid mimicking environment the Aβ is present in helical 
form. The two helices present at residues 15–24 and 29–35 and the surrounding region 
are unstructured and flexible. Another NMR study shows that Aβ40 adopts a β-hairpin 
structure when interacts with another binding protein which might represent the 
transient metastable structure needed for aggregation initiation (Hoyer et al., 2008).  
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With the accessibility of high-end computing and improved parallelization, it has now 
become possible to study the aggregation of Aβ peptides at a longer timescale by using 
explicit all-atom MD. Aβ40 and Aβ42 peptides prefer β-sheet conformation when present 
in the form of a dimer (the overall β-content is ≈ 20% while α-helical content is below 
10%). The conversion from α-helix to β-sheet is a slow process and hence believed to 
be the rate-limiting lag phase of amyloid aggregation (Xu et al., 2005). Aβ42 has two 
extra amino acid residues at the C-terminus and due to higher solvent exposure at this 
site, it follows an aggregation pathway that is quite different from Aβ40 (Yan and Wang, 
2006). This is probably the reason behind its high cytotoxicity as compared to Aβ40 
despite it being present at a lower concentration in the CSF in AD. However, since 
amyloid aggregation usually happens at a much longer timescale and experiments show 
that the process can exceed hours, in-vitro to follow the full aggregation pathway from 
monomers to the fibril is beyond the current computational reach of all-atom 
simulations.  
Atomistic models yield the required molecular resolution but because of the limited 
time- and length-scales that they can access, they can only probe the earliest stages of 
aggregation. A way forward is to utilize coarse-grained models that enable simulation 
of larger systems and for longer simulation times by compromise the resolution. The 
process of self-assembly of Aβ as studied by using these coarse-grain methods show 
the presence of amorphous aggregates before ordered fibril formation. In the first stage, 
called the "burst" stage, highly mobile oligomers of varying sizes are formed which 
form a significant number of inter and intrachain contacts in the second step giving rise 
to compact but disordered structures. The presence of amorphous aggregates prior to 
the formation of ordered fibrils is seen in many simulation studies; for example 
simulations of several polyalanine peptides show their assembly into discorded 
oligomers and then amorphous aggregates prior to the formation of b-sheet rich 
structures (Nguyen and Hall, 2006). Coarse grain simulations rationalize the 
experimental observations that the end product of aggregation differs depending upon 
the experimental conditions such as temperature and concentration (Wu and Shea, 
2011). Peptides with higher b-sheet propensities give rise to ordered b-sheet rich fibrils 
(on-pathway) while peptides with smaller b-sheet propensities can form amorphous 
aggregates (Bellesia and Shea, 2007, 2009). Similarly low temperatures favor 
amorphous aggregates as the peptide does not have sufficient energy to overcome the 
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kinetic barriers while at high temperatures longer and fewer b-sheet rich fibrils are 
formed (Nguyen and Hall, 2004). Auer and co-workers showed in their simulations that 
at higher concentrations, the formation of disordered oligomers is favored though their 
properties are temperature-dependent. At lower concentrations, the peptides directly 
convert to b-sheet structures without passing through the disordered oligomeric phase 
(Auer, Dobson and Vendruscolo, 2007).  
In nature, there is a tendency for the system to be driven by thermodynamics but the 
organization that is formed in the biological systems is modulated by the kinetics of the 
process. Complex systems like proteins are characterized by large free energy 
landscapes that are separated by free energy barriers that are hard to escape with the 
available thermal energy and as a result the system is kinetically trapped. Because we 
wanted to explore the thermodynamics and the resultant organizational structure of the 
aggregate, if the system was not trapped, two approaches were considered, i-e 
temperature replica exchange MD (T- REMD) and Hamiltonian replica exchange MD 
(H-REMD) (Sugita and Okamoto, 1999). REMD simulations have been successfully 
applied to many aggregation studies of Aβ dimer (Man, Nguyen, and Derreumaux, 
2017). There is, however, an important limitation of temperature REMD that the range 
in temperature that can be covered becomes markedly reduced with an increase in 
system size. The configuration exchanges are based on a Monte Carlo energy criterion 
and as the system size increases the energy distributions decrease in their overlap, which 
needs to be compensated by reducing the temperature differences. This implies more 
replicas and a limited temperature range making the method computationally expensive 
and less effective. So, for larger system as ours (System-II) in explicit solvent, T-REMD 
is not a method of choice as the number of replicas needed to cover a given range of 
temperature is roughly equal to the square root of the number of degrees of freedom. 
And for such larger systems this can become computationally very expensive 
(Fukunishi, Watanabe and Takada, 2002). An alternative to this method is Hamiltonian 
REMD which is generally run at constant temperature and only Hamiltonians (energy 
functions) of the molecules of interest (the proteins) are modified but not of the rest of 
the system (Affentranger, Tavernelli and Di Iorio, 2006). HREMD studies carried out 
by Strodel and coworkers for Aβ42 show that the β-sheet content of Aβ dimer increases 
at lower pH, while the metal chelation can increase the exposed hydrophobic surface 
area, leading to an increase in aggregation and polymerization.  
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Current evidence shows that Aβ plaques formation occurs years before the actual 
manifestation of the disease. Though the details about earlier events of AD are still not 
resolved, it is expected that in this process, at low concentrations, only monomers are 
present in solution. However, as the concentration exceeds a critical aggregation 
concentration (cac), larger aggregates are formed. The supersaturation drives this 
process and dictates the final size, shape, and morphology of the nuclei and the fibril 
(Yang et al., 2006).  Some of the deposits of Aβ are diffused while others are dense core 
fibrillar forms based on their staining with Aβ specific dyes such as Congo red and 
Thioflavin (Serrano-Pozo et al., 2011). Diffused plaques are generally present in 
cognitively intact elderly people while dense core plaques are related to AD. It is still 
not known how long the entire process takes, but some researchers speculate that it may 
take years to occur in the body (C. Vickers et al., 2015). 
Here we explore the effects of concentration on the kinetics and the structure formed 
both by all-atom and coarse-grain methods. As it has been already established that it 
takes days in-vitro for the formation of mature fibrils, which is beyond the reach of 
computational resources that we have today. A way forward to access larger systems 
with longer timescales is to coarse grain a molecular model which is an approach we 
have taken here. Since, in this study MARTINI force field was used for the coarse-
graining the amyloid structures, the secondary structure was conserved throughout the 
simulation, which does not allow the peptide structure to reorganize.  After all of these 
outstanding issues, we can say that this study is a fair approximation of the phenomenon 
of self-assembly. We used H-REMD as an enhanced sampling method to investigate 
the structure and conformation of equilibrium structure as the timescales in the body 
are likely to be orders of magnitude slower. 
 
4.3 Methodology 
Three types of simulations were performed; 
(i) Atomistic simulations with various system sizes (peptide concentrations) to 
monitor Aβ aggregation process in detail;  
(ii) Coarse-grained (CG)MD simulations using martini force fields with the same 
systems in two steps (for fast sampling). During the first step, we investigated 
the effect of concentration of the monomers on the shape of aggregate. This was 
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a screening step in distance restrained CG-MD was used. In the second step, we 
selected the concentration at which peptides formed 1-Dimensional fibril; A 
longer simulation of 2 μs was run to look for any internal re-organization of the 
fibrillar structure into a more-ordered form.   Another set of simulations was 
performed for unidirectional growing partially ordered fibril to observe the 
effect of temperature on the shape of the fibril;  
(iii) H-REMD simulations to see if the unidirectional structure obtained from CG is 
the equilibrium structure? 
The monomers were initially modeled as a pair of β-strands and the coordinates were 
taken from the NMR structure of Aβ(17−42) (PDB ID: 2BEG) (Lührs et al., 2005a). This 
structure consists of parallel in register β-sheets that contains two β-strands (residues 
18−26 and 31−42) connected by a turn region (residues 27−30).   
The all-atom molecular dynamic (MD) simulation was performed using GROMACS 
package (version 5.1.1) (M.J. Abraham, D. van der Spoel, E. Lindahl, B. Hess and 
Team, 2015) with  GROMOS96 53A6 force field and SPC/E water (Berendsen, Grigera 
and Straatsma, 1987). All of the systems at various peptide concentrations (number of 
peptides 20, 40, 60, 80, and 100) were solvated in a cubic box where the distance 
between solute and the edges of the box was 1nm. The systems were electro-neutralized 
by adding counter ions and replacing water molecules. Before starting the dynamics, 
the systems were energy minimized using steepest descent algorithm to remove any bad 
contacts. Equilibration was done in two steps using NVT and NPT. The NVT step 
consisted of 100 ps simulation with peptides constrained.  NPT equilibration was carried 
out for 400 ps using Parrinello-Rahman barostat to maintain a constant pressure (1 atm) 
(M Parrinello and Rahman, 1981). Electrostatic interactions were calculated using the 
Particle Mesh Ewald summation method (PME) with 0.16 grid spacing (Darden, York 
and Pedersen, 1993). The cut-off radius for both electrostatic and van der Waals 
interactions was set to 1.2nm. LINCS method was used to constraint the bond lengths 
(Hess et al., 1997). All the systems were simulated for 200ns with a time-step of 2fs. 
The structural analysis was performed using VMD (Humphrey, Dalke, and Schulten, 
1996) and GROMACS analysis tools.  
For the CG representation, elastic network ElNeDyn, was applied to the Aβ structure, 
which generates harmonic bonds between the backbone beads and preserves the overall 
β-sheet structure (Periole et al., 2009). The upper and lower elastic bond cut-offs were 
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set to 0.9nm and 0.5nm respectively and the elastic bond force constant was set to 500 
kJmol-1.  
All the coarse grain simulations were performed with the GROMACS package (version 
5.1.1) (M.J. Abraham, D. van der Spoel, E. Lindahl, B. Hess and Team, 2015). The 
aggregation process was studied by randomly placing varying numbers of Aβ 
monomers at six different concentrations of peptides (number of peptides 20, 40, 60, 
80, and 100) with a distance between peptides and the box edges of at least 1.5nm. The 
system was solvated with pre-equilibrated CG water beads for coarse-grain systems and 
neutralized by adding counter-ions and replacing water molecules. Energy 
minimization of each system was done by using steepest descent minimization. The 
solvent and ions were equilibrated around the protein for 500ps in two steps i.e. NVT 
and NPT using Particle mesh Ewald (PME) algorithm to calculate electrostatic 
interactions. V-rescale algorithm was used for temperature coupling. Parrinello-
Rahman algorithm was used for pressure coupling with isotropic pcoupletype. For 
electrostatic and van der Waals interactions, we used a straight cut off (1.2 nm). The 
detail of all the systems used in this study is described in Error! Not a valid bookmark 
self-reference.. 
The length of coarse grain simulation was 400ns for each run except for System-II that 
was run for 2μs. The simulation temperature was set on 360K for the screening step. 
While for the second step of coarse grain study i-e the effect of temperature on the shape 
of the aggregate, three different temperatures were used i-e 300K, 400K and 500K. 
Analysis was performed by calculating Rg and SASA at various concentrations. Cluster 
analysis was done for quantitative characterize of the observed assembly process, two 
Aβ monomers belong to the same cluster if the distance between any beads of the two 
monomers is less than 0.7 nm (Xu, Chen and Wang, 2014). The aspect ratios were 
calculated to qualify for the formation of unidirectional growth of amyloid fibril.  
The replica exchange simulations were performed with the stochastic dynamics (SD) 
that do not need an external thermostat (Bussi, 2014). The Parrinello−Rahman barostat 
was used for pressure coupling in the NPT ensemble with a time step of 20 fs. The 
nonbonded peptide-peptide interactions scaled in each replica using the soft-core 
scaling method with α = 0.5, softcore power p = 1.0, and interaction radius of σ = 0.3 
when van der Waals parameters were zero. λ = 0 represents that all the interactions are 
switched on and λ = 1 where all the interactions including van der Waals and columbic 
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are switched off.  The simulations run in parallel and non-interacting with Δλ = 0.02. 
Hamiltonian Replica exchanges were attempted every 10, 500, and 1000 steps for three 
test runs. The starting coordinates of the peptides were generated by inserting them 
randomly in the box, running energy minimization and equilibration using the full force 
field. The results of HREMD were analyzed by using bar and energy algorithms 
implemented in Gromacs.  
Table 4.1: Simulation conditions showing Number of amyloids, water molecules, counter 
ions (NA), simulation box size, temperatures and simulation length 
Screening 
Step (1) 








1 20 20 16 16 16 360 400 
2 40 40 16 16 16 360 400 
3 60 60 16 16 16 360 400 
4 80 80 16 16 16 360 400 
5 100 100 16 16 16 360 400 
 
 
Figure 4.2. The initial CG structure of Aβ showing backbone beads in grey and side chains in blue. 
 
Chapter 4: Molecular Simulations Reveal a Sweet Spot for Fibril Formation of Beta Amyloid (17-42) 
Beenish Khurshid - December 2020       85 
4.4 Results 
Secondary structure and topology of spontaneously aggregated Aβ peptides at various 
concentrations – all-atom MD 
The self-assembly events were monitored for Aβ peptides at five different 
concentrations i-e 20, 40, 60, 80, and 100 peptides. Representative snapshots from 
simulations of all the systems IA, IIA, IIIA, IVA, and VA are shown in Figure 4.3. 
These snapshots indicate spontaneous self-assembly of monomers initially in α-helical 
conformation into β-sheet rich aggregates in 200ns long simulations minimizing their 
solvent accessible surface area (SASA) see Figure 4.4. SASA analysis shows a rapid 
initial decrease that reflects a very fast assembly process. The secondary structure 
content analysis shows that the self-assembly is accompanied by a conversion from α-
helix to β-sheets (see Table 4.2).  For all the systems, though β-sheet rich aggregates 
were formed but not ordered and topologically quite diverse (see Figure 4.3). We 
observed a good amount of local order of β-sheets particularly at lower concentrations 
i-e system-I (20 peptides) and system-II (40 peptides). While at higher concentrations 
β-sheet rich conformations were formed that were completely disordered. Since time 
scales accessible to atomistic simulations do not allow us to follow the complete self-
assembly process, we carried out CG simulations with the same system concentrations. 
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Figure 4.3. Atomistic simulations carried out at five different concentrations of Aβ 
revealed various morphologies of Aβ showing some local order but were not able to give 
rise to unidirectional Aβ fibrils; Total number of peptides are (a) 20, (b) 40, (c) 60, (d) 80 
and (e) 100  
 
Figure 4.4. Solvent accessible surface area (SASA in nm2) vs time (ns) shows there is a 
drastic decrease in SASA in the first few nanoseconds. After which it which remains 
converged to an equilibrium till the end of the simulation without any further decrease. 
This implies a very fast aggregation of Aβ peptides that gives rise to β-sheet rich 
aggregates that remain trapped in their conformation throughout the simulation.   
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Coil β-sheet β-bridge Bend Turn 
I (20) 0.55 0.26 0.05 0.10 0.01 
II (40) 0.49 0.34 0.03 0.09 0.01 
III(60) 0.61 0.20 0.04 0.10 0.01 
IV(80) 0.61 0.20 0.04 0.10 0.01 
V(100) 0.62 0.20 0.03 0.10 0.01 
 
Coarse-grained molecular dynamics (MD) simulations at different concentrations 
The initial coarse grain structure of the Aβ17-42 peptide is shown in Figure 4.2. The effect 
of concentration on the aggregation was determined by running a series of simulations 
with different amyloid concentrations.  A varying number of amyloids were randomly 
placed in the box to observe whether they aggregate to form fibrils or not. And if they 
do so, what is the degree of order in these aggregates. Although factors such as pH, 
temperature, and simulation conditions affect the outcome of such simulations, we 
investigated the effect of concentration and temperature only. The results show that 
supersaturation greatly affects the process of assembly and hence the shape of the 
aggregate; which is in accordance with the literature (Liang, Wang and Shen, 2016). 
With an increasing concentration of Aβ, the hydrophobicity increases that leads to the 
formation of larger dense aggregates.  These computational simulations of Aβ17-
42 peptide might be helpful to understand the spontaneous formation of different 
nanostructures via self-assembly (see Figure 4.5). It shows the snapshots of the Aβ17-
42 peptide systems at various concentrations using coarse-grained models. All the 
peptides aggregated in five systems, but with different aggregation morphologies 
ranging from spherical to longitudinal fibril like and sheet-like aggregates with 
hydrophobic residues residing in the interior and charged residues directed outside 
towards the water. Moreover, analyzing the trajectory revealed that at lower 
concentration (system-I), neighboring peptides aggregated into small clusters and that 
these small clusters merged into one large cluster in a very short time (see cluster 
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distribution in Figure 4.6). The resultant spherical aggregate is formed within 25ns and 
maintains its structure throughout 400ns. The system with 40 peptides (system-II) gave 
rise to laterally growing, unidirectional, disordered protofibrils immediately in the 1st 
few nanoseconds. This shows that at this particular concentration Aβ17-42 peptide could 
self-assemble into a nano rod-like structure. The peptides at still higher concentrations 
could not form a unidirectional growing nanorod or fibril rather the simulations with 
peptide 60, 80, and 100 yielded a glass-like amorphous aggregate (here referred to as 
nanosheets). To investigate the stability of longitudinal fibril like structure, we extended 
the simulation of this system to 2μs. It is apparent from Figure 4.5b that the growth of 
elongated fibril does take place, but the structure is not ordered. The monomers 1st give 
rise to disordered oligomers, and then they lock into disordered fibrillar aggregate. This 
disordered phase is so stable that it is unable to reorganize itself into well-ordered 
protofibril even after 2μs. We did not see any dissociation in these structures once they 
were formed.  This inference is well in line with the work done by Sorenson et.al in 
2011 who carried out a similar kind of study on decapeptide hIAPP protofibrils and 
observed the formation of disordered assemblies (Sørensen et al., 2011). 
To study the process of aggregation in detail, we measured the solvent accessible 
surface area and radius of gyration for all the systems. The SASA greatly reduced in all 
the five systems. In system-I, the value of SASA reduces from 500nm to 300nm. The 
value of Rg for this system is very small (2.0nm) as it forms a spherical aggregate. The 
x, y, and z components of this aggregate are almost the same confirming the formation 
of a spherical structure. For system-II that contains 40 peptides gives rise to long, 
unidirectional unbranched but disordered fibril like structure within 6ns. The value for 
SASA in system-II decreases from 971nm to 610nm in the first few nanoseconds and 
then fluctuate around a mean value. The Rg for this system is twice the value for system-
I aggregate because of its longitudinal structure.  For the systems-III, IV, and V, 
consisting of 60, 80, and 100 peptides the value of SASA reduces from 1420nm-880nm, 
1500nm-1100nm, and 1900nm-1400nm and Rg is 3.4, 4.2nm and 4.5nm respectively. 
Large values of Rg indicate the formation of diffuses sheet-like aggregates.  
To look for 1-dimensionality of these aggregates which is generally seen in the fibril 
forming peptides, we calculated their moments of inertia (MOIs) along the principal 
axes for the largest cluster present in the system. The results showed that only system-
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II is forming a 1-Dimensional fibrillar structure with an aspect ratio of 5.1. The details 
of aspect ratios are presented in Table 4.3. 
 
 
Figure 4.5. Structures of aggregates formed by Aβ at various peptide concentrations for 
400ns in three independent replica studies. 
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
90   Beenish Khurshid - December 2020 
 
Figure 4.6. The plots show the rapid assembly of Aβ into a single aggregate. (A) plot of the 
number of aggregates (clusters) vs time shows that higher the concentration, more 
quickly the aggregates are formed. (B) Zoom in to the time zone where the aggregate 
formation is taking place from monomers to oligomers and finally aggregates (for which 
number of clusters = 1); (C) Decrease in the radius of gyration; dramatic decrease at the 
lowest concentration because a spherical structure is formed.	




The growth of ordered fibrils was not observed in any of the simulations. For longer 
fibril-like structure, it was observed that the fibril once formed, gets stuck in the 
disordered conformation and stays as such even after 2μs. To study the effect of 
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temperature on the shape of the fibril, a set of three additional simulations was run at 
300K, 400K and 500K. The structure of the fibril remained stable till 400K; however, 
at 500K, an amorphous aggregate was observed which indicates the denaturation of 
peptides. Hence it gives an idea that there is a specific concentration; temperature pair 
parameter, which gives rise to unidirectional pseudo fibrils (see Figure 4.7).  
 
 
Figure 4.7. Effect of temperature on the shape of the fibril. The figure shows that with 
an increase in temperature the unidirectional fibril like structure collapses into globular 
aggregate. 
4.5 Discussion: 
Concentration-dependent Aβ peptides aggregation leads to the formation of various Aβ 
conformations 
Self-assembly is an association reaction which gives rise to supramolecular structures. 
Formations of tertiary structures of proteins require concentrations to be above the 
saturation level. In fact the supersaturation should be beyond the metastable zone width 
to overcome the nucleation barrier. And from the protein crystallization point of view 
it is known that there is a sweet spot with respect to supersaturation for the crystal 
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nucleation and a separate one for the crystal growth. Higher supersaturation gives rise 
to amorphous structures whilst lower supersaturation in-principal to ordered structures, 
although the time scale in the latter case could be very long. Studies show that the order 
fibril formation could take days in-vitro. A careful inspection of the trajectory shows 
that there is a rapid encounter of the monomers in the first few ns followed by the 
formation of disordered oligomers. These oligomers form the fibrils quickly, but they 
do not resemble the mature ordered fibrils. This may be because of the time scale that 
we are using in our simulation, which restricts the formation of fully ordered mature 
fibrils.  
Several in-vitro studies show the oligomerization of Aβ is concentration-dependent and 
results in the formation of aggregates of diverse sizes and lengths. At very low 
concentration (below 20 μM), no oligomers are formed even after 10 days. The 
concentration of Aβ42 (below 30 μM) gave rise to prefibrillar oligomers while at higher 
concentrations (50–75 μM) ordered fibrils were readily formed.  The prefibrillar 
oligomers at lower concentrations do not form ordered fibrils but convert into another 
kind of oligomers of the same shape and size but different toxicity (Ladiwala et al., 
2012).  
The unidirectional fibril like structure formed in System-II was simulated for 2μs. The 
structure remained stable throughout with no disintegration. Self-assembly of proteins 
is an irreversible phenomenon. But usually it means that the rate of disassembly is very 
slow, and the equilibrium always remains towards fibrillar form rather than monomeric 
form. Simulations at various temperatures show that the long fibril-like structure is 
thermally quite stable and retains its structure till 400K. Beyond that the structure is 
unable to hold its shape and collapse to a disordered globular structure. Because at this 
point the thermal energy becomes higher than the bonding energy, the individual 
molecules start moving with respect to each other, and a spherical structure is formed 
as it reduces the interfacial energy. 
The crystallization of proteins like any other compound is driven by the minimization 
of free energy of the system (Weber, 1991). When the solution reaches a state of 
supersaturation it is thermodynamically driven to an equilibrium state that corresponds 
to a new energy minimum which is approximately 3-6 kcal/mole lower than the energy 
of the system when it was in a saturated state (Drenth and Haas, 1992). The molecules 
make new non-covalent interactions thus losing their degrees of freedom. This results 
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in the formation of aggregates that can either be crystalline or amorphous, but the 
amorphous aggregates are usually more favorable kinetically and hence dominate the 
process. The final structure depends upon the strength of interaction between the 
molecules. If it is above a few KT, the structure remains kinetically trapped in a 
particular conformation and does not lead to an ordered crystalline structure. As for Aβ 
peptides the binding energy between two anti-parallel β-strands forming a β-sheet is ≈ 
20 kcal/mole, it is not possible for the peptides to undergo an internal rearrangement to 
form an ordered structure.  
Non-specific hydrophobic interactions lead to the formation of diffused aggregates 
Self-assembly of peptides is a ubiquitous phenomenon that is driven by hydrophobic 
interactions and hydrogen bonding.  This self-assembly drives the amyloids to 
aggregate into first disordered oligomeric form and then fibrillar form. The peptide 
concentration controls the oligomerization of these peptides in the solution (Schmit, 
Ghosh, and Dill, 2011). The hot spots for aggregation which are charged residues on 
protein surfaces form complementary interactions with the same amino acid on the other 
protein. Several amino acids in the peptide are hydrophobic and they remain buried in 
the core in the native state but as the amyloid starts to unfold these hydrophobic residues 
reveal themselves and inter-protein associations increase. Similar effects are commonly 
observed in experimental studies (Shivu et al., 2013).  Aβ undergo aggregation in a two-
step process. First, they formed globular micelle like oligomers, which then cluster to 
give rise to a bigger aggregate.   A closer inspection shows that the main interactions, 
which stabilize the aggregate are hydrophobic. Residues ALA 42, ILE 41, VAL 40, 
VAL 39, VAL36, MET 35, LEU34, ILE 32, ILE 31, ALA30, ALA24, PHE20, PHE 19, 
VAL18, LEU17 are all hydrophobic. Thus, the hydrophobic interactions are the main 
driving force behind the self-assembly process of Aβ peptides. The non-polar residues 
exclude the water molecules and form a hydrophobic core (see Figure 4.8). This 
hydrophobic core is the hub of stability found in the cluster. 
Self-assembly at one particular concentration leads to the formation of long 1-D fibrillar 
structures while others lead to diffused aggregates. The difference in behavior seems to 
lie in the way these peptides assemble. The terms “self-assembly” and “aggregation” 
are often used interchangeably, but in reality, both processes are different. Self-
assembly is dominated by specific hydrogen bonding while aggregation is driven 
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through hydrophobic interactions. That is probably the reason that hydrophobicity 
driven structures are amorphous or less ordered as compared to self-assembled 
structures. In our simulations, at high supersaturation, the increased hydrophobicity 
results in the rapid aggregation of Aβ. The process is very fast because non-specific 
hydrophobic interactions are formed rapidly while hydrogen bonding depends upon 
distance and angle parameters, so these are formed slowly.  that the peptides don’t get 
a chance to re-organize themselves into an ordered structure 
The protein aggregation process is largely a mystery in the sense that we are still not 
sure if the nuclei are formed from strict monomer-monomer or monomer-dimer addition 
or coalescence of small clusters. It is also not clear whether the process is initiated by 
an ordered nucleus or there is certain rearrangement that occurs in the nuclei leading to 
the formation of ordered aggregates. What is generally believed is that if there are strong 
directional forces, the resultant morphology will reflect those directional forces. For 
example, in a crystal nucleus, there are interactions between the molecules that are 
repeated periodically.  The structures having strong one-dimensional interactions will 
give rise to linear structures. Having strong two-dimensional forces will give rise to 
two-dimensional morphology. While aggregates having three-dimensional interaction 
forces, which are similar in magnitude (isotropic forces) will give rise to a three-
dimensional structure. At the earlier stage of the nucleation, for the later one would 
expect a spherical nucleus because this (sphere) minimizes the interfacial free energy. 
The amorphous aggregates are characterized by random, non-specific interactions and 
they tend to form much faster than the regular crystals as seen in this study. As a result, 
at high supersaturation, the peptides do not get the time to re-align themselves into 
unidirectional structures. 
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Figure 4.8. Spherical aggregate formed by 20 peptides. Blue beads show the hydrophobic 
core while red beads are charged. 
 
H-REMD may not be the method of choice for large self-assembling peptide systems: 
H-REMD simulations were performed to enhance conformational sampling compared 
to that of classic and coarse-grain MD and get an equilibrium structure. To our 
knowledge this is the first attempt to use H-REMD for such large systems comprising 
of many copies of peptides in an explicit solvent that tried to compare the results of 
classic MD of similar timescales with H-REMD. Previous studies, for example, have 
successfully used this method to study folding behaviors and self-assembly of peptides 
but the simulations either consist of a very small system (only containing one or to 
peptides) or a very short duration. For this specific problem of concentration-dependent 
peptide aggregation, we needed a large number of copies of the same peptide that 
needed to be simulated for longer times to get an organization into a fibrillar aggregate. 
But we could not get a good exchange rate that is a pre-requisite for a successful replica 
exchange. Though a very strong overlap between various replicas was found yet the 
exchange probability was extremely low. Several test runs were carried out to adjust the 
scaling factors such as Δλ and time step for exchange but none of them produced desired 
exchange probability. This points to the limitations of such enhanced sampling 
techniques for larger systems. The distribution curves obtained for various test runs are 
presented here in Figure 4.9.  
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Figure 4.9. Histograms of the potential energy distribution of the individual replicas 
differentiated by the colors obtained from Hamiltonian replica exchange MD for a self-
assembling system containing 40 peptides in explicit water at three different exchange 
time-steps (a). 10; (b) 500 and (c) 1000. The curve on the extreme left is for unmodified 
parameters while the right one is for most strongly modified force field parameters. 
4.6 Implications 
Higher supersaturation, more hydrophobicity ultimately leads to higher aggregation 
propensity. Our results suggest that at higher supersaturation, non-specific hydrophobic 
interactions lead to the formation of larger aggregates. In-vivo these aggregates 
(amorphous) due to insolubility do not convert into dense core fibrils associated with 
sporadic AD which implies that these aggregates might not be toxic.  To put the results 
in perspective, it’s important to show the limitations of the methodology we used. α to 
β-sheet conversion is crucial for Aβ assembly. But in CG models, secondary structure 
is constrained, and we cannot see the evolution of secondary structure. The absence of 
directional hydrogen bonding leaves no opportunity for the fibril to re-organize into an 
ordered structure. Also, MARTINI is thought to over-stabilize peptide-peptide 
interaction which may the reason for rapid aggregate formation.  Though our results 
still lack the time scale that is required to completely follow the aggregation process but 
provide a potential in the elucidation of the Aβ assembly process. 
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5.1 Abstract 
Recently, it has been shown that the amyloid burden in the retina correlates to that of 
the brain, and that curcumin (a natural fluorescent dye) can be used to detect the deposits 
non-invasively by retina imaging. We have investigated the molecular basis for 
curcumin’s specificity for hierarchical Aβ structures using molecular dynamics 
simulation, with a focus on how curcumin can detect and discriminate differing amyloid 
morphologies. Curcumin inhibits and breaks up β-sheet formation in Aβ monomers. 
With disordered Aβ structures, curcumin forms a coarse-grained composite structure. 
With an ordered fibril, curcumin’s interaction is highly specific, the curcumin molecules 
depositing in the fibril groove. Curcumin has a tendency to self-aggregate, which is 
finely balanced with its affinity for Aβ amyloid. This tendency concentrates curcumin 
molecules at its deposition sites potentially increasing the fluorescence signal, which is 
probably why curcumin is such an effective amyloid imaging agent. 
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5.2 Introduction 
Given the immense societal impact of Alzheimer’s disease (AD), the identification of 
patients with the early form of AD (prodromal AD) is a health imperative. There is as 
yet no definitive diagnostic test for this pre-symptomatic phase of AD. Diagnosis of 
full-blown AD in the clinic involves assessment and evaluation of symptoms and 
cognitive skills, coupled with biochemical blood tests and brain imaging using magnetic 
resonance imaging (MRI), X-ray based computerized tomography (CT) or positron 
emission tomography (PET) which involves the use of a radiative tracer substance 
(Marcus, Mena, and Subramaniam, 2014). The biochemical tests and imaging are non-
specific and are mostly used to rule out other conditions. Progress towards diagnosing 
prodromal AD is promising but still confined to research i.e. clinical trials. The current 
framework includes more specific PET scans using tau and beta amyloid (Aβ) binding 
ligands and the use of biomarkers that include Aβ, β-site APP-cleaving enzyme 1 gene 
(BACE 1), soluble Aβ precursor protein (sAPP), and anti-Aβ antibodies found in the 
cerebral spinal fluid and blood plasma (Hampel et al., 2010). Beyond current technical 
challenges, the application of these methods (particularly amyloid-specific PET) to 
screen large populations in a clinical setting would be prohibitive both economically 
and because of safety concerns (exposure to radioactive isotopes).  
Ab accumulation is considered to begin as early as 20 years before the manifestation of 
clinical dementia (Beason-Held et al., 2013).This prodromal phase therefore represents 
the best opportunity-window for therapy. In recognizing the need for early therapeutic 
intervention, one confronts another equally significant hurdle: the need to identify at-
risk patients at the earliest stages of AD development, ideally non-invasively. A recent, 
exciting finding is the detection of Ab deposits and p-tau in the retina, both in animal 
models and humans afflicted by AD (Colligris et al., 2018). This has a sound basis, 
given that the retina shares many physiological and anatomical features with the brain 
and is considered to be a projection of the central nervous system (CNS). Moreover, in 
vivo studies show that the plaque burden in the retina correlates to that of the brain 
(Koronyo-Hamaoui et al., 2011) and can be detected earlier than the detection of 
amyloid deposits in the brain (Zhang-Nunes et al., 2006). The retina therefore offers a 
potentially non-invasive and accessible route to identifying at-risk patients with 
prodromal AD. Indeed, the concept has been demonstrated in live patients using the 
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pigment curcumin as the amyloid-specific fluorescence probe coupled with a modified 
scanning laser ophthalmoscope (Goozee et al., 2016). 
Curcumin, a bright yellow pigment is a constituent of the Indian spice turmeric. The 
structure of Curcumin is flexible with two aromatic rings at the ends with a long linker 
region joining both the rings (see Figure 5.1). Structural analysis shows that Curcumin 
exits in solution in two tautomeric forms; keto and enol (Priyadarsini, 2014). At pH 
below 7, Curcumin exits in keto form while above pH 7, it exits in enolate form. The 
Curcumin tautomers are responsible for the so much talked about hydrophobicity of 
Curcumin (Lee et al., 2013).  Due to its hydrophobicity and flexibility, Curcumin is 
known to bind a huge number of biomolecules. It appears that both of the aromatic rings 
and the rigid linker are critical to curcumin’s specificity for amyloid. Removing one of 
the rings or altering the length/flexibility of the linker results in the loss of its activity 
to inhibit Aβ aggregation (Reinke and Gestwicki, 2007) and by implication a loss in its 
binding affinity for Aβ. Interestingly, other amyloid ligands e.g. congo red and 
chrysamine G (Maiti and Dunbar, 2018) share these features too. 
 
Figure 5.1. Structure of curcumin showing the hydrophobic linker region and the polar 
substituted aromatic rings. 
Small molecules such as thioflavin S and T and congo red are used as amyloid tracers 
for a very long time, but they suffer from some serious drawbacks. Thioflavin is weakly 
hydrophobic; that’s why its binding affinity to amyloid fibrils is low (Wu, Bowers and 
Shea, 2011) (Wu, Bowers and Shea, 2011). While congo red is amyloid non-specific 
(Yakupova et al., 2019) so it also stains other non-amyloid deposits such as elastin 
(Horobin and James, 1970), collagen, elastotic dermis, hyaline deposits (Lendrum, 
Slidders and Fraser, 1972) in colloid milium and lipid proteinosis (Bayer-Garner and 
Smoller, 2002). Curcumin, on the other hand, is not only amyloid specific as it can 
differentiate between AD and non-AD deposits with 80.6% specificity (Frost et al., 
2013) but is also able to discriminate between various Aβ morphologies i-e core, 
neurite, diffuse, and burned-out plaques (Maiti et al., 2016) Whilst its therapeutic 
success in clinical trials remains controversial, curcumin-based near-infrared (NIR) 
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fluorescence imaging probes (CRANAD-2, CRANAD-44, and CRANAD-28) have 
been developed and have a higher binding affinity for Aβ assemblies (with a Ki of 0.07 
nM for F18 labeled curcumin binding for fibrillar Aβ) than the well-known molecular 
imaging probes, such as the Pittsburgh compound B (PiB) employed in fludeoxyglucose 
positron emission tomography (FDG-PET) (Ryu et al., 2006; Xiong et al., 2011). 
Unlike other Aβ-specific dyes, curcumin also has an additional property of being able 
to inhibit amyloid aggregation (Maiti and Dunbar, 2018). It binds to Aβ oligomers and 
fibrils and retards plaque formation (Yang et al., 2005). 
Here we explore the molecular level interaction of curcumin with Aβ and its various 
morphologies employing molecular dynamics simulation (MD), to identify the 
molecular origin of curcumin’s specificity for Aβ. We have investigated the interaction 
of curcumin at multiple levels: (i) its interaction with a single Aβ monomer; (ii) 
interaction with Aβ molecules during their aggregation (self-assembly); and (iii) 
curcumin’s interaction with a preformed fibril. In this way we develop a ground-up 
understanding of curcumin’s interaction. Such an approach also enables us to rationalize 
how curcumin interacts with the various Aβ morphologies and stages that characterize 
the full Aβ pathway from individual Aβ molecules to fully-developed fibrils. 
We employed standard unbiased MD - the interaction of curcumin is strong and specific 
and there appears to be no ergodicity (dependence on starting configuration) issues, 
making the interaction trajectories wholly accessible using unbiased MD. The self-
assembly systems comprised 24 monomers of Aβ42 with a varying number of curcumin 
molecules namely 2, 5,19, 77, and 308 molecules, including a control without curcumin. 
For the interaction of curcumin with the pre-formed fibril, we constructed Aβ fibril 
(based on the PDB structure 2BEG) with two parallel β-sheets, each comprising twenty-
five, antiparallel in-register β-strands. For the interaction of curcumin with the pre-
formed fibril, we investigated two curcumin concentrations, namely 5 and 30 curcumin 
molecules, which were located randomly in the initial configuration. Details of the 
simulations are given in Supplementary Information. 
The simulations reveal that curcumin’s interaction with the Aβ42 monomer is non-
specific, with the curcumin molecule continuously moving around and interacting with 
a multiple number of residues including PHE, LEU, VAL, ALA and ILE. Wherever the 
curcumin molecule locates itself about the Aβ structure, it destroys the β-sheet in its 
vicinity. When it leaves that position, the β-sheet reappears.  Curcumin is found to hover 
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over the whole structure for most of the time which is in accordance with earlier 
literature (Zhao et al., 2012). Illustrative conformations of Aβ42 monomer with 
curcumin are shown in Figure 5.2. At the higher curcumin concentration, Aβ42 : 
curcumin ratio of 1:4, curcumin disrupts Aβ42 such that more than 50% of Aβ42 is in the 
coil conformation with only about 13% β-sheet content, compared to 26% coil and 36% 
β-sheet content in the control (without curcumin). Energetically, curcumin’s interaction 
with Aβ monomer is relatively strong, the estimated binding energy using the MM-
PBSA method being ΔGbinding= -17 ±5 kcal mol-1, which equates to about ≈23 kbT. The 
significance of expressing binding energies in terms of KT is that it is a good order-of-
magnitude estimate for the energy needed for a process to occur at a particular 
temperature. A useful rule of thumb is that if a process needs energy ranging from 15KT 
to 30KT, it would occur at an appreciable rate. Above 30KT, the process would be very 
slow, while below 15KT the processes would be too fast to accomplish any significant 
phenomenon. 
In the self-assembly simulations without curcumin, the Aβ molecules form a disordered 
structure rich in β-sheets. Indeed, such morphology representing the early stage of Aβ 
aggregation has been observed in earlier studies (Wei, Mousseau, and Derreumaux, 
2007). In the presence of curcumin, the emergent structures are coarse composite-like 
and disordered (see Figure 9.8). Although, the Aβ and curcumin are integrated in the 
aggregates, the integration is not homogeneous. Structurally, the aggregates are devoid 
of any β-sheets, in contrast to the structure formed for pure Aβ. A noteworthy feature is 
that curcumin shows a strong affinity for itself (indeed, curcumin has a low solubility) 
which drives it to form large clusters of pure curcumin that are then integrated with Aβ 
but in a coarse-grained manner. Could this concentrated curcumin density in these 
aggregates serve to possibly amplify the fluorescence signal?  
Whilst curcumin’s interaction with an Aβ monomer is non-specific, its interaction with 
the pre-formed fibril is highly specific, as almost all curcumin molecules deposit within 
a particular groove on the fibril. In the system containing 30 curcumin molecules, whilst 
some individual molecules of curcumin were attracted directly to the fibril surface, 
others formed aggregates through their stacking  (one curcumin on top of another), 
which then deposited on the surface of fibril in all the three replicates of the study 
(Figure 5.3) and  figure 9.12 in the supplementary information.  This is due to the 
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hydrophobic nature of curcumin (consistent with its low aqueous solubility), which 
drives its self-assembly in aqueous medium.  
 
Figure 5.2. Snapshots of the interaction of Aβ 42 with curcumin 200 ns into the 
trajectory. (Top) Initial Aβ helical structure obtained from the protein data bank 
(PDB:1IYT). (Bottom, Left) Without curcumin; (Bottom, Middle) Aβ and curcumin in a 
1:1 ratio; (Bottom, Right) Aβ and curcumin in a 1:4  ratio. Curcumin is represented by a 
skeleton line structure in red. The peptide structure is shown in cartoon representation 
where yellow color represents β-strands, red ribbon-like structure represents a-helix, 
and green and white colors show turns and coil regions respectively.   It is evident from 
the figure that curcumin destroys the β-sheet structure in its vicinity, and the higher the 
concentration of curcumin, the lower is the β-sheet content. 
Beyond the primary and dominant preference of the curcumin for the Aβ fibril groove, 
the simulations reveal that a curcumin molecule can enter the hydrophobic core of the 
fibril via the open ends (see Figure 5.3b), and show a minor presence at the hairpin 
region around GLY29. Within the fibril groove, there is considerable scope for the 
alignment of the curcumin molecules, and through population analysis, we are able to 
identify 2 main modes of curcumin binding (see Figure 5.3c): (i) parallel alignment with 
the fibril axis; and (ii) perpendicular to the fibril axis; In the (predominant) parallel-
mode, the curcumin molecules are aligned perpendicular to the β-sheets and intercalate 
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two and in some case three or even four β-sheet strands, preferentially binding to the 
two GLY33 on two different Aβ units. In the perpendicular-mode, the curcumin is 
aligned parallel to the β-sheets and is localized to a low-width surface path that runs 
along the fibril containing hydrophobic residues specifically MET, ILE, and VAL that 
are present very close to the well-known G33XXXG37 motif of  Aβ fibril. We observed 
similar binding preferences at the lower concentration system where only four curcumin 
molecules are present. Out of four curcumin molecules, two binds to the GXXXG motif 
parallel to the β-strands, one of them goes into the core of the fibril while the other is 
present around the hairpin region around GLY29 (see Figure 9.9). Similar binding 
patterns have also been observed for other amyloid dyes— Congo Red33, BTH, and 
ThT (Wu et al., 2008). It is due to the presence of the C-terminal residues 28-42 
representing a hydrophobic domain associated with the cell membrane in APP and 
hydrophobicity of curcumin (Wu et al., 2008). 
 
Figure 5.3. Binding of curcumin to Aβ fibril. (a) The fibril is shown in cartoon 
representation (yellow- β-sheets, green –turns, white-coil), while curcumin is represented 
as a surface in red to give a clear perspective of the highly-specific binding, (b) An 
enlarged image of the fibril end where curcumin is seen to enter into the core of the 
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fibril. (c) A plot of the population of curcumin molecules oriented and located at various 
positions on the Aβ fibril. 
 
The specific interactions were confirmed using the radial distribution function to 
ascertain the probability of finding a curcumin molecule at a certain distance from the 
individual active site residues. As anticipated, sharp peaks for residues GLY, VAL, ILE, 
and MET were found at 1.3 Å, 1.0 Å, 0.7 Å and 0.4 Å respectively (Figure 9.10).  All 
three parts of curcumin i.e. two aromatic rings and the linker region bearing the diketone 
moiety show comparable probabilities suggesting their equal participation in binding to 
the Aβ fibril. Earlier MD simulations and NMR experiments have proposed the 
importance of MET35 (Friedemann et al., 2015) GLY33 (Harmeier et al., 2009) and 
the hydrophobic turn located at C-terminal GLY37–GLY38 (Lin et al., 2008). 
Based on sampling, the interaction (free) energy of individual curcumin molecules for 
the Aβ fibril groove is between -25 ±5 kcal mol-1 to -31±7 kcal mol-1, which is larger 
than the curcumin- Aβ monomer interaction. This equates to about ≈ 34 - 42kbT, 
indicating that the interaction is strong and essentially (spontaneously) irreversible. The 
major contribution comes from the van der Waal’s energy (-22 kcal mol-1) that 
corresponds to the hydrophobic interaction. Free energy decomposition analysis 
indicates that the key residues i.e. those with the strongest interaction (ΔGbinding > 2.0 
kcal mol-1) are GLY, VAL, ILE, and MET (Figure 9.11).  
Considering the full set of simulation results, the interaction of curcumin with Aβ shows 
distinctive features with respect to its interaction with the Aβ monomer, Aβ disordered 
structures, and with an ordered fibrillar structure. Curcumin exhibits a non-specific 
interaction with the Aβ monomer, which is essentially a hydrophobic interaction. Being 
hydrophobic itself, curcumin endeavors to reduce its interface with water being 
attracted to the hydrophobic regions on the Aβ which is in accordance with an MD study 
showing that curcumin in water is always present as an aggregated state (Hazra, Roy 
and Bagchi, 2014). The non-specific interaction implies that curcumin is likely to 
concentrate in any region of the brain where there is a high concentration of peptides or 
proteins with exposed hydrophobic stretches like Aβ. Therefore, in principle, curcumin 
(and curcumin-based imaging probes) should be able to detect the pre-amyloid stage, 
though the sensitivity is likely to be low. 
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The self-assembly simulations yield a disordered Aβ structure, with which curcumin 
interacts to form an integrated composite structure but at a coarse-grained level, 
comprising significant curcumin-only and Aβ-only regions. The cause for the formation 
of curcumin-only regions is the tendency of curcumin to aggregate itself, due to its low 
solubility in aqueous media. The high concentration of curcumin within the curcumin-
only regions may be responsible for the increased fluorescence signal strength, 
rationalizing the ability of curcumin to discriminate between the deposited (disordered) 
amyloid and high concentrations of Aβ in solution. 
The interaction of curcumin with the fibrillar structure is highly specific, with the 
curcumin depositing within the fibril groove. Here again, a particular feature (as a result 
of curcumin’s strong affinity for itself) is that the curcumin does not form a 
monomolecular layer on the surface of the groove, but rather forms a continuous 
curcumin-only deposit over the whole region of the fibril groove. The surface grooves 
created by aligned sidechains in the fibril parallel to the growing axis presents a large 
surface area to the curcumin molecules for binding, thus establishing extra contacts. 
This likely explains the higher binding energy of this curcumin-fibril complex (-25 - -
30 kcal/mol) than the curcumin-monomer complex (-17 kcal/mol). This unique form of 
interaction concentrating the number of curcumin molecules interacting with the fibril, 
in principle may serve to increase the fluorescence signal.   
In summary we have explained the molecular basis for the specificity of curcumin for 
Aβ and its amyloid structures and can rationalize how curcumin can detect and 
discriminate between Aβ in solution and between differing amyloid morphologies. A 
unique feature of the curcumin molecule appears to be its tendency to self-aggregate, 
which is finely balanced with its affinity for Aβ and its amyloid structures. The self-
aggregation tendency concentrates curcumin molecules at its deposition sites serving to 
increase the fluorescence signal, which is probably why curcumin is such an effective 
amyloid imaging agent. Further, the molecular-level insights gained here would be 
invaluable in designing more effective and more discriminating curcumin-based 
imaging agents. To our knowledge our results provide new insight into how to further 
optimize curcumin and its derivatives for personalized treatment of AD. 
5.3 Experimental section 
The experimental details can be found in Appendix B. 
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6.1 Abstract 
Glycosaminoglycans (GAGs) in particular heparan sulfate and heparin are found co-
localized with Aβ amyloid. They have been shown to enhance fibril formation, 
suggesting a possible pathological connection. We have investigated heparin’s 
assembly of the KLVFFA peptide fragment using molecular dynamics simulation, to 
gain a molecular-level mechanistic understanding of how GAGS enhance fibril 
formation. The simulations reveal an exquisite process wherein heparin accelerates 
peptide assembly by first ‘gathering’ the peptide molecules, and then assembling them. 
Heparin does not act as a mere template but is tightly coupled to the peptides, yielding 
a composite protofilament structure. The strong intermolecular interactions suggest 
composite formation to be a general feature of heparin’s interaction with peptides. 
Heparin’s chain flexibility is found to be essential to its fibril promotion activity, and 
the need for optimal heparin chain length and concentration has been rationalized. These 
insights yield design rules (flexibility; chain-length) and protocol guidance (heparin: 
peptide molar ratio) for developing effective heparin-mimetics and other functional 
GAGs 
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6.2 Introduction 
Amyloid deposits are characterized by hierarchically structured fibrils, each comprising 
helices or bundles of protofilaments composed of stacked b-strands of the protein 
(Rambaran and Serpell, 2008). The formation of amyloid is a general phenomenon 
being exhibited by some 30 different human proteins (Stathopulos et al., 2008). Notable 
examples include the peptide amyloid-β (Aβ) linked with Alzheimer’s disease, and the 
islet amyloid polypeptide (IAPP) associated with type II diabetes. Amyloid formation 
is also thought to play a functional role i.e. as a part of an essential physiological 
response, with evidence suggesting that the process can serve to sequestrate (rogue) 
peptides/proteins, store hormones, or modulate mechanical properties of cells (Fowler 
et al., 2007). 
In vivo, amyloid deposits invariably contain additional ‘co-factors’ that include lipids, 
nucleic acids, proteoglycans (PG), glycosaminoglycans (GAGs), serum amyloid P 
component, apolipoprotein E, collagen and metal ions (Stewart and Radford, 2017), 
reflecting the crowded, heterogeneous biological environment. The role of GAGs in 
amyloidosis is now considered to be significant, with much attention focusing on 
heparan sulfate and heparin and how they modulate the mechanistic and kinetic 
pathways.   
Heparin has been shown to enhance fibril formation of many amyloidogenic proteins 
in-vitro including amylin(Jha et al., 2011), synuclein (Cohlberg et al., 2002), 
transthyretin (Bourgault, James P Solomon, et al., 2011), tau protein (Goedert et al., 
1996) and the intrinsically low-amyloidogenic peptide (PLB 1-23) acetylated 
cytoplasmic domain of the phospholamban transmembrane protein (Madine et al., 
2013). Heparan sulfate has been found to accelerate the oligomer formation of native 
human muscle acylphosphatase (mAcp) (Motamedi-Shad et al., 2012). These 
enhancement effects can include a reduction in the lag phase of the nucleation 
step(Vilasi et al., 2011), an increase in the rate and/or extent of elongation of the fibrils, 
and/or increase in fibril yield (Ramachandran and Udgaonkar, 2011), the exact nature 
of the enhancement effect being peptide-specific (Iannuzzi, Irace and Sirangelo, 2015).  
The fibril enhancement role of GAGS offers an additional target for developing 
therapeutic agents for amyloid-based diseases. Inhibition of heparan sulfate 
biosynthesis in animal models can result in the complete loss of fibril formation and 
amyloid deposition (Elimova et al., 2004; Suk et al., 2006). Further, heparin has been 
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shown to convert toxic, soluble peptide oligomers into insoluble stable fibrils that are 
resistant to proteolysis, suggesting a neuroprotective role (Bergamaschini et al., 2002; 
Bourgault, James P. Solomon, et al., 2011). Indeed, GAG mimetics are being tested 
clinically for Alzheimer’s disease, and as potential diagnostic agents for amyloid 
(Gervais et al., 2001; Ma et al., 2007). 
A molecular-level mechanistic understanding of how GAGS enhances fibril formation 
is lacking, though essential for the further development of this field. It has been a 
challenge to develop a coherent mechanistic model given that GAGs can exert their 
action at multiple levels, from inducing β-sheet structure in monomers, facilitating the 
assembly of monomers and/or oligomers,(Suk et al., 2006; Bourgault, James P 
Solomon, et al., 2011) to enhancing extension of the protofilaments resulting in 
different fibril morphologies (McLaurin et al., 1999). For heparan sulfate and heparin, 
it has been speculated that they serve as molecular scaffolds to facilitate fibril formation 
(Motamedi-Shad, Monsellier and Chiti, 2009). However, a recent study of heparin-
facilitated aggregation of the neuropeptide b-endorphin has revealed that heparin does 
not act as a mere scaffold but is an integral component of the resulting fibril 
(Nespovitaya et al., 2017). As to whether this could be a general phenomenon (i.e. not 
just restricted to b-endorphin) requires a better understanding of the nature and strength 
of the interaction of heparin with peptides.  
Heparin is an unbranched, linear polymer of disaccharide units consisting of N-sulfated 
glucosamine (GlcNS) and iduronic acid linked by a (1–4) glycosidic bond (see Figure 
6.1) (Dreyfuss et al., 2009). The anionic, sulfate groups give heparin the highest 
negative charge density of any known biomolecule (Pita, 2015). The sulfates appear to 
be critical to heparin’s fibril enhancement role, as their removal has been found to result 
in the loss of heparin’s ability to promote the aggregation of Aβ40 and Aβ42. (Castillo et 
al., 2001). 
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Figure 6.1. Chemical structure of the disaccharide repeating unit of heparin. The 
saccharide unit on the left is glucosamine (GlcN) whilst that on the right is iduronic acid 
(IdoA) 
Proteins and polyelectrolytes such as heparin form complexes primarily due to 
electrostatic interactions. These complexes vary in stoichiometry and architecture 
depending on several factors such as pH (Xu et al., 2012), the charge on the protein, 
ionic concentration of the solution (Seyrek et al., 2003), the degree of polymerization 
(dp) (Iannuzzi, Irace and Sirangelo, 2015), hydrophobicity (Sofronova et al., 2017), 
stiffness and flexibility of the polyelectrolyte (Cooper et al., 2005). Generally, 
aggregation is enhanced with increasing GAGs chain length, although for some 
proteins, the effect on fibril assembly plateaus when the chain length becomes 
sufficiently long (dp ≫ 18, where dp is the number of saccharide units) (Jha et al., 2011; 
Takase et al., 2016).  Short-length GAGs with dp ≤ 4  are essentially ineffective in 
accelerating fibrillogenesis. In contrast, medium-length GAGs, dp6 - dp12, can 
significantly reduce the lag phase and accelerate the conversion of oligomeric species 
into ordered fibrillar assemblies (Fraser, Darabie, and McLaurin, 2001; Quittot, 
Sebastiao and Bourgault, 2017). With respect to the molar heparin to peptide 
concentration ratio, a study on the prion-related protein fragment PrP, demonstrated that 
relatively low heparin to peptide ratios ranging from 0.2:1 to 0.5:1accelerated fibril 
formation. At even lower molar ratios (0.1:1 and below) the effect is less pronounced. 
Higher molar ratios (5:1, 2:1, and 1:1) of heparin to peptide were found to inhibit 
peptide aggregation (Bazar and Jelinek, 2010). 
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Here we present a first clear perspective of how heparin interacts with KLVFFA peptide 
to enhance fibrillogenesis using unbiased molecular dynamics simulations. The 
simulations reveal that heparin does not act as a mere template but is tightly coupled to 
KLVFFA peptides, yielding a composite protofilament structure. The strong 
intermolecular interactions suggest composite formation to be a general feature of 
heparin’s interaction with peptides. Also, heparin’s flexibility is found to be essential 
to its fibril promotion activity, and we have rationalized the need for optimal chain 
length and heparin: KLVFFA peptide concentration ratio. These insights will underpin 
therapeutic approaches including the design of more effective GAG mimetics for 
chelating and minimizing toxicity of oligomers, and for modulating amyloidosis, both 
its inhibition and promotion. 
6.3 Methodology 
A significant issue with molecular simulation is the limited timescales (at best a few 
microseconds) that are accessible. Indeed, the self-assembly of multiple units of the full 
Aβ into an ordered structure is outside the timescales of unbiased molecular dynamics 
(MD) simulation. Given this, we investigated the heparin-promoted assembly of the 
KLVFFA fragment peptide (lysine-leucine-valine-phenylalanine-phenylalanine-
alanine), which is a stretch of hydrophobic amino acids (residues 16-21) in Aβ, rather 
than the full Aβ. The KLVFFA peptide is the shortest fragment for which experimental 
evidence of amyloid formation is available (Antzutkin, 2004). Solid-state NMR shows 
that this fragment acts as a prototype for aggregation, forming antiparallel strands 
leading to the formation of fibrils (Miravalle et al., 2000; Ma and Nussinov, 2002; 
Baumketner et al., 2006; Liang et al., 2014). 
 Nine distinct sets of simulations were carried out: (i) simulation of a single heparin 
molecule; (ii) the interaction of a single KLVFFA monomer (PDB 2Y2A) (Colletier et 
al., 2011) with a single heparin molecule (flexible and restrained in its extended form); 
(iii) the self-assembly of the KLVFFA peptides alone, which served as a control; (iv) 
the assembly of the KLVFFA peptides in the presence of heparin; (v) assembly of the 
KLVFFA peptides in the presence of a heparin molecule that was restrained in its 
extended conformation to investigate the role of flexibility of heparin; (vi) the effect of 
heparin: peptide concentration on KLVFFA assembly; (vii) the effect of heparin chain 
length (degree of polymerization) on heparin-promoted KLVFFA assembly. (viii) the 
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self-assembly of the KLVFFA dimers (PDB 3OW9) (Colletier et al., 2011) alone; and 
(ix) the assembly of the KLVFFA dimers in the presence of heparin. The full 
complement of simulations carried out is listed in Table 1. 
Given that the heparin molecule is significantly charged, the ionic strength of the 
solvent environment is likely to be critical as it would modulate the Columbic inter-
molecular interactions.  We, therefore, conducted the above simulation studies in a low 
ionic strength environment in which just sufficient Na+ counterions were added to 
balance the net charge of the system, and a physiological ionic strength environment 
that contained additional Na+ and Cl ions to yield a 150 mM NaCl.  
Finally, on noting that pre-formed Aβ KLVFFA dimers aggregated faster than 
monomers (Munter et al., 2007; Portillo et al., 2015), we explored the assembly of pre-
formed KLVFFA peptide dimers alone and in the presence of heparin (simulation 
studies (xiii) and (ix)). The simulations of the KLVFFA monomers showed that there 
are kinetic barriers to the monomer organization once the molecules become locked 
onto heparin. The necessary re-alignment to get anti-parallel β-sheet arrangements 
become the rate-limiting step, delaying the peptide organization process beyond the 
timescales of unbiased MD. In contrast, the pre-formed dimer simulations revealed 
rapid fibrillation of the peptides to yield partially ordered aggregates, revealing the 
generic features of the ordering process.  
The structure of heparin dp24 (PDB 3IRJ) (Khan et al., 2010) was taken from the 
protein data bank. The structures of shorter heparin fragments were based on heparin 
18-mer (PDB 3IRI) (Khan et al., 2010) with the topologies being obtained from the 
PRODRG server and reviewed for accuracy. The charges were assigned from literature, 
which had been calculated using ab-initio calculations at 6-31G** (Verli and 
Guimarães, 2004). Unless otherwise indicated, the heparin molecule comprised 24 
saccharide units (dp=24).  In the self-assembly and heparin-facilitated assembly 
simulations, there were 20 KLVFFA monomers. Each of the assembly simulations were 
run with 3 replicates. The initial set of coordinates for each was randomized, with the 
KLVFFA peptide molecules being placed randomly around the heparin molecule to 
ensure that the process kinetics were not biased by the choice of starting coordinates.  
To investigate whether flexibility and bending of the heparin molecule is essential for 
its assembling role, we simulated the facilitated peptide-assembly with the heparin 
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molecule position-restrained to remain in the extended form using restraints on all of 
the atoms with a force constant of 500 kJ mol-1 nm2. 
Table 6.1. Details of simulation studies carried out. This entire complement of 
simulations was repeated in a low ionic strength (system neutralized with counterions) 
and in a physiological ionic strength aqueous environment (150 mM NaCl). Unless 
otherwise stated the heparin chain length in terms of the degree of polymerization was 
dp = 24. 
Study 
No. 






(i) Heparin alone in water 1 - 
(ii) Heparin’s interaction with single KLVFFA  1 1 
(iii) Self-assembly of KLVFFA (alone) in water - 20 
(iv) KLVFFA assembly in the presence of heparin 1 20 
(v) KLVFFA assembly in the presence of restrained 
heparin in extended conformation 
1 1 
1 20 





(vii) Effect of heparin chain length on KLVFFA dp2 (12) 20 
dp4 (6) 20 
dp6 (4) 20 
dp8 (3) 20 
dp24 (1) 20 
(viii) Self-assembly of pre-dimerized KLVFFA in 
water 
- 10 
 (ix) Assembly of pre-dimerized KLVFFA in the 
presence of heparin 
1 10 
 
Systems investigating the effects of different molar ratios of heparin: peptide on the 
assembly of KLVFFA peptides contained 1:20, 1:100 and 2:20 heparin: peptide 
molecules. For the effect of heparin chain length on heparin’s propensity to promote 
KLVFFA peptide assembly, the heparin fragments investigated included chain lengths 
of 2, 4, 8, 12, and 24 saccharide units (dp2, dp4, dp8, dp12 and dp24). 
All the simulations were carried out at 360K and pressure of 1 bar using Gromacs 5.0.4 
(Van Der Spoel, Lindahl, Hess, Groenhof, Alan E Mark, et al., 2005). The higher 
temperature serves to accelerate potential conformational and configurational 
transitions of the peptide assembly, an approach employed by the others to enhance 
sampling (Cino, Choy and Karttunen, 2012). The systems were equilibrated in the NVT 
ensemble and then in NPT ensemble using a velocity-rescaling thermostat (Bussi, 
Donadio and Parrinello, 2007) and the Berendsen barostat (Berendsen et al., 1984) to 
control the temperature and pressure respectively. In the production run, the Parrinello–
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Rahman barostat was used with coupling time of 2ps and an isothermal compressibility 
of 4.5 × 10−5 bar−1 (M. Parrinello and Rahman, 1981). The timestep used was 2.0 fs. 
PME was used to calculate long-range electrostatics with a  grid spacing of 0.16 nm, 
and a real-space cutoff of 1 nm (Di Pierro, Elber and Leimkuhler, 2015). Both Van der 
Waals and neighbor list cutoffs describing short-range interactions were set to 1.0 nm. 
The simulations were run for up to 200ns of trajectory unless stated otherwise.  Heparin 
and the KLVFFA fragments monomer (PDB 2Y2A) and dimers (PDB 3OW9) with the 
ends uncapped were modeled using the Gromos96 53a6 force field as employed and 
validated by others (Pol-Fachin and Verli, 2008; Pol-Fachin, Fernandes and Verli, 2009; 
Pol-Fachin et al., 2012; Wei et al., 2014). The analyses of the simulation trajectories 
were performed using Gromacs analysis tools and VMD (Humphrey, Dalke, and 
Schulten, 1996). For example we used the gmx clustsize tool to follow the process of 
self-assembly in terms of the number of aggregates/clusters and size of the largest 
aggregate present in solution. The free energy of KLVFFA peptide binding to heparin 
was estimated using the MM-PBSA method (Kumari, Kumar, and Lynn, 2014). 
6.4 Results and discussion 
KLVFFA interacts strongly with heparin and is unable to move up or down the heparin 
molecule 
The simulations reveal that heparin by itself in a low ionic strength environment exists 
in an extended chain form with an average end-to-end distance of around 9.2 nm, with 
a limited propensity to flex or coil. This is expected as the charged sulfate and 
carboxylate moieties are content in the polar aqueous environment and repulsion 
between the charged groups is also likely to encourage the extended form. In the higher 
ionic strength environment, this distance reduces slightly to an average of 8.8 nm. It 
appears that the repulsion between the charged heparin moieties is screened by the 
increased ionic strength enabling the heparin to adopt a less extended chain (Figure 
6.2a).  
We consider now the inclusion of a KLVFFA monomer into both systems (low and 
high ionic strength), whilst also investigating the role of flexibility of the heparin 
molecule. For both the flexible and the restrained extended-form of heparin, the 
KLVFFA peptide quickly attaches to one of the anionic sites on heparin through its 
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lysine residue. For the restrained (extended) heparin at both ionic strengths, the 
KLVFFA monomer, once attached, resides essentially at the same anionic site 
throughout the simulation (see Figure 9.11 b & d). This confirms that heparin does not 
act as a track on which a KLVFFA peptide can readily move up or down. For the case 
of heparin in its fully flexible form, KLVFFA remains localized on the heparin chain at 
high ionic strength but can explore a much larger displacement range at low ionic 
strength (Figure 9.12). This occurs as a result of the flexing of the heparin molecule, 
which enables the KLVFFA molecule to detach from one location to another as another 
strongly interacting site on the heparin molecule comes in close proximity to the 
KLVFFA peptide. Thus, it appears that the conformational flexibility of heparin is 
essential to its facilitation of the assembly of Aβ peptides (see also later discussion). 
The attachment of the single KLFVAA monomer to heparin doesn’t produce any 
significant change in heparin’s conformation: the average end-to-end distance reduces 
from 9.2 nm to 8.8 nm for the low ionic strength system, and from 8.8 nm to 8.3 nm for 
the high ionic strength media (Figure 6.2b).  
MM-PBSA calculations show that the binding of the KLVFFA monomer to heparin is 
strong, the binding free energy being  -122.7±24 kcal/mol in the low ionic strength 
environment and as expected (due to charge screening) lower -92.1±19 kcal/mol in the 
high ionic strength system (see a detailed breakdown in Table 6.2). The major 
contribution to the total binding energy comes from the electrostatic interactions 
between the lysine residues of the KLVFFA and negative groups on the heparin (see 
Figure 9.13). 
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Figure 6.2. End to end distance analysis of heparin chain at two ionic strengths in an 
aqueous environment. (a) Heparin chain alone. (b) Heparin in the presence of a single 
KLVFFA peptide. 
 
Table 6.2. A breakdown of the free energy of binding ΔG of KLVFFA peptide with 
heparin in low and high ionic strength (150mM NaCl) aqueous environments calculated 
by the MM-PBSA method 
Energy component ΔG / kcal mol-1 
0 mM NaCl 
ΔG / kcal mol-1 
150 mM NaCl 
van der Waals energy -15.5 -23.0 
Electrostatic energy -254.2 -204.2 
Polar solvation energy  149.42 138.5 
SASA1 energy -2.5 -3.5 
 
Total binding energy  -122.7 ±24 -92.2±19 
1 SASA (solvent accessible surface area) used to calculate Gnonopolar energies in mm-pbsa method 
KLVFFA peptides aggregate to form ordered oligomers but not a fibrillar structure in 
200 ns of MD simulation 
The self-assembly of KLVFFA peptide monomers without heparin in both low and high 
ionic strength aqueous media results in the formation of 2-3 ordered aggregates but not 
a contiguous fibrillary structure (Figure 6.3). Oligomeric structures form relatively 
rapidly over a period of about 45ns, and then aggregate further to yield 2-3 larger 
structures. On formation, the oligomers begin to order internally to form antiparallel β-
sheets. The rapid aggregation of the KLVFFA peptides is driven by strong attraction 
resulting from the hydrophobic effect. The aggregation is slightly faster (see Figure 
6.3b) and the aggregate size is bigger (see Figure 6.3c) in the higher ionic strength 
system, which would be expected (and has been observed by others) (Hoyer et al., 2002; 
Yun et al., 2007) given that the chemical potential of the hydrophobic KLVFFA would 
be enhanced in a stronger ionic environment. 
Aggregation of KLVFFA peptides on heparin takes place in two steps: selection and 
assembly 
Considering heparin-facilitated assembly of KLVFFA peptides, in all six simulations 
(3 at low ionic strength and 3 at high ionic strength, each beginning from a different 
starting configuration), we note that there are two distinct stages: a rapid selection and 
localization of the peptides onto the heparin framework, followed by a cooperative 
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process of heparin-induced assembly of the KLVFFA peptides. The peptide localization 
onto heparin appears to compete with peptide-peptide interactions with a few of the 
peptides self-aggregating (mostly as dimers) in isolation, comprising anti-parallel b-
sheets. In due course, these aggregates also become attached to the heparin. The isolated 
peptide-peptide aggregates occur mostly in the high-ionic strength simulations, 
presumably because the high ionic strength screens the charge-chargee interaction 
between the KLVFFA peptides and heparin whilst also increasing the chemical 
potential of the hydrophobic KLVFFA peptides, thus favoring peptide-peptide 
interaction. 
 
Figure 6.3. (a) Snapshot of the self-assembly of KLVFFA peptides (monomers) at 200 ns 
simulation time in 150 mM NaCl in water. (b) Number of peptide aggregates formed 
during the self-assembly of KLVFFA peptides as a function of time for both the 0 mM 
and 150 mM ionic strength systems. (c) Maximum aggregate size for the self-assembly of 
KLVFFA peptides as a function of time for both the 0 mM and 150 mM ionic strength 
systems. (Cluster criteria: cut-off of 0.35 nm). 
The heparin-induced assembly process (second stage) involves bending and unbending 
of heparin, carrying along with it the adsorbed KLVFFA peptide units that re-align and 
attach to other peptide units, all the while enhancing the development of a more coherent 
protofilament. The emerging protofilament remains integrated with heparin throughout 
the process. 
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The heparin-facilitated assembly in general is faster relative to the self-assembly of 
KLVFAA peptides but shows variability that depends on the starting coordinates and is 
further modulated by the ionic strength of the media. 
At the lower ionic strength, the peptides aggregate onto the heparin to form two 
intertwined helices of the stacked β-sheets and the heparin (Figure 6.5a, b &c), the final 
structure generally being extended. The aggregation of the peptides in the presence and 
absence of heparin is compared in Figure 4. The number of aggregates inclusive of 
heparin and KLVFFA peptides converges to a single structure within the time period 
25-45ns in all three simulations, reflecting the rapid localization of the KLVFFA 
molecules onto the heparin. The peptides Only clustering (reflecting the development 
of a more contiguous peptide structure, albeit whilst integrated with the heparin) is a 
little slower and is characterized by numerous fluctuations that result from the flexing 
of the heparin molecule and the attachment/detachment of the peptides in a bid to form 
a more contiguous structure. 
 
Figure 6.4. Evolution of the number of aggregates inclusive of heparin and peptides and 
peptides-only. The plot of peptides and heparin aggregates (black) reflects the initial, 
rapid association of the peptides with the heparin (within about 45 ns), whilst the 
peptides-only aggregates plot (red) reflects the relatively slower, facilitated assembly of 
the peptides. Note the numerous, repetitive peptide-peptide cluster making and breaking 
events as the heparin flexes to align and order the emergent protofilament. 
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At the higher ionic strength, the resulting peptide-heparin composite shows a greater 
variation in morphology (see Figure 6.6) ranging from annular to linear structures. In 
one instance, the heparin molecule with attached KLVFFA peptides folds itself into a 
ring-like structure. Additionally, in these systems, we also observe the formation of 
Isolated KLVFFA peptide only aggregates, some of which eventually attach to the 
heparin molecule. As noted earlier, the greater charge screening of the higher ionic 
strength enables heparin to sample more retracted conformations, and also increases the 
chemical potential of the hydrophobic peptides thus encouraging peptide-peptide 
cluster formation alongside localization of the KLVFFA peptides onto the heparin 
molecule. Here we see both effects playing a role. 
 
Figure 6.5. (a) Snapshots of KLVFFA peptides–heparin structures in 0 mM NaCl at 200 
ns for three separate simulations each started from a different random configuration. (b) 
Snapshot of the complex from the second simulation system (c) Snapshot of the complex 
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from the third simulation but with a “surface” representation to show the formation of a 
contiguous structure. Heparin and peptides are shown in CPK and cartoon (secondary 
structure) representation respectively. 
Heparin flexibility appears to be essential for its role in assembling peptides 
To investigate whether the flexibility and bending of the heparin molecule are essential 
for its assembling role, we simulated the heparin-facilitated KLVFFA peptide assembly 
with the heparin molecule restrained in its fully extended form. The KLVFFA peptides 
quickly localized onto the heparin framework (see Figure 6.7a) but there was no 
subsequent organization or assembly of peptides, only some local ordering of the 
attached oligomers at higher ionic concentration (see Figure 6.7b; peptides only 
aggregates & Figure 6.7e,f). This is in contrast to the assembly process involving a fully 
flexible heparin molecule, which yields a more contiguous peptide protofilament albeit 
integrated with heparin (see Figure 6.7c). 
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Figure 6.6. Snapshots of KLVFFA peptides–heparin structures in 150 mM NaCl at 200 
ns for three separate simulations each started from a different random configuration, 
showing wide variation in the emergent morphology 
These results clearly illustrate that heparin’s flexibility is essential to its role in 
facilitating amyloid formation. The peptide-heparin interaction is strong and limits the 
movement of the peptide once it is adsorbed onto the heparin. The idea of the heparin 
framework providing a strongly interacting but an iso-potential surface along which the 
peptide molecules can freely translocate (enabling it to form a contiguous structure) is 
appealing, but unfortunately is not borne out. 
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Figure 6.7. (a) Total number of aggregates (including KLVFFA peptide aggregates and 
heparin) as a function of time at both ionic concentrations, reflecting rapid localization 
of the peptide molecules onto the heparin. (b) Number of peptides-only aggregates as a 
function of time at both ionic concentrations. The plot shows that peptides assemble into 
a single structure when heparin is fully flexible within 100ns whilst there are still 3-4 
loose aggregates when heparin is restrained in its extended state. (c) Snapshots of the 
heparin-peptides composite for the heparin molecule when fully flexible at 0 mM. (d, e) 
Heparin restrained in its fully extended form at 0 mM and 150 mM NaCl. For these 
restrained heparin systems, the lack of a contiguous peptide structure is apparent. 
 
Instead, the formation of a contiguous protofilament structure comes via peptide 
detachment/attachment that occurs as the heparin molecule flexes, bringing peptide 
molecules located at one site of the heparin molecule into the interaction zone of 
another. 
Given that heparin’s preference, when alone, is to be in its extended form, what induces 
the heparin molecule to flex and bring the attached peptides units together? Whilst the 
origin of this force is difficult to disentangle, the interactions suggest that it is a 
combination of strong, attractive hydrophobic force between the (hydrophobic) peptide 
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units, and electrostatics. Unlike valence bonds, electrostatic interactions do not become 
saturated. Hence, the strong electrostatic interactions responsible for localizing the 
peptide units onto the heparin, are also able to act between an attached peptide and other 
regions of the heparin. It appears that the combined hydrophobic effect and electrostatic 
interactions are sufficient to overcome the repulsion between the anionic sulfate 
moieties on the heparin and any elastic energy penalty associated with its bending. 
 
 
Figure 6.8. The KLVFFA peptide-heparin composite resulting from heparin’s assembly 
of KLVFFA peptides. Both the formed peptide protofilament and the heparin form 
helical structures that are intertwined. The heparin helix is characterized by a pitch 
consisting of four disaccharides with a translation of 2.0-2.1nm along the axis. (a) 
Heparin is represented as VDW beads (sulfur in yellow; oxygen in red; carbon in 
turquoise), whilst the Aβ peptide protofilament is represented in surface form. (b) 
represents peptides’ secondary structure intertwined against heparin shown in CPK 
representation. 
Heparin-peptide interaction is not transitory; heparin forms an integral part of the 
resulting protofibrils 
It is well established that GAGs, and in particular heparan sulfate, are found co-
localized with Aβ amyloid (Zhang et al., 2014). This begs the question of whether the 
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GAGs are an integral component of the fibrils or merely just co-localize within the 
amyloid mass. Indeed, a recent study provides evidence that heparin forms an integral 
component of the emerging fibrils for the endogenous opiate β-endorphin.  
As noted above, the current simulations also reveal that heparin does not act as a 
mere template but is tightly coupled to the KLVFFA peptides, yielding a 
composite protofilament structure consisting of intertwined helices of the stacked 
β-sheets and the heparin (Figure 6.8). The binding energy between the two helices 
(comprising 20 KLVFFA peptides and 1 heparin molecule) was calculated to be 
around -2000kcal/mol, which equates to > 3500 kbT (thermal energy at T=310 
K). Given this huge value and the intertwining nature of the two helices, there is 
little or no possibility of their (un-aided) dis-entanglement. However, any 
unwinding of the helices is likely to occur stepwise, beginning from one of the 
ends. The interaction energy between a single peptide and heparin ranges from -
90±19 kcal/mol to -120±25 kcal/mol depending upon the ionic strength of the 
solution, whilst the inter-peptide interaction (that between the anti-parallel 
peptide strands) is about -20 kcal/mol. Therefore, the lowest bound for detaching 
the peptide strand, one residue at a time, from the composite would be -90 
kcal/mol and for stripping away altogether an individual peptide molecule from 
the end would be -110 kcal/mol. These values equate to >150 kT, again pointing 
to an extremely low probability for the unwinding/detachment process. 
Furthermore, any stepwise disentanglement would require coordinated molecular 
displacements. 
Given the tendency of the KLVFFA peptides and heparin to form inter-twined 
helices coupled with the strong, electrostatic heparin-peptide interaction, we infer 
that the formation of composite heparin-peptide protofilaments is a general 
phenomenon. 
Lower heparin: peptide concentration ratio is more effective because peptide monomers 
do not get partitioned amongst individual heparin molecules 
We investigated how the aggregation kinetics depend upon the molar concentration 
ratio of heparin to KLVFFA peptide. Simulations containing the low molar ratio of 1 
heparin molecule:100 KLVFFA peptides (monomers) revealed very fast peptide 
aggregation and structuring. At low ionic strength, this results in a single dense fibrillar 
structure that appeared to comprise two protofilaments integrated around the heparin 
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molecule (Figure 6.9a). At high ionic strength, there were two distinct pathways: 
formation of a heparin-peptide structure and ordered filamentous peptide-only 
structures (Figure 6.9d). As stated earlier, the high ionic strength enhances the 
hydrophobic peptide-peptide interactions whilst screening charge-charge interactions, 
thereby facilitating the development of peptide-only protofilaments. 
 
 
Figure 6.9. Assembly of KLVFFA peptides at various heparin: peptide molar ratios at 
0mM (Left-hand side) & 150mM NaCl (Right-hand side). (a,d). 1:100; (b,e). 1:20; (c, f). 
2:20 heparin: peptide molar ratio. The encircled structure in (d) shows the formation of 
a well-ordered fibril at 150mM. 
At a higher molar ratio of 1 heparin:20 KLVFFA peptides, for both ionic strength 
environments, all of the peptides assembled around the heparin giving rise to an 
integrated structure (see Figure 6.9b & e).  At a still higher molar ratio of 2 heparin 
molecules:20 KLVFFA peptides (i.e. 1:10), the peptide units apportioned themselves 
amongst the 2 heparin molecules, from which they did not dissociate and hence were 
unable to form a contiguous structure (Figure 6.9c & f). Each sub-population attached 
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to a particular heparin molecule, being small in number can only yield at best a small 
local oligomeric peptide structure.  
 
 
Figure 6.10. The effect of different heparin chain lengths on heparin-facilitated assembly 
of KLVFF peptides at 0 mM. (a) dp2, (b) dp4, (c) dp6, (d) dp8 and (e) dp24; where dp is 
the number of saccharide units. Longer heparin chain lengths (dp=8 and dp=24) are 
more effective at facilitating peptide assembly. Shorter heparin chain lengths (dp=4 and 
dp=6).are less effective as they form multiple heparin-peptide complexes that then 
aggregate only slowly. The disaccharide (dp=2) complexes show a marginal reversal in 
trend by aggregating together, courtesy of their faster diffusion rate that enhances 
complex-complex interactions. 
These results are consistent with experimental observations and are intuitive (Bazar and 
Jelinek, 2010; Takase et al., 2016; So et al., 2017). At lower heparin: KLVFFA peptide 
ratio i.e. as the relative number of peptides is increased, an individual heparin molecule 
can attract a full complement of peptide units, the number of peptides being 
commensurate with the available sites on the heparin and then heparin facilitates their 
assembly into a protofilament structure. We surmise that at very low heparin: peptide 
ratios, the relatively few heparin molecules will facilitate peptide assembly, but their 
effect will be localized and not impact much on the bulk of the solution. 
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Shorter heparin chain lengths are less effective as they partition the peptides to form 
multiple heparin-peptide complexes that aggregate only slowly 
The simulations reveal that peptide assembly (towards the development of a 
contiguous aggregate structure) is facilitated by the longer heparin chain length 
of dp24 (i.e. 24 saccharide units) at lower ionic strength. Heparin chain lengths 
of dp4, dp6 and dp8 did not yield a contiguous peptide structure that includes all 
of the peptide molecules, as the peptide molecules get apportioned amongst the 
individual heparin units that then do not in general show any significant tendency 
to come together (see Figure 6.10). For dp8, the KLVFFA peptides did yield an 
ordered protofilament that spanned two of the heparin dp8 units. 
In contrast, the shortest chain length studied, the disaccharide heparin dp2, shows two 
distinct behaviors: promotion of peptide assembly for the low ionic strength 
environment, and little or no effect in the high ionic strength environment.  The 
promotion at low ionic strength, whilst unexpected, does not contradict any experiments 
as dp2 fragments have never been studied experimentally in this context. The heparin 
dp2-peptide complexes formed quickly and then aggregated to form 1-2 clusters 
followed by some ordering of the KLVFFA peptides. It appears that being small units, 
further aggregation of these dp2-peptide complexes can be driven by the complex 
peptides courtesy of the hydrophobic effect. In principle, such a potential must also exist 
for the larger heparin units but will be counteracted by their greater inertia due to their 
size. Indeed, estimated diffusion coefficients of the various heparin chain lengths in 
pure water from simulation bear this out: D(dp2) = 4.3±1.8 x 10-5 cm2/s ; D (dp4) = 
4.8±2.0 x 10-5 cm2/s; D (dp6) = 4.0±3.0 x 10-5 cm2/s; D (dp8) = 3.1±1.7 x 10-5 cm2/s; D 
(dp24) = 0.4±0.3 x 10-5 cm2/s. In the high ionic strength environment, the shorter 
heparin chains dp2 was ineffective in accelerating the aggregation. While larger chains 
dp4-dp18 significantly increase the aggregation of peptides giving rise to larger peptide 
aggregates. dp24 doesn’t enhance further aggregation (Figure 9.14). The extent of 
formation of peptide aggregates for the various sized heparin units at both ionic 
strengths is shown in Figure 6.11. 
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Accessing longer time scale ordering: heparin-induced assembly of pre-formed peptide 
dimers 
A limitation of unbiased molecular dynamics is the relatively short time scales (of the 
order of a microsecond) that can be accessed (Lemkul et al., 2012). Experiments show 
that dimers aggregate remarkably faster than the monomers and there may be some 
subtle differences in the microstructure of monomers and dimers that is responsible for 
the marked increase in the aggregation propensity of dimer (Munter et al., 2007; Portillo 
et al., 2015). To observe the development of an ordered heparin- KLVFFA peptide 
composite protofilament in a shorter timescale, we simulated heparin-induced assembly 
of pre-formed KLVFFA peptide dimers in the form of anti-parallel β-sheets. We also 
looked at the interaction of a single dimer with heparin and carried out the control 
simulation of the self-assembly of the pre-formed peptide dimers alone i.e. without 
heparin. 
 
Figure 6.11.  Number of KLVFFA peptide aggregates observed for the various heparin 
chain lengths (dp2-dp24) at the end of each simulation. (a) At low ionic concentration, 
larger chain lengths favor greater KLVFFA peptide aggregation (fewer aggregates), 
though shortest chain length dp2 shows distinct behavior and also promotes peptide 
aggregation. (b) At higher ionic concentration the aggregation increases (fewer 
aggregates) with an increase in chain length up to dp8, whilst dp24 doesn’t enhance 
further aggregation 
Assembly of KLVFFA peptide dimers alone led to the formation of ordered oligomers 
but never a single, ordered protofilament structure over the 200 ns simulation time, just 
like monomers (Figure 6.12a). However, the oligomeric structures form more rapidly 
after about 50 ns into the trajectory (as compared to 145ns for monomeric KLVFFA), 
and then rearrange and order but do not associate any further (Figure 6.12b). 
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In the simulations investigating heparin-facilitated assembly of the preformed KLVFFA 
peptide dimers, the peptides rapidly localize onto the heparin which then displays a 
choreographic-like behavior, flexing and unflexing until the attached peptide dimers are 
assembled into a single stable protofilament, concluding the process just under 200 ns 
(Figure 6.13). This causes kinking in the heparin chain and reduces the end-to-end 
distance up to 4.0nm (see Figure 9.15). 
 
Figure 6.12. (a) Snapshot of the self-assembly of preformed dimers of the peptide 
KLVFFA at 200 ns. (b) Total no. of aggregates (peptides only) as a function of 
simulation time for self-assembly of monomers and pre-formed peptide dimers.  Dimers 
rapidly come together while monomer fragments take time to order and form 
antiparallel β-sheets resulting in slower aggregation. 
 
The protofilament structure is not ‘released’ but remains integrated with the heparin 
molecule. As with monomer peptides, the assembly also takes place in two distinct 
stages (Figure 6.14). However, in the case of dimers, the process is much faster, with 
the selection and localization of the peptides onto the heparin framework taking only 5 
ns (Figure 6.14). 
Mapping molecular insights from heparin’s assembly of KLVFFA to larger peptides 
and proteins 
The current study looked specifically at the effect of heparin on the assembly of the 
peptide KLVFFA at two ionic strengths. Nevertheless, many of the simulations results 
fully rationalize experimental observations with respect to heparin’s interaction with 
other larger and complex peptides/proteins, suggesting that the inferences from the 
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results may be generic. Thus, the simulations not only reproduce heparin’s promotion 
of peptide aggregation and formation of contiguous peptide aggregates (and by 
inference, protofibrils, and fibrils) at both low and high ionic strengths but also 
rationalize the effects of variations in heparin chain length as observed, for example, 
for the 8kDa fragment of gelsolin (65 residues), human muscle acylphosphatase (about 
98 residues) (Motamedi-Shad, Monsellier and Chiti, 2009; Motamedi-Shad et al., 2012) 
and a monomer of transthyretin (127 residues).  
 
Figure 6.13. Heparin-facilitated assembly of preformed dimers of KLVFFA in the 
presence of 1 molecule of heparin. The trajectory reveals two distinct stages, rapid 
association and localization of the peptides onto the heparin which occurs in about 5 ns, 
and the heparin-facilitated assembly of the associated peptides into a protofilament, 
which is concluded well before 200 ns.  
Further, the simulations rationalize the effects of heparin: peptide molar ratio observed 
for the prion-related fragment PrP (Bazar and Jelinek, 2010). Peptide/protein molecular 
size effects and the nature of the amino acid residues will undoubtedly modulate the 
mechanistic picture uncovered here for heparin-KLVFFA peptide. The optimum 
heparin chain length and molar ratio will depend on the commensurability of the stacked 
peptides with the interaction sites on the heparin (Noborn et al., 2011). For large 
peptides, from diffusional inertia considerations, we should not expect the peptides 
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localizing unto the heparin molecule (as observed for KLVFFA here) but rather the 
heparin (being of a relatively smaller size) being attracted to the larger peptide 
molecules. 
An important question raised in the literature concerns the first step of heparin/peptide 
interaction i.e. whether the peptide units localize onto the heparin framework or do they 
aggregate first to form oligomers before adsorbing onto heparin (Motamedi-Shad et al., 
2012). Whilst KLVFFA shows a tendency to adsorb on heparin’s surface first and then 
self-assemble due to hydrophobic interactions, this does depend on the ionic strength of 
the aqueous environment. At 150 mM NaCl ionic strength, self-association of the 
peptides begins to compete with the peptide-heparin association. What happens for a 
particular peptide would depend on how the peptide-peptide interaction, particularly the 
hydrophobicity, fares relative to the peptide-heparin interaction. 
 
Figure 6.14. Total no. of aggregates (inclusive of heparin and peptides) as a function of 
simulation time for the heparin-facilitated assembly of peptide monomers and pre-
formed peptide dimers. Dimers are rapidly attracted to the heparin to form a single 
aggregate (only 5ns) while monomers attachment is slower. 
6.5 Summary and significance 
Whilst there is much experimental data on heparin’s promotion of peptide 
fibrillogenesis, a molecular-level understanding of the process has been lacking. Here 
we have employed molecular dynamics simulation to provide a first clear perspective 
of how heparin promotes the initial stages of fibrillogenesis, addressing many of the 
outstanding questions regarding its activity and mode of action. The simulations 
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corroborate the experimentally observed Aβ fibrillogenesis activity of heparin. Heparin 
achieves this by first rapidly selecting the peptides from the surrounding solution (in 
line with earlier inferences from experiments) (Motamedi-Shad et al., 2012), and then 
by repeated flexing, relocates and assembles the peptide components to yield an ordered 
protofilaments. The heparin-peptide interactions (mostly electrostatic) are strong, and 
there appears to be no scope for individual peptide molecules to move up and down the 
heparin framework as it was a track. This explains the need for the heparin to flex as a 
means of relocating peptides. We were able to demonstrate that flexing is essential for 
heparin’s assembling activity. A further consequence of the strong interaction is that the 
formed protofilament structure is not ‘released’ but remains integrated with the heparin 
molecule. This provides the basis for earlier experimental evidence for heparin being 
an integral component of the formed fibrils for the case of β-endorphin (Nespovitaya et 
al., 2017), and suggests GAGs forming composite fibrils to be a more general 
phenomenon. The simulations rationalize the optimum heparin chain-length and the 
dependency of its aggregation enhancement activity on the heparin: peptide molar 
concentration ratio. Higher heparin: peptide ratio is less effective as the peptide 
molecules (sparsely) partitioned amongst the heparin molecules, reducing the 
probability of assembling a contiguous protofilament.	
An important finding of this study is that pre-dimerized peptides aggregate remarkably 
faster than the monomers as supported by various experimental studies (Walsh et al., 
1997; Munter et al., 2007; Portillo et al., 2015). In our simulations, at the higher peptide 
concentration, the aggregation of dimers in the presence of heparin is some eight times 
faster than that of monomers. The monomer-dimer transition for KLVFFA is 
significant.  These findings and insights underpin significant biological and therapeutic 
implications. In particular, we have identified design rules (flexibility; chain-length) 
and protocol guidance (heparin: peptide molar ratio) for developing effective heparin-
mimetics and other functional GAGs. 
6.6 References 
 
Antzutkin, O. N. (2004) ‘Amyloidosis of Alzheimer’s A beta peptides: solid-state 
nuclear magnetic resonance, electron paramagnetic resonance, transmission electron 
microscopy, scanning transmission electron microscopy and atomic force microscopy 
Chapter 6: Heparin-assisted amyloidogenesis uncovered through molecular dynamics simulations 
Beenish Khurshid - December 2020       139 
studies’, Magnetic Resonance in Chemistry, 42(2), pp. 231–246. 
Baumketner, A. et al. (2006) ‘Amyloid beta-protein monomer structure: a 
computational and experimental study.’, Protein science : a publication of the Protein 
Society, 15(3), pp. 420–8. doi: 10.1110/ps.051762406. 
Bazar, E. and Jelinek, R. (2010) ‘Divergent heparin-induced fibrillation pathways of a 
prion amyloidogenic determinant’, ChemBioChem, 11(14), pp. 1997–2002. doi: 
10.1002/cbic.201000207. 
Berendsen, H. J. C. et al. (1984) ‘Molecular dynamics with coupling to an external 
bath’, The Journal of Chemical Physics. doi: 10.1063/1.448118. 
Bergamaschini, L. et al. (2002) ‘Heparin attenuates cytotoxic and inflammatory activity 
of Alzheimer amyloid-β in vitro’, Neurobiology of Aging, 23(4), pp. 531–536. doi: 
10.1016/S0197-4580(02)00003-9. 
Bourgault, S., Solomon, James P, et al. (2011) ‘Sulfated glycosaminoglycans accelerate 
transthyretin amyloidogenesis by quaternary structural conversion.’, Biochemistry. NIH 
Public Access, 50(6), pp. 1001–15. doi: 10.1021/bi101822y. 
Bourgault, S., Solomon, James P., et al. (2011) ‘Sulfated Glycosaminoglycans 
Accelerate Transthyretin Amyloidogenesis by Quaternary Structural Conversion’, 
Biochemistry. American Chemical Society, 50(6), pp. 1001–1015. doi: 
10.1021/bi101822y. 
Bussi, G., Donadio, D. and Parrinello, M. (2007) ‘Canonical sampling through velocity 
rescaling’, The Journal of Chemical Physics. American Institute of Physics, 126(1), p. 
014101. doi: 10.1063/1.2408420. 
Castillo, G. M. et al. (2001) ‘The Sulfate Moieties of Glycosaminoglycans Are Critical 
for the Enhancement of β-Amyloid Protein Fibril Formation’, Journal of 
Neurochemistry. Blackwell Science Ltd, 72(4), pp. 1681–1687. doi: 10.1046/j.1471-
4159.1999.721681.x. 
Cino, E. A., Choy, W. Y. and Karttunen, M. (2012) ‘Comparison of secondary structure 
formation using 10 different force fields in microsecond molecular dynamics 
simulations’, Journal of Chemical Theory and Computation, 8(8), pp. 2725–2740. doi: 
10.1021/ct300323g. 
Cohlberg, J. A. et al. (2002) ‘Heparin and other glycosaminoglycans stimulate the 
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
140   Beenish Khurshid - December 2020 
formation of amyloid fibrils from ??-synuclein in vitro’, Biochemistry, 41(5), pp. 1502–
1511. doi: 10.1021/bi011711s. 
Colletier, J.-P. et al. (2011) ‘Molecular basis for amyloid-beta polymorphism.’, 
Proceedings of the National Academy of Sciences of the United States of America, 108, 
pp. 16938–43. doi: 10.1073/pnas.1112600108. 
Cooper, C. L. et al. (2005) ‘Polyelectrolyte-protein complexes’, Current Opinion in 
Colloid and Interface Science, pp. 52–78. doi: 10.1016/j.cocis.2005.05.007. 
Dreyfuss, J. L. et al. (2009) ‘Heparan sulfate proteoglycans: structure, protein 
interactions and cell signaling’, Anais da Academia Brasileira de Ciências, 81(3), pp. 
409–429. doi: 10.1590/S0001-37652009000300007. 
Elimova, E. et al. (2004) ‘Amyloidogenesis recapitulated in cell culture: a peptide 
inhibitor provides direct evidence for the role of heparan sulfate and suggests a new 
treatment strategy’, The FASEB Journal, 18(14), pp. 1749–51. doi: 10.1096/fj.03-
1436fje. 
Fowler, D. M. et al. (2007) ‘Functional amyloid - from bacteria to humans’, Trends in 
Biochemical Sciences, 32(5), pp. 217–224. doi: 10.1016/j.tibs.2007.03.003. 
Fraser, P. E., Darabie, A. A. and McLaurin, J. (2001) ‘Amyloid-beta Interactions with 
Chondroitin Sulfate-derived Monosaccharides and Disaccharides. IMPLICATIONS 
FOR DRUG DEVELOPMENT’, Journal of Biological Chemistry, 276(9), pp. 6412–
6419. doi: 10.1074/jbc.M008128200. 
Gervais, F. et al. (2001) ‘Glycosaminoglycan mimetics: a therapeutic approach to 
cerebral amyloid angiopathy.’, Amyloid : the international journal of experimental and 
clinical investigation : the official journal of the International Society of Amyloidosis, 
8 Suppl 1, pp. 28–35. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11676287 
(Accessed: 20 July 2017). 
Goedert, M. et al. (1996) ‘Assembly of microtubule-associated protein tau into 
Alzheimer-like filaments induced by sulphated glycosaminoglycans’, Nature, 
383(6600), pp. 550–553. doi: 10.1038/383550a0. 
Hoyer, W. et al. (2002) ‘Dependence of α-synuclein aggregate morphology on solution 
conditions’, Journal of Molecular Biology, 322(2), pp. 383–393. doi: 10.1016/S0022-
2836(02)00775-1. 
Chapter 6: Heparin-assisted amyloidogenesis uncovered through molecular dynamics simulations 
Beenish Khurshid - December 2020       141 
Humphrey, W., Dalke, A. and Schulten, K. (1996) ‘VMD: visual molecular dynamics.’, 
Journal of molecular graphics, 14(1), pp. 33–8, 27–8. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/8744570 (Accessed: 16 May 2017). 
Iannuzzi, C., Irace, G. and Sirangelo, I. (2015) ‘The Effect of Glycosaminoglycans 
(GAGs) on Amyloid Aggregation and Toxicity’, Molecules. Multidisciplinary Digital 
Publishing Institute, 20(2), pp. 2510–2528. doi: 10.3390/molecules20022510. 
Jha, S. et al. (2011) ‘Mechanism of amylin fibrillization enhancement by heparin’, 
Journal of Biological Chemistry, 286(26), pp. 22894–22904. doi: 
10.1074/jbc.M110.215814. 
Khan, S. et al. (2010) ‘Semi-Rigid Solution Structures of Heparin by Constrained X-
ray Scattering Modelling: New Insight into Heparin-Protein Complexes’, Journal of 
Molecular Biology, 395(3), pp. 504–521. doi: 10.1016/j.jmb.2009.10.064. 
Kumari, R., Kumar, R. and Lynn, A. (2014) ‘G-mmpbsa -A GROMACS tool for high-
throughput MM-PBSA calculations’, Journal of Chemical Information and Modeling, 
54(7), pp. 1951–1962. doi: 10.1021/ci500020m. 
Lemkul, J. A. et al. (2012) ‘Molecular Modeling of the Amyloid β -Peptide : 
Understanding the Mechanism of Alzheimer ’ s Disease and the Potential for 
Therapeutic Intervention Molecular Modeling of the Amyloid β -Peptide : 
Understanding the Mechanism’. 
Liang, C. et al. (2014) ‘Kinetic intermediates in amyloid assembly’, Journal of the 
American Chemical Society, 136(43), pp. 15146–15149. doi: 10.1021/ja508621b. 
Ma, B. and Nussinov, R. (2002) ‘Stabilities and conformations of Alzheimer’s β-
amyloid peptide oligomers (Aβ16-22, Aβ16-35, and Aβ10-35): Sequence effects’, 
Proceedings of the National Academy of Sciences of the United States of America. doi: 
10.1073/pnas.212206899. 
Ma, Q. et al. (2007) ‘Heparin Oligosaccharides as Potential Therapeutic Agents in 
Senile Dementia’, Curr Pharm Des., 13(15), pp. 1607–1616. doi: 
10.1016/j.micinf.2011.07.011.Innate. 
Madine, J. et al. (2013) ‘Heparin Promotes the Rapid Fibrillization of a Peptide with 
Low Intrinsic Amyloidogenicity’, Biochemistry, 52(50), pp. 8984–8992. doi: 
10.1021/bi401231u. 
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
142   Beenish Khurshid - December 2020 
McLaurin, J. et al. (1999) ‘Interactions of Alzheimer amyloid-beta peptides with 
glycosaminoglycans effects on fibril nucleation and growth.’, European journal of 
biochemistry, 266(3), pp. 1101–10. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/10583407 (Accessed: 7 May 2017). 
Miravalle, L. et al. (2000) ‘Substitutions at codon 22 of Alzheimer’s Aβ peptide induce 
diverse conformational changes and apoptotic effects human cerebral endothelial cells’, 
Journal of Biological Chemistry, 275(35), pp. 27110–27116. doi: 
10.1074/jbc.M003154200. 
Motamedi-Shad, N. et al. (2012) ‘Rapid oligomer formation of human muscle 
acylphosphatase induced by heparan sulfate.’, Nature structural & molecular biology, 
19(5), pp. 547–54, S1-2. doi: 10.1038/nsmb.2286. 
Motamedi-Shad, N., Monsellier, E. and Chiti, F. (2009) ‘Amyloid formation by the 
model protein muscle acylphosphatase is accelerated by heparin and heparan sulphate 
through a scaffolding-based mechanism’, Journal of Biochemistry, 146(6), pp. 805–
814. doi: 10.1093/jb/mvp128. 
Munter, L. M. et al. (2007) ‘GxxxG motifs within the amyloid precursor protein 
transmembrane sequence are critical for the etiology of Aβ42’, EMBO Journal, 26(6), 
pp. 1702–1712. doi: 10.1038/sj.emboj.7601616. 
Nespovitaya, N. et al. (2017) ‘Heparin acts as a structural component of β-endorphin 
amyloid fibrils rather than a simple aggregation promoter’, Chem. Commun., 53(7), pp. 
1273–1276. doi: 10.1039/C6CC09770G. 
Noborn, F. et al. (2011) ‘Heparan sulfate/heparin promotes transthyretin fibrillization 
through selective binding to a basic motif in the protein.’, Proceedings of the National 
Academy of Sciences of the United States of America, 108(14), pp. 5584–5589. doi: 
10.1073/pnas.1101194108. 
Parrinello, M. and Rahman, A. (1981) ‘Polymorphic transitions in single crystals: A 
new molecular dynamics method’, Journal of Applied Physics. doi: 10.1063/1.328693. 
Di Pierro, M., Elber, R. and Leimkuhler, B. (2015) ‘A Stochastic Algorithm for the 
Isobaric-Isothermal Ensemble with Ewald Summations for All Long Range Forces’, 
Journal of Chemical Theory and Computation. doi: 10.1021/acs.jctc.5b00648. 
Pita, R. (2015) ‘The EU Regulatory Landscape of Non-Biological Complex Drugs’, in, 
Chapter 6: Heparin-assisted amyloidogenesis uncovered through molecular dynamics simulations 
Beenish Khurshid - December 2020       143 
pp. 357–380. doi: 10.1007/978-3-319-16241-6_11. 
Pol-Fachin, L. et al. (2012) ‘GROMOS 53A6 GLYC , an Improved GROMOS Force Field 
for Hexopyranose-Based Carbohydrates’, Journal of Chemical Theory and 
Computation. American Chemical Society, 8(11), pp. 4681–4690. doi: 
10.1021/ct300479h. 
Pol-Fachin, L., Fernandes, C. L. and Verli, H. (2009) ‘GROMOS96 43a1 performance 
on the characterization of glycoprotein conformational ensembles through molecular 
dynamics simulations’, Carbohydrate Research. doi: 10.1016/j.carres.2008.12.025. 
Pol-Fachin, L. and Verli, H. (2008) ‘Depiction of the forces participating in the 2-O-
sulfo-α-l-iduronic acid conformational preference in heparin sequences in aqueous 
solutions’, Carbohydrate Research, 343(9), pp. 1435–1445. doi: 
10.1016/j.carres.2008.04.016. 
Portillo, A. et al. (2015) ‘Role of monomer arrangement in the amyloid self-assembly’, 
Biochimica et Biophysica Acta - Proteins and Proteomics, 1854(3), pp. 218–228. doi: 
10.1016/j.bbapap.2014.12.009. 
Quittot, N., Sebastiao, M. and Bourgault, S. (2017) ‘Modulation of amyloid assembly 
by glycosaminoglycans: from mechanism to biological significance’, Biochemistry and 
Cell Biology, 95(3), pp. 329–337. doi: 10.1139/bcb-2016-0236. 
Ramachandran, G. and Udgaonkar, J. B. (2011) ‘Understanding the kinetic roles of the 
inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau 
protein.’, The Journal of biological chemistry. American Society for Biochemistry and 
Molecular Biology, 286(45), pp. 38948–59. doi: 10.1074/jbc.M111.271874. 
Rambaran, R. N. and Serpell, L. C. (2008) ‘Amyloid fibrils: abnormal protein 
assembly.’, Prion. doi: 10.4161/pri.2.3.7488. 
Seyrek, E. et al. (2003) ‘Ionic strength dependence of protein-polyelectrolyte 
interactions’, Biomacromolecules, 4(2), pp. 273–282. doi: 10.1021/bm025664a. 
So, M. et al. (2017) ‘Heparin-induced amyloid fibrillation of β2-microglobulin 
explained by solubility and a supersaturation-dependent conformational phase 
diagram’, Protein Science, 26(5), pp. 1024–1036. doi: 10.1002/pro.3149. 
Sofronova, A. A. et al. (2017) ‘Protein-polyelectrolyte complexes: Molecular dynamics 
simulations and experimental study’, Polymer, 113, pp. 39–45. doi: 
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
144   Beenish Khurshid - December 2020 
10.1016/j.polymer.2017.02.047. 
Van Der Spoel, D. et al. (2005) ‘GROMACS: fast, flexible, and free.’, Journal of 
computational chemistry, 26(16), pp. 1701–18. doi: 10.1002/jcc.20291. 
Stathopulos, P. B. et al. (2008) ‘Sonication of proteins causes formation of aggregates 
that resemble amyloid’, Protein Science, 13(11), pp. 3017–3027. doi: 
10.1110/ps.04831804. 
Stewart, K. L. and Radford, S. E. (2017) ‘Amyloid plaques beyond Aβ: a survey of the 
diverse modulators of amyloid aggregation’, Biophysical Reviews, 9(4), pp. 405–419. 
doi: 10.1007/s12551-017-0271-9. 
Suk, J. Y. et al. (2006) ‘Heparin accelerates gelsolin amyloidogenesis’, Biochemistry, 
45(7), pp. 2234–2242. doi: 10.1021/bi0519295. 
Takase, H. et al. (2016) ‘Structural requirements of glycosaminoglycans for facilitating 
amyloid fibril formation of human serum amyloid A’, Amyloid, 23(2), pp. 1350–6129. 
doi: 10.3109/13506129.2016.1168292. 
Verli, H. and Guimarães, J. A. (2004) ‘Molecular dynamics simulation of a 
decasaccharide fragment of heparin in aqueous solution’, Carbohydrate Research, 
339(2), pp. 281–290. doi: 10.1016/j.carres.2003.09.026. 
Vilasi, S. et al. (2011) ‘Heparin induces harmless fibril formation in amyloidogenic 
W7FW14F apomyoglobin and amyloid aggregation in wild-type protein In Vitro’, 
PLoS ONE, 6(7). doi: 10.1371/journal.pone.0022076. 
Walsh, D. M. et al. (1997) ‘Amyloid β-protein fibrillogenesis–Detection of a 
protofibrillar intermediate’, Journal of Biological Chemistry, 272(35), pp. 22364–
22372. doi: 10.1074/jbc.272.35.22364. 
Wei, Y. et al. (2014) ‘Design of novel cell penetrating peptides for the delivery of 
trehalose into mammalian cells’, Biochimica et Biophysica Acta - Biomembranes. doi: 
10.1016/j.bbamem.2014.02.011. 
Xu, Y. et al. (2012) ‘Effect of heparin on protein aggregation: Inhibition versus 
promotion’, Biomacromolecules, 13(5), pp. 1642–1651. doi: 10.1021/bm3003539. 
Yun, S. et al. (2007) ‘Role of Electrostatic Interactions in Amyloid β-Protein (Aβ) 
Oligomer Formation: A Discrete Molecular Dynamics Study’, Biophysical Journal, 
Chapter 6: Heparin-assisted amyloidogenesis uncovered through molecular dynamics simulations 
Beenish Khurshid - December 2020       145 
92(11), pp. 4064–4077. doi: 10.1529/biophysj.106.097766. 
Zhang, G. et al. (2014) ‘Towards understanding the roles of heparan sulfate 
proteoglycans in Alzheimer’s disease.’, BioMed research international, 2014, p. 
516028. doi: 10.1155/2014/516028. 
 
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
146   Beenish Khurshid - December 2020 
7 Summary and conclusions 
The cell, the smallest unit of life, together with its organelles function as factories to 
produce energy to sustain life. The cellular environment is very crowded and highly 
complex including many biomolecules such as proteins and nucleic acids. This 
environment is strictly supervised by a network of regulatory mechanisms to maintain 
stable conditions for growth, reproduction, and maintenance. Any small change in the 
cellular environment may affect the structure of proteins, activity of enzymes, protein 
binding to nucleic acids, catalytic reactions, protein assembly, and many more. One 
such failure leads to misfolding of proteins into harmful assemblies that are the cause 
of neurodegenerative diseases such as Alzheimer’s disease (Jahn and Radford, 2005). 
Despite billions of dollars invested in AD drug development, almost all the clinical trials 
have been a failure. An obvious question is why are we failing? Are we exploiting the 
wrong target? Is disease-intervention too late? The lack of a sufficient understanding of 
the process of amyloidogenic peptide assembly, the intermediates involved and the 
internal and external factors affecting this assembly pose is what appears to be limiting 
us. A molecular-level picture of the events taking place during peptide assembly is 
crucial to understanding this problem. Although it is often difficult to link molecular 
studies to in-vivo and in-vitro observations, the advances in modeling and computing 
power have been invaluable in developing insights into fibril formation from the 
molecular level (Ding, LaRocque and Dokholyan, 2005; Gsponer and Vendruscolo, 
2006; Nag et al., 2011; Tofoleanu and Buchete, 2012; Barale et al., 2019; Martin et al., 
2019). 
The principal aims of this thesis were to contribute to understanding how Aβ molecules 
interact to form higher-order assemblies and the mechanism by which the peptide 
aggregates are modulated by certain endogenous and exogenous chemical co-factors. 
Below, we indicate the key contribution, and summarise and contextualize the findings 
and conclusions within the broader aims and the current state of the field. 
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7.1 Effects of force fields on peptides of variable size and 
complexity  
Almost all modeling (other than first principles-based) involves the use of parameters. 
In molecular simulation it is the force field, comprising the potential energy function 
and associated parameters. The accuracy of the force field is critical to linking 
molecular simulations to the real world. Given this, we carried out a systematic 
comparison of the three popular force fields, AmberGS, Gromos53a6, and OPLS-aa, as 
to how well they reproduce various hierarchical structures of Aβ. Force fields have been 
compared previously but only for the single Aβ monomer. Here we have considered the 
structures ranging from 5-mer protofilament to 18-mer ring fibrils which test the force 
fields not just in terms of the monomer interactions but also interactions between 
protofilaments and include long-range higher-order structure features such as twisting 
of the structures. We have put the results in the context of nucleation theory which 
predicts that nanostructures, depending on their interfacial and bulk-free energies, can 
in principle degrade despite an accurate force field and also that structural disorder of 
the molecules at the structure-solvent interface are expected to be disorder to minimize 
the overall free energy. 
The study revealed significant differences between the force fields in terms of the 
conformation, structural stability, and secondary structure propensity. It appears that 
none of these three force fields can be said to be better than the others. Each has its 
strengths and weaknesses, and the choice of forcefield depends on the application. Our 
study indicates that for the Aβ monomer AmberGS is biased towards helical structures. 
Gromos53a6 favors the formation of a pair of anti-parallel β-sheets, so it seems a better 
choice for studying α-helix-β-sheet conversion, which is a crucial step of Aβ 
aggregation.  For large more complex structures such as dodeca-fibrils and ring fibrils, 
OPLS-aa is a slightly more preferable choice because it resulted in a decent agreement 
with experiments. We conclude that the force field bias during MD simulations of 
biomolecules cannot be ignored and hence, there is a need for further reparameterization 
and force field development. 
7.2 Self-assembly pathways and forces driving them  
This study was designed with a viewpoint to understand the nucleation-based 
polymerization of Aβ peptides. Aβ fibrils are highly ordered pseudocrystalline 
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
148   Beenish Khurshid - December 2020 
structures that are the end-product of Aβ aggregation. This whole process of nucleation 
and growth is not straightforward; it generates a heterogenous mixture of Aβ peptides 
ranging from misfolded peptides to small disordered oligomers to large fibrils. The 
process is driven by hydrophobic interactions and hydrogen bonding. And there is an 
intricate interplay between them. If the process is dominated by hydrogen bonding, 
classic nucleation takes place that results in the formation of ordered fibrils. But if it is 
driven predominantly by hydrophobicity, there is a rapid coalesce of peptide into 
disordered aggregates that are believed to be formed without passing through a lag 
phase.  
In our study, we used five different concentrations of Aβ peptides ranging from 20 -100 
peptides in explicit solvent. All the systems aggregated very fast and resulted in 
structures that vary in morphology depending on the concentration. At lower 
concentrations, small spherical aggregates were formed while at very high 
supersaturation, amorphous aggregates were formed. There was a sweet spot for the 
evolution of a single, unidirectional growing fibril like aggregate which lies somewhere 
in the middle range concentration. The structure was highly stable and maintained its 
conformation even at 400K. But at 500K, it collapsed into a spherical structure.  Our 
study clearly shows that at very high supersaturation the self-assembly of Aβ is 
governed by hydrophobicity resulting in amorphous sheet-like structures. 
An implication of this phenomenon in the body may be that at very high supersaturation, 
the formation of dense core fibrils is limited, and only diffused aggregates are formed. 
That may be one of the reasons that diffused plaques are observed in healthy elderly 
people while dense-core plaques are related to AD.  
7.3 Towards non-invasive amyloid detection – interaction of 
curcumin with Aβ species 
An issue often raised with current clinical trials for Alzheimer’s therapy is that in almost 
all studies the patients being treated have pathologies which so severe and advanced 
that it is simply impossible to regress. Having acknowledged that it is then essential we 
can identify patients at the earliest stages of the disease. It is now thought that 
Alzheimer’s onset can occur some 20 years before symptoms begin to show up, the so-
called prodormal stage. So how does one identify at-risk patients? In 2017,  a proof of 
concept trial successfully used a curcumin based probe for amyloid imaging in retina of 
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live patients (Koronyo et al., 2017). Further, curcumin can discriminate between various 
Aβ assemblies such as diffuse, neuritic, burnt out and core plaques (Koronyo-Hamaoui 
et al., 2011; Maiti and Dunbar, 2016; Koronyo et al., 2017)(Maiti and Dunbar, 
2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 
2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 
2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 
2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 
2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 
2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 
2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 2018)(Maiti and Dunbar, 2018). 
These results are amazing, a non-invasive method, and the possibility of discriminating 
the various polymorphic forms of Aβ some of which may be more amenable to therapy 
than others. What is lacking is the molecular basis for curcumin’s specificity for 
amyloid and its ability to discriminate between different Aβ structures, which we have 
addressed via molecular simulation. 
The MD simulations reveal the remarkable specificity of curcumin for mature fibrils 
and a more nuanced interaction with Aβ molecules in solution and amorphous-like 
structures. The interaction of curcumin with the monomer is non-specific (B-E = -17 
kcal/mol) while that with the fibril is highly specific (B-E= -25 - -30 kcal/mol). The 
curcumin molecules bind to a specific region “grooves” containing the GXXXG 
hydrophobic patch on the mature fibril. With disordered Aβ structures, curcumin forms 
a coarse-grained composite structure with curcumin-only and Aβ-only regions. The 
reason for curcumin-only regions is due to hydrophobic interactions and it may be the 
reason for increased fluorescence signal strength as observed in many experiments 
(Koronyo et al., 2017).  This rationalizes the ability of curcumin to discriminate 
between the amyloid aggregates and high concentrations of Aβ in solution which is 
probably why curcumin is such an effective amyloid imaging agent.  
Also, unlike many amyloid imaging agents, curcumin exhibits dual activity. It not only 
binds to various forms of Aβ to act as an amyloid tracer but also inhibits Aβ’s 
conversion from oα-helix/coil to β-sheet rich conformation, thus acting as an 
oligomerization inhibitor. Curcumin destroys β-sheets local to it and slightly 
strengthens the α-helical content of Aβ. The higher helical propensity of the Aβ is 
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associated with reduced fibril formation.  Indeed, this study supports the rationale that 
curcumin has both protective and imaging role in amyloidosis. 
7.4 Endogenous species enhancing amyloid self-assembly 
(selection and assembly process) 
Glycosaminoglycans (GAGs) are found to co-localize with amyloid plaques in the brain 
suggesting that they may enhance amyloid formation (McLaurin et al., 1999; Bourgault, 
James P Solomon, et al., 2011; Noborn et al., 2011; Takase et al., 2016). A key 
endogenous GAG is heparan sulfate. The anticoagulant heparin is similar to heparan 
sulfate and has been used in in-vitro studies as a proxy for heparan sulfate. Whilst there 
is plenty of experimental data on the interaction heparin with Aβ, the molecular 
perspective and understanding has been lacking. The study in Chapter 6 attempted to 
develop a molecular-level picture of how heparin promotes amyloid assembly.  
Our MD simulation study rationalizes the experimentally observed Aβ fibrillogenesis 
enhancement activity of heparin. Without heparin, Aβ peptides could only form small 
oligomers in the timescale of the simulation but in the presence of heparin an 
intertwined composite of peptide-heparin is observed. Heparin interacts with Aβ via 
electrostatic interactions to form a contiguous structure. This structure is not released 
but remains integrated with Aβ with strong binding energy -92.1 kcal/mol to -122.7 
kcal/mol. This process of integration occurs in two steps, selections and assembly. In 
the first step there is a rapid localization of Aβ on heparin while during the second step, 
the continuous flexing and bending of heparin chain assembles the peptides into an 
ordered aggregate. This observation also led us to our second question, i-e if flexibility 
of heparin plays any role in facilitating amyloid assembly. We were able to demonstrate 
that chain flexibility of heparin is essential for its activity and if it is restrained into 
extended conformation, larger ordered aggregates are not formed rather small oligomers 
are observed. The chain length of heparin is also critical to modulate its aggregation 
enhancement activity. Shorter chain lengths (dp4, dp6 and dp8) are less effective as they 
partition the peptides to form multiple heparin-peptide complexes that aggregate only 
slowly while longer dp24 chain facilitate assembly. Similarly, higher heparin: peptide 
ratio is less effective as the peptide molecules (sparsely) partitioned amongst the heparin 
molecules, reducing the probability of assembling a contiguous protofilament. An 
important finding of this study is that rate of fibrilization of pre-dimerized peptides is 
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some eight times faster than that of monomers. The monomer-dimer transition for 
KLVFFA is significant. These findings and insights underpin significant design rules 
for developing effective heparin-mimetics and other functional GAGs. 
7.5 Challenges and limitations of molecular simulation of Aβ 
Molecular dynamics simulations provide a great deal of information about the protein 
folding mechanism, self-assembly, and interaction with different endogenous and 
exogenous species at a molecular level. But a considerable amount of time and 
computational resources are required to produce this kind of information even with 
highly parallelized and efficient MD codes (Teodoro et al., 2009). With the recent 
advances in CPU and GPU hardware, there is some progress towards sufficient data 
collection yet there is still a great need of improvement with respect to MD codes, GPU 
and CPUs, so that one could observe those processes quickly and efficiently that, at the 
moment may require weeks or even months of real-time. 
The present force fields generally have parameters available for major biomolecules 
such as protein, nucleic acids, and lipids but lack those for smaller molecules and 
ligands. Topology generation for biomolecules is easier as the available parameters can 
be applied efficiently but the problem arises where any foreign molecule even the 
common organic functional groups are involved. It is not a trivial task to generate 
topologies that are compatible with the parent force field. There are a few webservers 
available that generate topologies compatible with the Gromos force field but those 
parameters are advised to validate thoroughly (Schüttelkopf and Van Aalten, 2004; 
Malde et al., 2011). Parameterization of these topologies with other force fields requires 
quantum mechanical calculations and charge calculations using empirical fittings to 
reproduce known properties which is very time-consuming.  
There are some problems with the simulations conducted for Aβ peptide and its 
interaction with anti-aggregation agents that have not been properly addressed. For 
example, the choice of structure of Aβ is not unambiguous; the starting structure used 
in MD simulations in aqueous medium is obtained from NMR that was generated in 
non-aqueous solvents. Both the structures are different i-e a collapsed coil structure in 
aqueous solution (Zhang et al., 2000) and an α-helical structure in polar solvent (O 
Crescenzi et al., 2002). Aβ peptides are intrinsically disordered and can acquire has 
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many different conformations in water, so it is not clear if the starting structure that is 
being used in the MD simulations represents the real structure present in-vivo or not. 
Another problem that is often not addressed is the lack of sufficient MD sampling. Most 
of the simulations involve simplified models and shorter durations that are not sufficient 
to observe any relevant phenomenon.  To observe Aβ dynamics fully in aqueous 
solution, a good starting structure, a sufficiently long simulation for exhaustive 
sampling, and a number of replicates for reliability must be employed.  
One of the main reasons for the failure of AD drugs is the choice of target for anti-
aggregation therapy. While exploiting the monomer as the primary causative agent in 
AD might be an attractive rational, but there is a plethora of experimental evidences 
that suggests Aβ oligomers as the main neuro-toxic species involved in AD (Benilova, 
Karran and De Strooper, 2012). Some studies also emphasize the importance of mature 
Aβ fibrils as a potential target because they serve as reservoirs of toxic oligomers 
(Cohen et al., 2013). So for a successful anti-aggregation/anti-amyloid one needs to 
target all the culprits that are thought to be involved in this vicious cycle i-e monomers, 
toxic oligomers, and mature fibrils. A multi-targeted therapy against amyloid 
aggregation including inhibition of aggregation of Aβ monomers; disruption of toxic β-
sheets in amyloid oligomers and the compact structure of Aβ fibrils to prevent their 
surface to act as secondary nucleation sites should be considered.  
Molecular simulations have three major limitations: the accuracy of force fields, limited 
system sizes, and limited accessible timescale. We can model large (biological) systems 
but have to compromise molecular detail, an approach commonly employed to address 
this issue being coarse-grained simulation. Timescale is a big issue, particularly when 
we are dealing with phase transitions such as nucleation and growth, as in this thesis.  
Nucleation, the formation of an embryo of an ordered structure, is a statistically rare 
event process. This makes it challenging to simulate using standard simulation methods. 
In standard simulations we overcome this(badly) by increasing the supersaturation 
markedly to cause the event to occur in simulation timescales. Study this phenomenon 
requires the use of advanced simulation methods such as umbrella sampling (Kästner, 
2011) and metadynamics (Laio and Parrinello, 2002), which have generally been 
limited in their application to smaller molecule systems. These methods need to be 
extended in application to the biomolecules like Aβ.  
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In our coarse-grain simulations using MARTINI, we employed elastic networks to 
preserve the secondary structure of the peptides used because MARTINI does not have 
directional hydrogen bonds. As MARTINI does not have any special interactions to 
model directional hydrogen bonds, the secondary structure cannot change or evolve. 
Indeed, it has to be fixed at the outset. As a result the MARTINI force field cannot be 
used to study Aβ aggregation starting from a monomer which needs to be converted 
into a β-sheet for aggregation. However, to study the late-stage aggregation where β-
sheets are already formed, MARTINI can be used to get insights into the assembly 
process.  In this perspective, it would be good to specifically tune the interactions 
between hydrogen bonding beads. One approach could be to introduce additional beads 
representing hydrogen bond donors and acceptors and increase their interaction 
strengths. Another possibility might be to make patchy particles/beads with opposite 
charges acting as hydrogen bond donors and acceptors based on their underlying 
chemical group. 
 
Figure 7.1. (A) Thioflavin, (B) Congo red, (C) Curcumin. All three molecules are linear 
with aromatic groups separated by a linker region.  
We have shown in one of our studies (Chapter 5) that curcumin can not only provide 
easy and inexpensive means of detecting Aβ in the retina but also acts as an anti-
aggregation agent at different levels of Aβ organization i-e monomers, oligomers, and 
fibrils. Experiments show that curcumin and curcumin-based derivatives are more 
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sensitive for labeling and imaging Aβ plaques in the brain tissues of AD mice than 
classic Aβ binding dyes such as thioflavin and congo-red. Moreover, curcumin 
derivatives can discriminate between various morphologies of Aβ such as core, neuritic, 
diffuse, and burned-out, to a greater degree than other amyloid-binding dyes. In this 
perspective it is worth designing a study based on the comparison of curcumin and other 
classic dyes (thioflavin and congo red) to investigate what makes curcumin more 
sensitive than the others despite having the same chemical features. 
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Appendix A 
Table 9.1 Summary of Ab structures simulated in this study 
Stricture 
(PDB code) 
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Table 9.2 Summary of simulation details 
PDB No. of atoms 
(Chains) 
No. of water 
molecules 
Box size 
x y z (nm) 
No. of 
counterions 
1IYT 637 (1) 3865 5x 5 x5 3 
2BEG 1860(5) 6493 6 x6 x6 5 
2MXU 5724(12) 31218 10x10x10 12 
M3Q_3 5670(18) 69101 13x13x13 54 
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9.1 Aβ monomer 
 
Table 9.3 The details of secondary structure content of Aβ monomer 
Forcefield α-helix (%) β-sheet (%) Coil (%) Bend (%) Turn (%) 
AmberGS 73 0 15 4 4 
Gromos53a6 3 14 35 13 8 
OPLS-aa 22 0 33 21 18 
CD 3 12 59 - 26 
 
 
Figure 9.1. The averaged secondary-structure probability per residue in terms of regular 
secondary structure characteristics i-e α-helices, β-sheets, turns and coils etc. The 
structure in AmberGS shows an elbow-shaped structure containing two α-helices 
separated by a turn region at residue VAL24-ASN27, Gromos53aa6 favors the 
formation of β-sheets while OPLS-aa forms structure that is a mixture of helix and turns 
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Figure 9.2 The five most populated clusters for each simulated force field, the percentage 
of snapshots each cluster represents. (RMSD cut-off 0.25nm) and the end-to-end 
distance of the Aβ42 monomer showing a change in the structure of various 
conformations.  
 
Figure 9.3. Secondary structure of five most populated clusters of Aβ42 monomer 
showing change in the structure of various conformations for each simulated force field, 
calculated from stride* 
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9.2 U-shaped protofibril 
 
Table 9.4. Average interpeptide distances U-shaped protofibril (nm ± Std. Dev.)1 
 
Forcefields PHE19/GLY38 (nm) ALA21/VAL36 (nm) 
AmberGS   
Chain AB 0.63±0.04 0.62±0.09 
Chain BC 0.70±0.03 0.68±0.04 
Chain CD 0.87±0.05 0.80±0.01 
Chain DE 0.82±0.03 0.50±0.15 
 
Forcefields PHE19/GLY38 (nm) ALA21/VAL36 (nm) 
Gromos53a6   
Chain AB 0.98±0.1 0.74±0.06 
Chain BC 1.02±0.04 0.70±0.03 
Chain CD 1.00±0.06 0.69±0.04 
Chain DE 0.98±0.08 0.68±0.05 
 
Forcefields PHE19/GLY38 (nm) ALA21/VAL36 (nm) 
OPLS-aa   
Chain AB 1.22±0.1 1.06±0.12 
Chain BC 1.18±0.11 0.99±0.08 
Chain CD 1.12±0.10 0.98±0.06 




1 The distance between the side chains of PHE19-GLY38 and ALA21-VAL36 was calculated to study 
their hydrophobic interaction. The distances reproduced by AmberGS are very close to NMR strcutres i-
e (≈0.8nm) 
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Table 9.5.Average interpeptide Asp23 – Lys28 NH3+ _ COO– distances (nm ± Std. Dev.) 
Forcefields Chain AB Chain BC Chain CD Chain DE 
AmberGS 0.38± 0.05 0.37±0.02 0.38±0.02 0.31±0.01 
Gromos53a6 0.41±0.1 0.37±0.07 0.40±0.08 0.58±0.2 
OPLS-aa 0.37±0.07 0.35±0.02 0.36±0.01 0.35±0.03 
 
 
Figure 9.4. Cα-Cα distance between ALA21 and VAL36 in the last two chains of U-
shaped protofibril in AmberGS showing large fluctuations in the lower end of the 
protofibril. 
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Figure 9.5. Cα-Cα distance between PHE19 and GLY38 and ALA21 and VAL36 in the 
top and bottom  chains of U-shaped protofibril in OPLS-aa showing fluctuations in the 
beginning of the simulations but later converge to an equilibrium distance. 
 
Figure 9.6. Asp23 – Lys28 (COO - NH3+) forming the salt bridge responsible for 
maintaining the U-shape of the U-shaped protofibril. 
 
9.3 S-shaped fibril 
Table 9.6  Percentage of the secondary structure content S-shaped fibril calculated from 
the DSSP program from 400ns long simulation for AmberGS, Gromos53a6, and OPLS-
aa forcefields. 
Forcefields Coil (%) β-sheet (%) Bend (%) Turn (%) 
AmberGS 25 57 11 3 
Gromos53a6 12 80 4 0 
OPLS-aa 36 42 16 1 
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Table 9.7 Interchain distances between HIS14, LYS17, PHE19 & 20, ASN27, ALA30 and 
























AmberGS 0.48 0.49 0.50 0.51 0.48 0.48 0.51 
Gromos53a
6 
0.49 0.49 0.48 0.53 0.50 0.49 0.49 
OPLS-aa 9.3 0.51 0.50 0.50 0.49 0.62 0.48 
 
Table 9.8. Interchain salt bridges in S-shaped fibril ( Average interpeptide Asp23 – 
Lys28 NH3+ _ COO– distances (nm ± Std. Dev.) 
Forcefields Chain AB Chain BC Chain CD Chain DE Chain EF Chain FG Chain 
GH 




























OPLS-aa 1.01±0.17 0.84±0.10 0.78±0.06 0.78±0.06 0.79±0.07 0.77±0.09 0.75±0.05 0.75±0.06 0.76±0.06 0.78±0.10 3.24±0.41 
 
9.4 Ring fibril 
 
Figure 9.7. The three segments of this 3-fold symmetry fibril originally at 60° to each 
other but undergo a change especially for AmberGS and Gromos53a6 which give rise to 
distorted geometry. Out of three structures, (c) shows the least deviation from the 
original structure that is produced in OPLS-aa 
Chapter 9: Appendices 
Beenish Khurshid - December 2020       195 






AmberGS    
Chain A 1.80±0.37 0.76±0.13 0.85±0.28 
Chain B 1.93±0.52 1.70±0.48 1.25±0.35 
Chain C 1.98±0.27 1.57±0.14 1.43±0.21 
Chain D 3.78±0.59 1.75±0.26 1.54±0.20 
Chain E 2.24±0.24 1.48±0.19 1.42±0.09 
Chain F 3.44±0.65 3.43±0.77 1.57±0.27 
 




Gromos53a6    
Chain A 1.64±0.23 1.56±0.14 1.51±0.18 
Chain B 1.92±0.19 1.95±0.16 2.02±0.19 
Chain C 2.00±0.11 1.98±0.08 1.98±0.16 
Chain D 2.22±0.11 2.12±0.11 2.07±0.18 
Chain E 2.46±0.14 2.35±0.12 2.30±0.12 
Chain F 2.51±0.21 2.55±0.18 2.26±0.20 
 
Forcefields PHE19/GLY38 (nm) ALA21/VAL36 (nm) ASP23/LEU34 
(nm) 
OPLS-aa    
Chain A 1.47±0.16 1.20±0.09 1.25±0.10 
Chain B 1.69±0.14 1.77±0.15 1.85±0.09 
Chain C 2.09±0.08 1.79±0.09 1.95±0.09 
Chain D 2.11±0.11 2.05±0.08 1.92±0.14 
Chain E 2.21±0.12 2.21±0.10 2.05±0.12 
Chain F 2.47±0.23 2.65±0.15 2.24±0.23 
 
 
2 Average intra-sheet distances between PHE19-GLY38, ALA21-VAL36 and ASP23-LEU34 shows that 
in all the three force fields the inter-sheet distances are well-maintained in the upper half of the fibril but 
as we move down the inter-sheet distance increases leading to an opened structure at the end. 
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Appendix B 
9.6 Methodology 
The details of simulations containing various concentrations Aβ42 and curcumin carried 
out during this work: 
The interaction of curcumin with Aβ42 monomer 
Three simulations were carried out: (i) Aβ42 monomer alone in aqueous solution; (ii) an 
Aβ42 monomer and a single curcumin molecule in aqueous solution and (iii) An Aβ42 
monomer and 4 curcumin molecules in aqueous solution. 
Effect of curcumin on self-assembly of Aβ42 monomers 
The simulations investigated the effect of increasing concentration of curcumin on the 
self-assembly of Aβ42 monomers. A total of six simulations were carried out each 
containing 24 monomers of Aβ42, with a varying number of curcumin molecules namely 
2, 5,19, 77, and 308, with one of the simulations being a control without curcumin. 
These molar ratios correspond to 5 mM of Aβ42 monomers, and 0.25, 1, 4, 16, and 64 
mM of curcumin relative to water. Note that the simulated concentrations are in the 
milli-molar range and hence are markedly higher than experimental concentrations that 
are in the micromolar range to enhance the driving force for phase separation so as to 
make the system evolve quicker.   
Interaction of curcumin with Aβ42 fibril 
The fibril comprised a 25-mer unit of Aβ monomers of residues (17-42). Two 
simulations in a set of three were carried out with curcumin concentrations of 5 and 30 
molecules.   
The summary of simulations carried out and the models used are given in the Table 9.10 
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Table 9.10. Summary of Aβ42 models and simulations systems 
















Aβ42 fibril 1:4 100ns 
1:30 
 
9.7 Technical details 
The binding of curcumin with Aβ was explored using explicit-solvent, atomistic 
simulations on the nanosecond time scale. Aβ monomer (PDB id 1IYT), (Orlando 
Crescenzi, Tomaselli, Guerrini, Salvadori, Anna M. D’Ursi, et al., 2002) protofibril 
(PDB id 2BEG) (Lührs et al., 2005a)  and fibril (generated using CreateFibril v 2.5) 
(Smaoui et al., 2013) were chosen to serve as models. The fibril comprised a 25-mer 
unit of Aβ monomers of residues (17-42). The optimized structure and charges of 
curcumin diketone were taken from the work done by Son Tung Ngo et.al in 2012 (Ngo 
and Li, 2012). The simulations were carried out using Gromacs 5.1 package with 
parameters from the Gromos96 53A6 force field (Van Der Spoel, Lindahl, Hess, 
Groenhof, Alan E. Mark, et al., 2005), (Schuler, Daura and Van Gunsteren, 2001) 
coupled with the SPCE water model. Long range electrostatic interactions were 
calculated using Particle-Mesh Ewald (PME) (Darden, York and Pedersen, 1993) .The 
van der Waals interaction cutoff was 1.4nm, as was the cutoff for the real space Ewald 
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interaction.  All of the systems were subjected to energy minimization to remove any 
bad contacts using 5000 steps of the steepest descent algorithm and then equilibrated 
for 500ps using the NVT ensemble followed by NPT with the peptides positions 
restrained. The simulations were carried out at 360K and 0.001 kbar using the Nose-
Hoover thermostat and the Parrinello-Rahman barostat (isotropic mode) (Martyna, 
Klein and Tuckerman, 1992),(M. Parrinello and Rahman, 1981). The higher 
temperature was used to accelerate the system evolution given that standard MD 
simulations can only access limited timescale.  For trajectory analysis we used the 
analysis utilities in the Gromacs package, and VMD (Visual Molecular Dynamics) for 
visualisation (Biarnés et al., 2012). The binding energy of curcumin with the amyloid 
structures was calculated using the MM-PBSA(Kumari, Kumar and Lynn, 2014) 
method implemented in Gromacs 5.1. 
9.8 Results 
 
Figure 9.8. Upper panel: A typical oligomer formed at 0mM curcumin (control); Lower 
panel, 64mM curcumin system. At higher concentration curcumin destroys β-sheets and 
stabilizes off-pathway oligomers; Snapshot from a 100ns long simulation shows 
integrated curcumin-Aβ clusters via non-specific interactions. Aβ are represented by 
secondary structures while curcumin molecules are represented by red lines. (Water not 
shown for simplicity). (a), (b) & (c) represent the three replicate studies. 
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Figure 9.9. Interaction of curcumin with Aβ fibril at lower concentration of curcumin. 
(a) Figure shows the binding of curcumin with Aβ fibril in three different modes. (I &3) 
Curcumin parallel to the beta strands (BE= -30 & -25 kcal mol-1). (2) Curcumin 
interacting with the loop region between the β-strands parallel to fibril axis (BE=26 kcal 
mol-1). (4) Curcumin going into the core of the fibril (BE=-27 kcal mol-1); Curcumin is 
represented as line structure in red (b) Top view of curcumin entering the central cavity. 
(c)  The G33XXXG37 motif showing the main residues involved in binding with 
curcumin. 
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Figure 9.10. Rdf plots generated for curcumin molecules to track the dynamics of 
curcumin– Aβ fibril interaction. R1, R2 and L show the two aromatic and a linker 
region respectively.  At the bottom of the figure , the sequence of Aβ fibril is given  (from 
protein data bank) (Lührs et al., 2005b). The  sharp peaks for residues GLY, VAL, ILE 
and MET show the specificity of curcumin for these residues. 
 
Molecular Basis of Amyloid Disease: In Silico Modelling of Beta-Amyloid (Aβ) Aggregation 
202   Beenish Khurshid - December 2020 
 
Figure 9.11. Per-residue analysis of interaction energies of all the residues of Aβ fibril 
with curcumins calculated by MM-PBSA method. The periodicity of peaks represents 
the specific residues that are involved in the binding of curcumin to Aβ including 
methionine, glycine, valine and isoleucine.  Negative values indicate preferable 
interaction between a residue and curcumin molecule. The highest negative peaks 
representing glycines imply that Curcumin prefers to interact with GLY with both of its 
aromatic rings with a very strong binding. 
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Figure 9.12. Binding of curcumin to Aβ fibril in two replica studies showing highly-specific 
binding of curcumin to Aβ fibril, (b) A plot of the population of curcumin molecules 
oriented and located at various positions on the Aβ fibril in all the three replica studies 
showing that mode III i-e curcumin molecules lying perpendicular to the β-sheets is the 
most dominant mode of binding. 
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Figure 9.12. Comparison of peptide (monomer) position on heparin’s saccharide units at 
various time intervals. (a) Fully flexible heparin (dp24) at low ionic strength. (b). 
Position restrained heparin (dp24) at low ionic strength. (c) Fully flexible heparin (dp24) 
at high ionic strength. (d) Position restrained heparin (dp24) at high ionic strength.  It is 
clear from the plots that the movement of peptides is more restricted for the position-
restrained heparin. 
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Figure 9.13. (a) Minimum distance between various residues of KLVFFA and negatively 
charged sulpho groups of heparin (cut-off = 0.6nm). The results indicate that the lysine 
residues of the KLVFFA peptides are involved in binding. Once the contacts are formed, 
they remain conserved throughout the simulation time(200ns). (b) The major 
contribution to the binding includes electrostatic interactions between cationic sites 
(lysine) on the peptides and anionic sites on heparin.  (c) Peptide klvffa (dimer) binding 
to heparin, the interacting residues (lysines in both the strands) are shown in surface 
presentation. 
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Figure 9.14. The effect of different heparin chain lengths on heparin-facilitated assembly 
of KLVFFA peptides at 150mM. As the chain length increases, aggregation is also 
enhanced. Shorter heparin chain lengths (dp=4 and dp=6).are less effective as they form 
multiple heparin-peptide complexes that aggregate only slowly. (a) dp2, (b) dp4, (c) dp6, 
(d) dp8 and (e) dp24. Heparin and peptides are shown in CPK and cartoon (secondary 
structure) representation respectively 
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Figure 9.15. (a) The extended structure of a heparin molecule in neutral aqueous 
solution. The end-to-end distance of heparin is 11.5nm. (b) Snapshot of the heparin 
molecule in the presence of peptides (pre-dimerized) (not shown) where the end-to-end 
distance reduces to around 4nm. (c) Comparison of end to end distance of heparin in 
water and in the presence of peptides showing that it reduces significantly when heparin 
interacts with the peptides (dimers). 
 
